Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 180
Encontrada(s) 2 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Relationship between the risk of gastric cancer and adherence to the mediterranean diet according to different estimators. MCC—Spain Study

  • Álvarez Álvarez, Laura
  • Vitelli Storelli, Facundo Ezequiel
  • Rubín García, María
  • Aragonés, Nuria
  • Ardanaz, Eva
  • Castaño Vinyals, Gemma
  • Obón Santacana, Mireia
  • Dierssen Sotos, Trinidad
  • Salas Trejo, Dolores
  • Tardón, Adonina
  • Jiménez Moleon, José Juan
  • Alguacil, Juan
  • Chirlaque, María Dolores
  • Perez Gomez, Beatriz
  • Pollán, Marina
  • Kogevinas, Manolis
  • Martín Sánchez, Vicente
[EN]The aim was to assess the effect of adherence to the Mediterranean Diet, measured with five different indexes, on the risk of gastric cancer. Data come from the multicase-control study MCC—Spain, which included 354 gastric cancer cases and 3040 controls with data on diet. We used five indexes to evaluate adherence to the Mediterranean diet and assess the association between each pattern with the risk of gastric cancer, using multivariate logistic regression. The analyses were performed for the whole set of gastric cancer cases, by anatomical location (cardia and noncardia) and by histological type (intestinal and diffuse). According to the used index, a high adherence protects one from gastric cancer (between 48% (aOR = 0.52; CI 95% = 0.28–0.94) and 75% (aOR = 0.25; CI 95% = 0.12–0.52)), fromnon-cardia (between 48%(aOR = 0.52; CI 95% = 0.36–0.75) and 65% (aOR = 0.35; CI 95% = 0.23–0.52)), and from the intestinal type (between 41% (aOR = 0.59; CI 95% = 0.36–0.95) and 72% (aOR = 0.28; CI 95% = 0.16–0.50)), but not from the diffuse type. In conclusion, high adherence to a Mediterranean diet pattern is a protective factor for the risk of gastric cancer, with greater adherence leading to greater protection., SI, The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on 11 October 2007; by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078- Huelva, PS09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI17CIII/00034); by the Fundación Marqués de Valdecilla (API 10/09); by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)); by the Junta de Castilla y León (LE22A10-2); by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); by the Recercaixa (2010ACUP 00310); by the Regional Government of the Basque Country; by the Consejería de Sanidad de la Región de Murcia; by the European Commission grants FOOD-CT-2006-036224-HIWATE; by the Spanish Association Against Cancer (AECC) Scientific Foundation—grant GCTRA18022MORE; by the Catalan Government—Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850; by the Fundación Caja de Ahorros de Asturias; and by the University of Oviedo. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M Obón-Santacana received a post-doctoral fellowship from the Spanish Association Against Cancer (AECC) Scientific Foundation. M Obón-Santacana is part of group 55 of CIBERESP and AGAUR 2017SGR723. M. R-G. is supported by the Ministry of Education of Spain (FPU17/06488).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Identification of a 31-bp Deletion in the RELN Gene Causing Lissencephaly with Cerebellar Hypoplasia in Sheep

  • Suárez Vega, Aroa
  • Gutiérrez Gil, Beatriz
  • Cuchillo Ibáñez, Inmaculada
  • Sáez Valero, Javier
  • Pérez Pérez, Valentín
  • García Gámez, Elsa
  • Benavides Silván, Julio
  • Arranz Santos, Juan José
[EN] Lissencephaly is an inherited developmental disorder in which neuronal migration is impaired. A type of lissencephaly associated with cerebellar hypoplasia (LCH) was diagnosed in a commercial flock of Spanish Churra sheep. The genotyping of 7 affected animals and 33 controls with the OvineSNP50 BeadChip enabled the localization of the causative mutation for ovine LCH to a 4.8-Mb interval on sheep chromosome 4 using genome-wide association and homozygosity mapping. The RELN gene, which is located within this interval, was considered a strong positional and functional candidate because it plays critical roles in neuronal migration and layer formation. By performing a sequencing analysis of this gene's specific mRNA in a control lamb, we obtained the complete CDS of the ovine RELN gene. The cDNA sequence from an LCH-affected lamb revealed a deletion of 31 bp (c.5410-5440del) in predicted exon 36 of RELN, resulting in a premature termination codon. A functional analysis of this mutation revealed decreased levels of RELN mRNA and a lack of reelin protein in the brain cortex and blood of affected lambs. This mutation showed a complete concordance with the Mendelian recessive pattern of inheritance observed for the disease. The identification of the causal mutation of LCH in Churra sheep will facilitate the implementation of gene-assisted selection to detect heterozygous mutants, which will help breeders avoid at-risk matings in their flocks. Moreover, the identification of this naturally occurring RELN mutation provides an opportunity to use Churra sheep as a genetically characterized large animal model for the study of reelin functions in the developing and mature brain, SI, This work was supported by the Spanish Ministry of Science (Project AGL2009-07000) and by the European Commission 3SR Project (Sustainable Solutions for Small Ruminants; http://www.3srbreeding.eu) (to JJA). Fondo de Investigaciones Sanitarias (PS09/00684; PI12/00593), Fundación Ramón Areces, and CIBERNED, Instituto de Salud Carlos III from Spain (to JSV). Aroa Suarez-Vega is funded by an FPU contract from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)

  • García Pérez, Javier
  • Fernández de Larrea Baz, Nerea
  • Lope, Virginia
  • Molina de la Torre, Antonio José
  • O’Callaghan Gordo, Cristina
  • Alonso, María Henar
  • Rodríguez Suárez, Marta María
  • Mirón Pozo, Benito
  • Alguacil, Juan
  • Gómez Acebo, Inés
  • Ascunce, Nieves
  • Vanaclocha Espí, Mercedes
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Simó, Vicente
  • Jiménez Moleon, José Juan
  • Tardón, Adonina
  • Moreno, Víctor
  • Castaño Vinyals, Gemma
  • Martín Sánchez, Vicente
  • Aragonés, Nuria
  • Pérez Gómez, Beatriz
  • Kogevinas, Manolis
  • Pollán, Marina
[EN] Background: Colorectal cancer is the third most frequent tumor in males and the second in females worldwide. In Spain, it is an important and growing health problem, and epidemiologic research focused on potential risk factors, such as environmental exposures, is necessary. Objectives: To analyze the association between colorectal cancer risk and residential proximity to industries, according to pollution discharge route, industrial groups, categories of carcinogens and other toxic substances, and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Methods: MCC-Spain included 557 colorectal cancer cases and 2948 controls in 11 provinces, frequency matched by sex, age, and region of residence. Distances were computed from subjects’ residences to each of the 134 industries located in the study area. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (from 1 km to 3 km) to industrial facilities, adjusting for matching variables and other confounders. Results: Excess risk (OR; 95%CI) of colorectal cancer was detected near industries overall for all distances analyzed, from 1 km (2.03; 1.44–2.87) to 3 km (1.26; 1.00–1.59). In general, industries releasing pollutants to air showed higher excess risks than facilities releasing pollution to water. By industrial sector, excess risk (OR; 95%CI) was found near (≤3 km) production of metals (2.66; 1.77–4.00), surface treatment of metals (1.48; 1.08–2.02), glass and mineral fibers (2.06; 1.39–3.07), organic chemical industry (4.80; 3.20–7.20), inorganic chemical industry (6.74; 4.38–10.36), food/beverage sector (3.34; 2.38–4.68), and surface treatment using organic solvents (6.16; 4.06–9.36). By pollutants, the main excess risks (OR; 95%CI) were found near (≤3 km) industries releasing nonylphenol (9.19; 5.91–14.28), antimony (5.30; 3.45–8.15), naphthalene (3.11; 2.16–4.49), organotin compounds (2.64; 1.76–3.98), manganese (2.53; 1.63–3.93), dichloromethane (2.52; 1.74–3.66), and vanadium (2.49; 1.59–3.91). Conclusions: Our results support the hypothesis that residing in the proximity of industries may be a risk factor for colorectal cancer, SI, The authors thank all those who took part in this study providing questionnaire data. This study was funded by: Scientific Foundation of the Spanish Association Against Cancer (Fundación Científica de la Asociación Española Contra el Cáncer (AECC) – EVP-1178/14); “Acción Transversal del Cáncer”, approved on the Spanish Ministry Council on the 11th October 2007; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Spain's Health Research Fund (Fondo de Investigación Sanitaria - FIS 12/01416); Carlos III Institute of Health (ISCIII) grants, cofunded by ERDF funds–a way to build Europe– (grants PI08/0533, PI08/1359, PI08/1770, PS09/00773- Cantabria, PS09/01286-Leon, PS09/01662-Granada, PS09/01903- Valencia, PS09/02078-Huelva, PI11/00226, PI11/01403, PI11/01810, PI11/01889-FEDER, PI11/02213, PI12/00150, PI12/00265, PI12/ 00488, PI12/00715, PI12/01270, PI14/00613, PI14/01219, PI15/ 00069, PI15/00914, PI15/01032, PI17-00092); the Fundación Marqués de Valdecilla (API 10/09); the Fundación Caja de Ahorros de Asturias; the University of Oviedo; the Junta de Castilla y León (LE22A10-2); the Regional Government of the Basque Country; the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); the Catalan Government DURSI grant 2014SGR647; the European Commission grants FOOD-CT-2006- 036224-HIWATE; the Recercaixa (2010ACUP 00310); Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723; and the Spanish Association Against Cancer (AECC) Scientific Foundation. ISGlobal is a member of the CERCA Program, Generalitat de Catalunya
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Lifetime Swimming Pool Attendance and Cancer Risk: Findings from the Multicase-Control Study in Spain (MCC-Spain)

  • Donat Vargas, Carolina
  • Vallbona Vistós, Miquel
  • Castaño Vinyals, Gemma
  • Moreno González, Víctor
  • Aragonés, Nuria
  • Boldo, Elena
  • Molina de la Torre, Antonio José
  • Gómez Acebo, Inés
  • Guevara, Marcela
  • Jiménez Zabala, Ana
  • Amiano, Pilar
  • Molina Barceló, Ana
  • Fernández Tardón, Guillermo
  • Chirlaque, María Dolores
  • Pollán, Marina
  • Kogevinas, Manolis
  • Villanueva, Cristina M.
[EN] Swimming in pools involves inhalation and skin absorption of potential carcinogenic disinfection byproducts (DBPs) as well as physical activity, which is protective for some cancer sites. We evaluated the association between lifetime pool attendance and the risk of breast, colorectal, and prostate cancer in a multicase-control study that recruited 4,941 hospital-based cancer cases (1,724 breast, 2,111 colorectal, 1,106 prostate) and 4,039 population-based controls in Spain (2008–2013). Lifetime swimming pool attendance in summer (as a surrogate of outdoor pools) and the rest of the year (as a surrogate of indoor pools), socio-demographics, and lifestyle were ascertained in face-to-face interviews. Cancer risk associated with pool attendance markers was estimated using linear mixed-effect models, adjusting for covariates with recruitment area as a random effect. Participants reporting lifetime pool attendance compared to those who did not showed lower odds of breast and colorectal cancer (approximately 5% lower risk). Swimming more than 10 times/month did not increase the protective association. For breast and colorectal cancer, only pool attendance outside the summer months was associated with a lower risk, whereas it was associated with increased prostate cancer risk. Findings suggest that lifetime swimming in pools may reduce breast cancer and colorectal cancer risk despite DBP exposure. These novel findings require replication, SI, The study was partially funded by the \u201CAccion Transversal del Cancer\u201D, approved by the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/01662, PI11/01889, PI11/00226, PI12/01270, PI12/00715, PI14/0613, PI15/00914, PI17CIII/00034), by the Fundacio\u0301n Marque\u0301s de Valdecilla (API 10/09), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850, and by the Fundacio\u0301n Caja de Ahorros de Asturias and by the University of Oviedo. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program
Docta Complutense
Publication Artículo científico (JournalArticle)

Endogenous Hydrogen Sulfide has a Powerful Role in Inhibitory Neurotransmission to the Pig Bladder Neck

  • Leite Fernandes, Vitor Samuel
  • Fernandes Ribeiro, Ana Sofía
  • Martínez, María Pilar
  • Orensanz, Luis M.
  • Barahona Gomáriz, María Victoria
  • Martínez-Sáenz, Ana
  • Recio Visedo, María Paz
  • Benedito Castellote, Sara
  • Bustamante, Salvador
  • Carballido, Joaquín
  • García Sacristán, Albino
  • Prieto Ocejo, Dolores
  • Hernández Rodríguez, Medardo Vicente
Purpose: We investigated the possible involvement of H2S in nitric oxide independent inhibitory neurotransmission to the pig bladder neck. Materials and methods: We used immunohistochemistry to determine the expression of the H2S synthesis enzymes cystathionine γ-lyase and cystathionine β-synthase. We also used electrical field stimulation and myographs for isometric force recordings to study relaxation in response to endogenously released or exogenously applied H2S in urothelium denuded, phenylephrine precontracted bladder neck strips under noradrenergic, noncholinergic, nonnitrergic conditions. Results: Cystathionine γ-lyase and cystathionine β-synthase expression was observed in nerve fibers in the smooth muscle layer. Cystathionine γ-lyase and cystathionine β-synthase immunoreactive fibers were also identified around the small arteries supplying the bladder neck. Electrical field stimulation (2 to 16 Hz) evoked frequency dependent relaxation, which was decreased by DL-propargylglycine and abolished by tetrodotoxin (blockers of cystathionine γ-lyase and neuronal voltage gated Na(+) channels, respectively). The cystathionine β-synthase inhibitor O-(carboxymethyl)hydroxylamine did not change nerve mediated responses. The H2S donor GYY4137 (0.1 nM to 10 μM) induced potent, concentration dependent relaxation, which was not modified by neuronal voltage gated Na(+) channels, or cystathionine γ-lyase or cystathionine β-synthase blockade. Conclusions: Results suggest that endogenous H2S synthesized by cystathionine γ-lyase and released from intramural nerves acts as a powerful signaling molecule in nitric oxide independent inhibitory transmission to the pig bladder neck.
Docta Complutense
Publication Artículo científico (JournalArticle)

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

  • López-Valero, Israel
  • Saiz-Ladera, Cristina
  • Torres, Sofía
  • Hernández-Tiedra, Sonia
  • García-Taboada, Elena
  • Rodríguez-Fornés, Fátima
  • Barba, Marina
  • Dávila, David
  • Salvador-Tormo, Nélida
  • Guzmán Pastor, Manuel
  • Sepúlveda, Juan Manuel
  • Sánchez-Gómez, Pilar
  • Lorente Pérez, María Del Mar
  • Velasco Díez, Guillermo
Glioblastoma multiforme (GBM) is the most frequent and aggressive type of brain tumor due, at least in part, to its poor response to current anticancer treatments. These features could be explained, at least partially, by the presence within the tumor mass of a small population of cells termed Glioma Initiating Cells (GICs) that has been proposed to be responsible for the relapses occurring in this disease. Thus, the development of novel therapeutic approaches (and specifically those targeting the population of GICs) is urgently needed to improve the survival of the patients suffering this devastating disease. Previous observations by our group and others have shown that Δ9-Tetrahydrocannabinol (THC, the main active ingredient of marijuana) and other cannabinoids including cannabidiol (CBD) exert antitumoral actions in several animal models of cancer, including gliomas. We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), the benchmark agent for the treatment of GBM, synergistically reduces the growth of glioma xenografts. In this work we investigated the effect of the combination of TMZ and THC:CBD mixtures containing different ratios of the two cannabinoids in preclinical glioma models, including those derived from GICs. Our findings show that TMZ + THC:CBD combinations containing a higher proportion of CDB (but not TMZ + CBD alone) produce a similar antitumoral effect as the administration of TMZ together with THC and CBD at a 1:1 ratio in xenografts generated with glioma cell lines. In addition, we also found that the administration of TMZ + THC:CBD at a 1:1 ratio reduced the growth of orthotopic xenografts generated with GICs derived from GBM patients and enhanced the survival of the animals bearing these intracranial xenografts. Remarkably, the antitumoral effect observed in GICs-derived xenografts was stronger when TMZ was administered together with cannabinoid combinations containing a higher proportion of CBD. These findings support the notion that the administration of TMZ together with THC:CBD combinations – and specifically those containing a higher proportion of CBD – may be therapeutically explored to target the population of GICs in GBM.
Docta Complutense
Publication Artículo científico (JournalArticle)

Differential redox proteomics allows identification of proteins reversibly oxidized at cysteine residues in endothelial cells in response to acute hypoxia

  • Izquierdo-Álvarez, Alicia
  • Ramos, Elena
  • Villanueva, Joan
  • Hernansanz-Agustín, Pablo
  • Fernández-Rodríguez, Rubén
  • Tello, Daniel
  • Carrascal, Montserrat
  • Martínez Ruiz, Antonio
Adaptation to decreased oxygen availability (hypoxia) is crucial for proper cell function and survival. In metazoans, this is partly achieved through gene transcriptional responses mediated by hypoxia-inducible factors (HIFs). There is abundant evidence that production of reactive oxygen species (ROS) increases during hypoxia, which contributes to the activation of the HIF pathway. In addition to altering the cellular redox balance, leading to oxidative stress, ROS can transduce signals by reversibly modifying the redox state of cysteine residues in certain proteins. Using the “redox fluorescence switch” (RFS), a thiol redox proteomic technique that fluorescently labels reversibly oxidized cysteines, we analyzed endothelial cells subjected to acute hypoxia and subsequent reoxygenation. We observed a general increase in cysteine oxidation during hypoxia, which was reversed by reoxygenation, and two-dimensional electrophoresis revealed the differential oxidation of specific proteins. Using complementary derivatization techniques, we confirmed the modification of individual target proteins and identified specific cysteine residues that were oxidized in hypoxic conditions, thereby overcoming several limitations associated with fluorescence derivatization. These findings provide an important basis for future studies of the role of these modifications in HIF activation and in other acute adaptive responses to hypoxia.
Docta Complutense
Publication Artículo científico (JournalArticle)

Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter

  • Fernandes, Vítor S.
  • Fernandes Ribeiro, Ana Sofía
  • Martínez Sainz, María Del Pilar
  • López-Oliva Muñoz, María Elvira
  • Barahona Gomáriz, María Victoria
  • Orensanz Muñoz, Luis Miguel
  • Martínez Sáenz, Ana
  • Recio Visedo, María Paz
  • Benedito Castellote, Sara
  • Bustamante, Salvador
  • García Sacristán, Albino
  • Prieto Ocejo, Dolores
  • Hernández Rodríguez, Medardo Vicente
According to previous observations nitric oxide (NO), as well as an unknown nature mediator are involved in the inhibitory neurotransmission to the intravesical ureter. This study investigates the hydrogen sulfide (H2S) role in the neurogenic relaxation of the pig intravesical ureter. We have performed western blot and immunohistochemistry to study the expression of the H2S synthesis enzymes cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS), measurement of enzymatic production of H2S and myographic studies for isometric force recording. Immunohistochemical assays showed a high CSE expression in the intravesical ureter muscular layer, as well as a strong CSE-immunoreactivity within nerve fibres distributed along smooth muscle bundles. CBS expression, however, was not consistently observed. On ureteral strips precontracted with thromboxane A2 analogue U46619, electrical field stimulation (EFS) and the H2S donor P-(4-methoxyphenyl)-P-4-morpholinylphosphinodithioic acid (GYY4137) evoked frequency- and concentration-dependent relaxations. CSE inhibition with DL-propargylglycine (PPG) reduced EFS-elicited responses and a combined blockade of both CSE and NO synthase (NOS) with, respectively, PPG and NG-nitro-L-arginine (L-NOARG), greatly reduced such relaxations. Endogenous H2S production rate was reduced by PPG, rescued by addition of GYY4137 and was not changed by L-NOARG. EFS and GYY4137 relaxations were also reduced by capsaicin-sensitive primary afferents (CSPA) desensitization with capsaicin and blockade of ATP-dependent K+ (KATP) channels, transient receptor potential A1 (TRPA1), transient receptor potential vanilloid 1 (TRPV1), vasoactive intestinal peptide/pituitary adenylyl cyclase-activating polypeptide (VIP/PACAP) and calcitonin gene-related peptide (CGRP) receptors with glibenclamide, HC030031, AMG9810, PACAP6-38 and CGRP8-37, respectively. These results suggest that H2S, synthesized by CSE, is involved in the inhibitory neurotransmission to the pig intravesical ureter, through an NO-independent pathway, producing smooth muscle relaxation via KATP channel activation. H2S also promotes the release of inhibitory neuropeptides, as PACAP 38 and/or CGRP from CSPA through TRPA1, TRPV1 and related ion channel activation.
Docta Complutense
Publication Artículo científico (JournalArticle)

Legionnaires' disease

  • Cunha, Burke A
  • Burillo Albizua, Almudena
  • Bouza Santiago, Emilio
Since first identified in early 1977, bacteria of the genus Legionella are recognised as a common cause of community-acquired pneumonia and a rare cause of hospital-acquired pneumonia. Legionella bacteria multisystem manifestations mainly affect susceptible patients as a result of age, underlying debilitating conditions, or immunosuppression. Water is the major natural reservoir for Legionella, and the pathogen is found in many different natural and artificial aquatic environments such as cooling towers or water systems in buildings, including hospitals. The term given to the severe pneumonia and systemic infection caused by Legionella bacteria is Legionnaires' disease. Over time, the prevalence of legionellosis or Legionnaires' disease has risen, which might indicate a greater awareness and reporting of the disease. Advances in microbiology have led to a better understanding of the ecological niches and pathogenesis of the condition. Legionnaires' disease is not always suspected because of its non-specific symptoms, and the diagnostic tests routinely available do not offer the desired sensitivity. However, effective antibiotics are available. Disease notification systems provide the basis for initiating investigations and limiting the scale and recurrence of outbreaks. This report reviews our current understanding of this disease.
Docta Complutense
Publication Artículo científico (JournalArticle)

The axonal repellent Slit2 inhibits pericyte migration: Potential implications in angiogenesis

  • Guijarro-Muñoz, Irene
  • Cuesta Martínez, Ángel
  • Alvarez-Cienfuegos, Ana
  • Geng, Juanguao
  • Alvarez-Vallina, Luís
  • Sanz, Laura
The Slit family of secreted proteins acts through the Roundabout (Robo) receptors to repel axonal migration during central nervous system development. Emerging evidence shows that Slit/Robo interactions also play a role in angiogenesis. The effect of Robo signaling on endothelial cells has been shown to be context-dependent. However, the role of Slit/Robo in pericytes has been largely unexplored. The aim of this study was to determine the effect of Slit2 on primary human pericytes and to address the underlying mechanisms, including the receptors potentially implicated. We demonstrate that both Robo1 and Robo4 are expressed by human pericytes. In the presence of their ligand Slit2, spontaneous and PDGF-induced migration of pericytes was impaired. This antimigratory activity of Slit-2 correlated with the inhibition of actin-based protrusive structures. Interestingly, human pericyte interaction with immobilized Slit2 was inhibited in the presence of anti-Robo1 and anti-Robo4 blocking antibodies, suggesting the implication of both receptors. These results add new insights into the role of Slit proteins during the angiogenic process that relies on the directional migration not only of endothelial cells but also of pericytes.
Docta Complutense
Publication Artículo científico (JournalArticle)

Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle

  • Fernandes Ribeiro, Ana Sofía
  • Leite Fernandes, Vitor Samuel
  • Martínez Sainz, María Del Pilar
  • Martínez-Sáenz, Ana
  • Pazos Rodríguez, María Ruth
  • Orensanz Muñoz, Luis Miguel
  • Recio Visedo, María Paz
  • Bustamante Alarma, Salvador
  • Carballido Rodríguez, Joaquín
  • García Sacristán, Albino
  • Prieto Ocejo, Dolores
  • Hernández Rodríguez, Medardo Vicente
Aims: The current study investigates the role played by bradykinin (BK) receptors in the contractility to the pig bladder neck smooth muscle. Methods: Bladder neck strips were mounted in myographs for isometric force recordings and BK receptors expression was also determined by immunohistochemistry. Results: B2 receptor expression was observed in the muscular layer and urothelium whereas B1 expression was consistent detected in urothelium. A strong B2 immunoreactivity was also observed within nerve fibers among smooth muscle bundles. On urothelium-denuded preparations basal tone, BK induced concentration-dependent contractions which were reduced in urothelium-intact samples, by extracellular Ca(2+) removal and by blockade of B2 receptors and voltage-gated Ca(2+) (VOC) and non-VOC channels, and increased by cyclooxygenase (COX) inhibition. On phenylephrine-precontracted denuded strips, under non-adrenergic non-cholinergic (NANC) conditions, electrical field stimulation-elicited frequency-dependent relaxations which were reduced by B2 receptor blockade. In urothelium-intact samples, the B1 receptor agonist kallidin promoted concentration-dependent relaxations which were reduced by blockade of B1 receptors, COX, COX-1 and large-conductance Ca(2+) -activated K(+) (BKCa ) channels and abolished in urothelium-denuded samples and in K(+) -enriched physiological saline solution-precontracted strips. Conclusions: These results suggest that BK produces contraction of pig bladder neck via smooth muscle B2 receptors coupled to extracellular Ca(2+) entry via VOC and non-VOC channels with a minor role for intracellular Ca(2+) mobilization. Facilitatory neuronal B2 receptors modulating NANC inhibitory neurotransmission and urothelial B1 receptors producing relaxation via the COX-1 pathway and BKCa channel opening are also demonstrated.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Transcranial diffuse optical monitoring of microvascular cerebral hemodynamics after thrombolysis in ischemic stroke

  • Zirak, Peyman|||0000-0002-0331-6292
  • Delgado Mederos, Raquel|||0000-0003-3737-7226
  • Dinia, Lavinia|||0000-0003-3493-4840
  • Carrera, David
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Durduran, Turgut|||0000-0001-5838-1027
The ultimate goal of therapeutic strategies for ischemic stroke is to reestablish the blood flow to the ischemic region of the brain. However, currently, the local cerebral hemodynamics (microvascular) is almost entirely inaccessible for stroke clinicians at the patient bed-side, and the recanalization of the major cerebral arteries (macrovascular) is the only available measure to evaluate the therapy, which does not always reflect the local conditions. Here we report the case of an ischemic stroke patient whose microvascular cerebral blood flow and oxygenation were monitored by a compact hybrid diffuse optical monitor during thrombolytic therapy. This monitor combined diffuse correlation spectroscopy and near-infrared spectroscopy. The reperfusion assessed by hybrid diffuse optics temporally correlated with the recanalization of the middle cerebral artery (assessed by transcranial-Doppler) and was in agreement with the patient outcome. This study suggests that upon further investigation, diffuse optics might have a potential for bed-side acute stroke monitoring and therapy guidance by providing hemodynamics information at the microvascular level.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Cazier, Jean-Baptiste|||0000-0001-7581-9051
  • Tomlinson, Ian P. M.
  • Carvajal-Carmona, Luis G.|||0000-0001-7129-2918
  • Palles, Claire|||0000-0002-9670-2263
  • Lamas, Maria J.|||0000-0001-8875-3290
  • Baiget Bastús, Montserrat
  • Lopez-Fernandez, Luis A.|||0000-0003-3964-5837
  • Brea-Fernández, Alejandro|||0000-0003-1527-471X
  • Abulí, Anna|||0000-0001-9894-0639
  • Bujanda, Luis|||0000-0002-4353-9968
  • Clofent, Juan
  • Gonzalez, Dolors
  • Xicola, Rosa
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Jover, Rodrigo
  • Llor, Xavier|||0000-0002-6259-185X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Castells, Antoni|||0000-0001-8431-2033
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Ruiz-Ponte, Clara|||0000-0002-2200-0162
Background: Colorectal cancer (CRC) is a disease of complex aetiology, with much of the expected inherited risk being due to several common low risk variants. Genome-Wide Association Studies (GWAS) have identified 20 CRC risk variants. Nevertheless, these have only been able to explain part of the missing heritability. Moreover, these signals have only been inspected in populations of Northern European origin.Results: Thus, we followed the same approach in a Spanish cohort of 881 cases and 667 controls. Sixty-four variants at 24 loci were found to be associated with CRC at p-values <10-5. We therefore evaluated the 24 loci in another Spanish replication cohort (1481 cases and 1850 controls). Two of these SNPs, rs12080929 at 1p33 (P=0.042; P=5.523x10; OR (CI95%)=0.866(0.782-0.959)) and rs11987193 at 8p12 (P=0.039; P=6.985x10; OR (CI95%)=0.786(0.705-0.878)) were replicated in the second Phase, although they did not reach genome-wide statistical significance.Conclusions: We have performed the first CRC GWAS in a Southern European population and by these means we were able to identify two new susceptibility variants at 1p33 and 8p12 loci. These two SNPs are located near the SLC5A9 and DUSP4 loci, respectively, which could be good functional candidates for the association signals. We therefore believe that these two markers constitute good candidates for CRC susceptibility loci and should be further evaluated in other larger datasets. Moreover, we highlight that were these two SNPs true susceptibility variants, they would constitute a decrease in the CRC missing heritability fraction. © 2013 Fernández-Rozadilla et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas

  • Kamieniak, Marta M.
  • Muñoz-Repeto, Ivan
  • Rico, Daniel|||0000-0002-6561-2310
  • Osorio, Ana|||0000-0001-8124-3984
  • Urioste, Miguel|||0000-0001-7583-7305
  • García Donas, J.|||0000-0001-7731-3601
  • Hernando, Susana
  • Robles-Díaz, Luis|||0000-0002-8909-8520
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Cazorla-Jiménez, Alicia|||0000-0002-9534-8418
  • Sáez, Raquel
  • García-Bueno, José María|||0000-0003-3892-8894
  • Domingo, Samuel
  • Borrego, Salud|||0000-0002-2513-6161
  • Palacios, José|||0000-0002-6730-5066
  • Van De Wiel, Mark A.
  • Ylstra, Bauke
  • Benitez, Javier|||0000-0002-0923-7202
  • García, M. J.
Background: Few studies have attempted to characterise genomic changes occurring in hereditary epithelial ovarian carcinomas (EOCs) and inconsistent results have been obtained. Given the relevance of DNA copy number alterations in ovarian oncogenesis and growing clinical implications of the BRCA-gene status, we aimed to characterise the genomic profiles of hereditary and sporadic ovarian tumours.Methods:High-resolution array Comparative Genomic Hybridisation profiling of 53 familial (21 BRCA1, 6 BRCA2 and 26 non-BRCA1/2) and 15 sporadic tumours in combination with supervised and unsupervised analysis was used to define common and/or specific copy number features.Results:Unsupervised hierarchical clustering did not stratify tumours according to their familial or sporadic condition or to their BRCA1/2 mutation status. Common recurrent changes, spanning genes potentially fundamental for ovarian carcinogenesis, regardless of BRCA mutations, and several candidate subtype-specific events were defined. Despite similarities, greater contribution of losses was revealed to be a hallmark of BRCA1 and BRCA2 tumours.Conclusion:Somatic alterations occurring in the development of familial EOCs do not differ substantially from the ones occurring in sporadic carcinomas. However, some specific features like extensive genomic loss observed in BRCA1/2 tumours may be of clinical relevance helping to identify BRCA-related patients likely to respond to PARP inhibitors. © 2013 Cancer Research UK. All rights reserved.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

High frequency of CRB1 mutations as cause of Early-Onset Retinal Dystrophies in the Spanish population

  • Corton, Marta|||0000-0003-0087-1626
  • Tatu, Sorina D.
  • Avila-Fernandez, Almudena
  • Vallespín, Elena|||0000-0002-8080-8629
  • Tapias, Ignacio
  • Cantalapiedra, Diego
  • Blanco-Kelly, Fiona|||0000-0003-0052-5651
  • Riveiro-Alvarez, Rosa
  • Bernal, Sara|||0000-0003-4427-0574
  • García-Sandoval, Blanca
  • Baiget Bastús, Montserrat
  • Ayuso, Carmen|||0000-0002-9606-6957
Background: CRB1 mutations are reported as cause of severe congenital and early-onset retinal dystrophies (EORD) with different phenotypic manifestations, including Leber congenital amaurosis (LCA), retinitis pigmentosa (RP) and cone-rod dystrophies. Comprehensive mutational scanning of the whole gene has been only performed in few cohorts, mainly in LCA patients. Here, we aimed investigating the real prevalence of CRB1 mutations in the Spanish population by extensive screening of CRB1 mutations in a large cohort of LCA and EORP cases. Methods. This report integrates data from previous studies on CRB1 defects in our Spanish cohort of LCA and early-onset RP (EORP) with new findings from a comprehensive mutational screening of the whole gene. The molecular tools used include mutation genotyping arrays, whole-genome homozygosity mapping, an optimized high-resolution melting (HRM) analysis and Sanger sequencing. Results: A large clinically well-characterized cohort of 404 Spanish cases was studied, 114 of which suffered from LCA and 290 from EORP. This study reveals that 11% of Spanish patients carried mutations in CRB1, ranging from 9% of EORP to 14% of LCA cases. More than three quarters of the mutations identified herein have been first described in this Spanish cohort, 13 of them are unreported new variants and 13 had been previously reported in our previous studies. Conclusions: This work provides a wide spectrum of CRB1 mutations in the Spanish EORD patients and evidences the major role of CRB1 as causal gene in the Spanish EORP patients. It is noteworthy that a high rate of private mutations only described in our cohort has been found so far. To our knowledge, this study represents the most complete mutational screening of CRB1 in a Spanish LCA and EORP cohort, allowing us to establish gene-specific frequencies and to provide a wide spectrum of CRB1 mutations in the Spanish population. © 2013 Corton et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, Simone
  • Lorenzo Bermejo, Justo|||0000-0002-6568-5333
  • Chang-Claude, Jenny
  • Hoffmeister, Michael
  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Castells, Antoni|||0000-0001-8431-2033
  • Piñol, Virgínia
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Gonzalo, Victoria|||0000-0003-4611-5463
  • Ocaña, Teresa
  • Serradesanferm, Anna
  • Moreira, Leticia
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Piqué, Josep, M.
  • Ángel, L.
  • Javier, A.
  • Javier, O.
  • Cubiella, Joaquín|||0000-0002-9994-4831
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Abulí, Anna|||0000-0001-9894-0639
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Iglesias, Mar|||0000-0002-2274-4671
  • Seoane, Agustín|||0000-0001-8023-4445
  • Bory, Felipe
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Dedeu, Josep Maria|||0000-0003-0522-1032
  • Cristina, A.
  • Puigvehí, Marc|||0000-0002-3694-3241
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, D.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Cuquerella, Jaime
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Vicent, H.
  • Llor, Xavier|||0000-0002-6259-185X
  • Xicola, Rosa M.|||0000-0001-6466-1885
  • Piñol Pascual, Marta
  • Rosinach, Mercè
  • Roca, Anna
  • Pons, Elisenda
  • Hernández, José
  • Gassull Durò, Miquel Àngel|||0000-0001-7751-4833
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, Esther|||0000-0002-2777-0000
  • Montserrat, F.
  • Maria, E.
  • Reñé, Josep Maria
  • Piñol, Carmen
  • Buenestado, Juan
  • Viñas, Joan
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • González, Dolors
  • Roman, Eva|||0000-0001-9084-8555
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Concepción, Mar|||0000-0003-1821-0359
  • Martín Flix, Marta|||0000-0001-7849-3616
  • Pétriz, Lourdes
  • Daniel, M.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth-Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz-Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, Henry|||0000-0001-7003-399X
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts. © 2013 Picelli et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Trough colistin plasma level is an independent risk factor for nephrotoxicity, A prospective observational cohort study

  • Sorlí, Luisa|||0000-0001-9562-514X
  • Luque, Sonia|||0000-0002-3215-320X
  • Grau, Santiago|||0000-0002-8428-1836
  • Berenguer, Núria|||0000-0002-9163-8346
  • Segura, Concepción
  • Montero, María Milagro|||0000-0001-5991-6804
  • Álvarez Lerma, Francisco|||0000-0003-1768-3058
  • Knobel Freud, Hernando|||0000-0003-3186-6416
  • Benito, Natividad|||0000-0001-6410-013X
  • Horcajada, Juan Pablo|||0000-0001-9873-5459
Background: Data regarding the most efficacious and least toxic schedules for the use of colistin are scarce. The aim of this study was to determine the incidence and the potential risk factors of colistin-associated nephrotoxicity including colistin plasma levels.Methods: A prospective observational cohort study was conducted for over one year in patients receiving intravenous colistin methanesulfonate sodium (CMS). Blood samples for colistin plasma levels were collected immediately before (C) and 30 minutes after CMS infusion (C). Renal function was assessed at baseline, on day 7 and at the end of treatment (EOT). Severity of acute kidney injury (AKI) was defined by the RIFLE (risk, injury, failure, loss, and end-stage kidney disease) criteria.Results: One hundred and two patients met the inclusion criteria. AKI related to CMS treatment on day 7 and at the end of treatment (EOT) was observed in 26 (25.5%) and 50 (49.0%) patients, respectively. At day 7, C (OR, 4.63 [2.33-9.20]; P < 0.001) was the only independent predictor of AKI. At EOT, the Charlson score (OR 1.26 [1.01-1.57]; P = 0.036), C (OR 2.14 [1.33-3.42]; P = 0.002), and concomitant treatment with ≥ 2 nephrotoxic drugs (OR 2.61 [1.0-6.8]; P = 0.049) were independent risk factors for AKI. When C was evaluated as a categorical variable, the breakpoints that better predicted AKI were 3.33 mg/L (P < 0.001) on day 7 and 2.42 mg/L (P < 0.001) at EOT.Conclusions: When using the RIFLE criteria, colistin-related nephrotoxicity is observed in a high percentage of patients. C levels are predictive of AKI. Patients who receive intravenous colistin should be closely monitored and C might be a new useful tool to predict AKI. © 2013 Sorlí et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight, comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Davila-Batista, Veronica|||0000-0001-8888-395X
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier|||0000-0001-8569-861X
  • Tardón, Guillermo Fernández
  • Alguacil, Juan|||0000-0003-2703-9725
  • Vanaclocha Espí, Mercedes|||0000-0002-7202-2861
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Aragonés, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela|||0000-0001-9242-6364
  • Reguero Celada, Sofía
  • Pollán, Marina|||0000-0002-4328-1565
  • Martín, Vicente|||0000-0003-0552-2804
10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m 2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain

  • Vilaprinyo, Ester
  • Puig Reixach, Maria Teresa|||0000-0003-1402-7653
  • Rué, Montserrat|||0000-0002-7862-9365
Background: Reductions in breast cancer (BC) mortality in Western countries have been attributed to the use of screening mammography and adjuvant treatments. The goal of this work was to analyze the contributions of both interventions to the decrease in BC mortality between 1975 and 2008 in Catalonia. Methodology/Principal Findings: A stochastic model was used to quantify the contribution of each intervention. Age standardized BC mortality rates for calendar years 1975-2008 were estimated in four hypothetical scenarios: 1) Only screening, 2) Only adjuvant treatment, 3) Both interventions, and 4) No intervention. For the 30-69 age group, observed Catalan BC mortality rates per 100,000 women-year rose from 29.4 in 1975 to 38.3 in 1993, and afterwards continuously decreased to 23.2 in 2008. If neither of the two interventions had been used, in 2008 the estimated BC mortality would have been 43.5, which, compared to the observed BC mortality rate, indicates a 46.7% reduction. In 2008 the reduction attributable to screening was 20.4%, to adjuvant treatments was 15.8% and to both interventions 34.1%. Conclusions/Significance: Screening and adjuvant treatments similarly contributed to reducing BC mortality in Catalonia. Mathematical models have been useful to assess the impact of interventions addressed to reduce BC mortality that occurred over nearly the same periods. © 2012 Vilaprinyo et al.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Aberrant repair and fibrosis development in skeletal muscle

  • Mann, Christopher J.
  • Perdiguero, Eusebio, 1968-
  • Kharraz, Yacine
  • Aguilar, Susana
  • Pessina, Patrizia
  • Serrano, Antonio L.
  • Muñoz Cánoves, Pura, 1962-
The repair process of damaged tissue involves the coordinated activities of several cell types in response to local and systemic signals. Following acute tissue injury, infiltrating inflammatory cells and resident stem cells orchestrate their activities to restore tissue homeostasis. However, during chronic tissue damage, such as in muscular dystrophies, the inflammatory-cell infiltration and fibroblast activation persists, while the reparative capacity of stem cells (satellite cells) is attenuated. Abnormal dystrophic muscle repair and its end stage, fibrosis, represent the final common pathway of virtually all chronic neurodegenerative muscular diseases. As our understanding of the pathogenesis of muscle fibrosis has progressed, it has become evident that the muscle provides a useful model for the regulation of tissue repair by the local microenvironment, showing interplay among muscle-specific stem cells, inflammatory cells, fibroblasts and extracellular matrix components of the mammalian wound-healing response. This article reviews the emerging findings of the mechanisms that underlie normal versus aberrant muscle-tissue repair., This work was funded by MICINN (PLE2009-0124, SAF2009-09782, FIS-PS09/01267, SAF2010-21682, CIBERNED), Fundación Marató-TV3/R-Pascual, MDA, EU-FP7 (Myoage, Optistem and Endostem) and AFM.
Repisalud
Publication Artículo científico (JournalArticle)

MAX and MYC: a heritable breakup.

  • Cascon Soriano, Alberto
  • Robledo Batanero, Mercedes
The overexpression of MYC, which occurs in many tumors, dramatically disrupts the equilibrium between activation and repression of the oncogenic MYC/MYC-associated protein X (MAX)/MAX dimerization protein 1 (MXD1) network, favoring MYC-MAX complexes and thereby impairing differentiation and promoting cell growth. Although for some time it has appeared that MAX is necessary for both the activation and repression of the axis, recent evidence shows that MYC retains considerable biologic function in the absence of MAX. The presence of germline MAX mutations in patients with hereditary pheochromocytoma supports the predominant role of MAX as a negative regulator of the network and suggests that MYC deregulation plays a role in hereditary cancer predisposition. This finding also confirms the importance of impairment of the MYC/MAX/MXD1 axis in the development of aggressive neural tumors, because MYCN overexpression is an established genetic hallmark of malign neuroblastoma, and it is likely that MXI1 plays a relevant role in the development of medulloblastoma and glioblastoma. Finally, the likely malignant behavior of tumors with mutations in MAX points to MYC as a candidate therapeutic target in the treatment of metastatic pheochromocytoma.
Repisalud
Publication Artículo científico (JournalArticle)

Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain

  • Ledesma, Juan
  • Pozo Sanchez, Francisco
  • Pérez-Ruiz, Mercedes
  • Navarro, José María
  • Piñeiro, Luis
  • Montes, Milagros
  • Pérez Castro, Sonia
  • Suárez Fernández, Jonathan
  • García Costa, Juan
  • Fernández, Mirian
  • Galán, Juan Carlos
  • Cuevas, Maria Teresa
  • Casas Flecha, Inmaculada
  • Perez-Breña, Pilar
  • Spanish Influenza Surveillance System (SISS)
  • Jimenez-Jorge, Silvia
Background: A change of aspartic acid (D) to glycine (G) at position 222 in the haemagglutinin (HA) protein of pandemic influenza A (H1N1) 2009 viruses was described in Norway on November 2009 with considerable frequency in fatal and severe cases. This change was detected in other countries and was related only with severe disease. Other substitutions to glutamic acid (E) or asparagine (N) at position 222 were detected among pandemic viruses but it is unclear what implications might have in terms of severity. Objectives: To analyse the appearance of amino acid substitutions at position 222 in the HA protein of circulating viruses in Spain and to determine their relationships with the disease symptoms observed. Study design: Pandemic influenza A (H1N1) 2009 viruses detected in respiratory samples of 273 severe and 533 non-severe cases from different Spanish regions were selected for sequencing of a partial segment of HA1 subunit and studied to monitor substitutions at position 222. Results: D222G substitution was only detected in viruses from 14 severe cases (5.12%). D222E was found in viruses from 47 severe (17.21%) and from 52 non-severe cases (9.75%). D222N occurred in viruses from 3 additional severe cases (0.37%). Conclusion: Appearance of D222G and D222E substitution in HA of pandemic influenza A (H1N1) viruses circulating in Spain might be related with severe respiratory disease.
Repisalud
Publication Artículo científico (JournalArticle)

Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain

  • Ledesma, Juan
  • Pozo Sanchez, Francisco
  • Reina, Gabriel
  • Blasco, Miriam
  • Rodríguez, Guadalupe
  • Montes, Milagrosa
  • López-Miragaya, Isabel
  • Salvador, Carmen
  • Reina, Jordi
  • Ortíz de Lejarazu, Raúl
  • Egido, Pilar
  • López Barba, José
  • Delgado-Sanz, Concepcion
  • Cuevas, Maria Teresa
  • Casas Flecha, Inmaculada
  • Spanish Influenza Surveillance System (SISS)
  • Larrauri, Amparo
  • Jimenez-Jorge, Silvia
Background: Genetic diversity of influenza A(H1N1)2009 viruses has been reported since the pandemic virus emerged in April 2009. Different genetic clades have been identified and defined based on amino acid substitutions found in the haemagglutinin (HA) protein sequences. In Spain, circulating influenza viruses are monitored each season by the regional laboratories enrolled in the Spanish Influenza Surveillance System (SISS). The analysis of the HA gene sequence helps to detect the genetic diversity and viral evolution. Objectives: To perform an analysis of the genetic diversity of influenza A(H1N1)2009 viruses circulating in Spain during the season 2010-2011 based on analysis of the HA sequence gene. Study design: Phylogenetic analysis based on the HA1 subunit of the haemagglutinin gene was carried out on 220 influenza A(H1N1)2009 viruses circulating during the season 2010-2011. Results: Six different genetic groups were identified among circulating A(H1N1)2009 viruses, five of them were previously reported during season 2010-2011. A new group, characterized by E172K and K308E changes and a proline at position 83, was observed in 12.27% of the Spanish viruses. Conclusion: Co-circulation of six different genetic groups of influenza A(H1N1)2009 viruses was identified in Spain during the season 2010-2011. Nevertheless, at this stage, none of the groups identified to date have resulted in significant antigenic changes according to data collected by World Health Organization Collaborating Centres for influenza surveillance.
Repisalud
Publication Artículo científico (JournalArticle)

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

  • Comino-Méndez, Iñaki
  • Gracia-Aznárez, Francisco J
  • Schiavi, Francesca
  • Landa, Iñigo
  • Leandro-García, Luis J
  • Letón, Rocío
  • Honrado, Emiliano
  • Ramos-Medina, Rocío
  • Caronia, Daniela
  • Pita, Guillermo
  • Gómez-Graña, Alvaro
  • de Cubas, Aguirre A
  • Inglada-Pérez, Lucía
  • Maliszewska, Agnieszka
  • Taschin, Elisa
  • Bobisse, Sara
  • Pica, Giuseppe
  • Loli, Paola
  • Hernández-Lavado, Rafael
  • Díaz, José A
  • Gómez-Morales, Mercedes
  • González-Neira, Anna
  • Roncador, Giovanna
  • Rodríguez-Antona, Cristina
  • Benítez, Javier
  • Mannelli, Massimo
  • Opocher, Giuseppe
  • Robledo, Mercedes
  • Cascon Soriano, Alberto
  • Roncador, Giovanna
Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date, but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in MAX, the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of MAX alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional MAX mutations and suggested an association with malignant outcome and preferential paternal transmission of MAX mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells and by the amplification of MYCN in neuroblastoma and suggests that loss of MAX function is correlated with metastatic potential.
Repisalud
Publication Artículo científico (JournalArticle)

Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

  • Lonardo, Enza
  • Hermann, Patrick C
  • Mueller, Maria-Theresa
  • Huber, Stephan
  • Balic, Anamaria
  • Miranda-Lorenzo, Irene
  • Zagorac, Sladjana
  • Alcala, Sonia
  • Rodriguez-Arabaolaza, Iker
  • Ramirez, Juan Carlos
  • Torres-Ruiz, Raul
  • Garcia, Elena
  • Hidalgo, Manuel
  • Cebrián, David Álvaro
  • Heuchel, Rainer
  • Löhr, Matthias
  • Berger, Frank
  • Bartenstein, Peter
  • Aicher, Alexandra
  • Heeschen, Christopher
Nodal and Activin belong to the TGF-β superfamily and are important regulators of embryonic stem cell fate. Here we investigated whether Nodal and Activin regulate self-renewal of pancreatic cancer stem cells. Nodal and Activin were hardly detectable in more differentiated pancreatic cancer cells, while cancer stem cells and stroma-derived pancreatic stellate cells markedly overexpressed Nodal and Activin, but not TGF-β. Knockdown or pharmacological inhibition of the Nodal/Activin receptor Alk4/7 in cancer stem cells virtually abrogated their self-renewal capacity and in vivo tumorigenicity, and reversed the resistance of orthotopically engrafted cancer stem cells to gemcitabine. However, engrafted primary human pancreatic cancer tissue with a substantial stroma showed no response due to limited drug delivery. The addition of a stroma-targeting hedgehog pathway inhibitor enhanced delivery of the Nodal/Activin inhibitor and translated into long-term, progression-free survival. Therefore, inhibition of the Alk4/7 pathway, if combined with hedgehog pathway inhibition and gemcitabine, provides a therapeutic strategy for targeting cancer stem cells.
Repisalud
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publication Artículo científico (JournalArticle)

Internal Cumulated Dose of Toxic Metal(loid)s in a Population Residing near Naturally Occurring Radioactive Material Waste Stacks and an Industrial Heavily Polluted Area with High Mortality Rates in Spain.

  • Contreras-Llanes, Manuel
  • Alguacil, Juan
  • Capelo, Rocío
  • Gómez-Ariza, José Luis
  • García-Pérez, Javier
  • Perez-Gomez, Beatriz
  • Martin-Olmedo, Piedad
  • Santos-Sánchez, Vanessa
Huelva is a city in SW Spain with 150,000 inhabitants, located in the proximity of two heavy chemical industry complexes, the highest naturally occurring radioactive material (NORM) waste (phosphogypsum) stacks of Europe and a highly polluted estuary, with elevated cardiovascular disease and cancer mortality rates. This study analyses the association between cumulated exposure levels to 16 metal(loid)s (Al, As, Cd, Co, Cr, Cu, Fe, Mn, Mo, Ni, Pb, Se, Tl, U, V, and Zn) measured in the toenail of a sample ( = 55 participants) of the general control population of Huelva City who were involved in the MCC-Spain study and the spatial proximity patterns to the local polluting sources. Residents of the city of Huelva have higher levels of Fe, Ni, Cr, Se, As, and Co in their toenails compared to the levels found in populations with similar characteristics living in non-polluted areas. Moreover, the highest concentrations of As, Pb, Cd, Mo, and Se were found in toenails of participants living near the NORM waste stack, while the highest Cu, Zn, and Al contents corresponded to people residing near the industrial area. The spatial distribution of most of the metal(loid)s studied appears to be mainly controlled by anthropogenic factors.
Repisalud
Publication Artículo científico (JournalArticle)

MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

  • Burnichon, Nelly
  • Cascon Soriano, Alberto
  • Schiavi, Francesca
  • Morales, Nicole Paes
  • Comino-Méndez, Iñaki
  • Abermil, Nasséra
  • Inglada-Pérez, Lucía
  • de Cubas, Aguirre A
  • Amar, Laurence
  • Barontini, Marta
  • de Quirós, Sandra Bernaldo
  • Bertherat, Jérôme
  • Bignon, Yves-Jean
  • Blok, Marinus J
  • Bobisse, Sara
  • Borrego, Salud
  • Castellano, Maurizio
  • Chanson, Philippe
  • Chiara, María-Dolores
  • Corssmit, Eleonora P M
  • Giacchè, Mara
  • de Krijger, Ronald R
  • Ercolino, Tonino
  • Girerd, Xavier
  • Gómez-García, Encarna B
  • Gómez-Graña, Alvaro
  • Guilhem, Isabelle
  • Hes, Frederik J
  • Honrado, Emiliano
  • Korpershoek, Esther
  • Lenders, Jacques W M
  • Letón, Rocío
  • Mensenkamp, Arjen R
  • Merlo, Anna
  • Mori, Luigi
  • Murat, Arnaud
  • Pierre, Peggy
  • Plouin, Pierre-François
  • Prodanov, Tamara
  • Quesada-Charneco, Miguel
  • Qin, Nan
  • Rapizzi, Elena
  • Raymond, Victoria
  • Reisch, Nicole
  • Roncador, Giovanna
  • Ruiz-Ferrer, Macarena
  • Schillo, Frank
  • Stegmann, Alexander P A
  • Suarez, Carlos
  • Taschin, Elisa
  • Timmers, Henri J L M
  • Tops, Carli M J
  • Urioste, Miguel
  • Beuschlein, Felix
  • Pacak, Karel
  • Mannelli, Massimo
  • Dahia, Patricia L M
  • Opocher, Giuseppe
  • Eisenhofer, Graeme
  • Gimenez-Roqueplo, Anne-Paule
  • Robledo, Mercedes
Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest-derived neoplasms. Recently we identified germline mutations in a new tumor suppressor susceptibility gene, MAX (MYC-associated factor X), which predisposes carriers to PCC. How MAX mutations contribute to PCC/PGL and associated phenotypes remain unclear. This study aimed to examine the prevalence and associated phenotypic features of germline and somatic MAX mutations in PCC/PGL.
Repisalud
Publication Artículo científico (JournalArticle)

Risk of prostate cancer in the proximity of industrial installations: A multicase-control study in Spain (MCC-Spain).

  • García-Pérez, Javier
  • Fernandez de Larrea-Baz, Nerea
  • Lope Carvajal, Virginia
  • Domínguez-Castillo, Alejandro
  • Espinosa, Ana
  • Dierssen-Sotos, Trinidad
  • Contreras-Llanes, Manuel
  • Sierra, Maria Angeles
  • Castaño-Vinyals, Gemma
  • Tardón, Adonina
  • Jiménez-Moleón, José J
  • Molina-Barceló, Ana
  • Aragonés, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Perez-Gomez, Beatriz
Background: Prostate cancer (PC) is the second most frequent tumor in men worldwide; however, its etiology remains largely unknown, with the exception of age and family history. The wide variability in incidence/mortality across countries suggests a certain role for environmental exposures that has not yet been clarified. Objective: To evaluate the association between risk of PC (by clinical profile) and residential proximity to pollutant industrial installations (by industrial groups, groups of carcinogens, and specific pollutants released), within the context of a Spanish population-based multicase-control study of incident cancer (MCC-Spain). Methods: This study included 1186 controls and 234 PC cases, frequency matched by age and province of residence. Distances from participants' residences to the 58 industries located in the study area were calculated and categorized into "near" (considering different limits between ≤1 km and ≤ 3 km) or "far" (>3 km). Odds ratios (ORs) and 95 % confidence intervals (95%CIs) were estimated using mixed and multinomial logistic regression models, adjusted for potential confounders and matching variables. Results: No excess risk was detected near the overall industries, with ORs ranging from 0.66 (≤2 km) to 1.11 (≤1 km). However, positive associations (OR; 95%CI) were found, by industrial group, near (≤3 km) industries of ceramic (2.54; 1.28-5.07), food/beverage (2.18; 1.32-3.62), and disposal/recycling of animal waste (2.67; 1.12-6.37); and, by specific pollutant, near plants releasing fluorine (4.65; 1.45-14.91 at ≤1.5 km) and chlorine (5.21; 1.56-17.35 at ≤1 km). In contrast, inverse associations were detected near industries releasing ammonia, methane, dioxins+furans, polycyclic aromatic hydrocarbons, trichloroethylene, and vanadium to air. Conclusions: The results suggest no association between risk of PC and proximity to the overall industrial installations. However, some both positive and inverse associations were detected near certain industrial groups and industries emitting specific pollutants.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Fluoroquinolone photodegradation influences specific basophil activation

  • Mayorga, Cristobalina
  • Aranda, Ana
  • Doña, Inmaculada
  • Montañez, M. Isabel
  • Blanca-López, Natalia
  • Ariza, Adriana
  • Nuin Plá, Neus Edurne
  • Blanca, Miguel
  • Miranda Alonso, Miguel Ángel
  • Torres, Mª José
  • Andreu, Inmaculada|||0000-0003-3409-9443
Fluoroquinolones (FQs) are photoreactive drugs, but it is not known whether laboratory light exposure can influence the induction of photoproducts and modify in vitro test results. The basophil activation test (BAT) has proven to be useful for evaluating immunoglobulin E (IgE)-mediated hypersensitivity to FQs, with a higher percentage of positive responders with ciprofloxacin (CIP) than with moxifloxacin (MOX). We studied the effect of laboratory light on CIP and MOX degradation, and drug-protein conjugate formation, and its influence on the BAT for evaluating IgE-mediated hypersensitivity to FQs. The results showed an important decrease in fluorescence emission intensity under light compared to dark conditions for MOX, and that BAT positivity was lower in light (17.9%) than in dark (35.7%) conditions. No changes were found for CIP in either fluorescence emission intensity or BAT results (46.4% in both conditions). We can conclude that light exposure is a critical factor in BAT results when photolabile drugs like MOX are used. Therefore, light is important when interpreting in vitro results. Copyright (C) 2012 S. Karger AG, Basel, We thank Ian Johnstone for his help with the English language version of the manuscript, and Jose Luis Rodriguez-Bada and Lidia Melendez for their technical support. This study was funded by the FIS-Thematic Networks and Co-operative Research Centres: RIRAAF (RD07/0064) and the Spanish Health Ministry (FIS PS09/01768, PI11/01416 and M Servet contract CP11/00154 for I.A.), the Andalusia Health Ministry (PI-0545-2010), and the Andalusia Economic Innovation and Science Ministry (CTS 06603).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease

  • Sivera, Rafael
  • Espinós-Armero, Carmen Ángeles
  • Vílchez, Juan J.
  • Mas, Fernando
  • Martínez-Rubio, Dolores
  • Chumillas, María José
  • Mayordomo, Fernando
  • Muelas, Nuria
  • Bataller, Luis
  • Palau, Francesc
  • Sevilla, Teresa
[EN] Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K). Most of these mutations present a recessive inheritance, but few autosomal dominant GDAP1 mutations have also been reported. We performed a GDAP1 gene screening in a clinically well-characterized series of 81 index cases with axonal CMT neuropathy, identifying 17 patients belonging to 4 unrelated families in whom the heterozygous p.R120W was found to be the only disease-causing mutation. The main objective was to fully characterize the neuropathy caused by this mutation. The clinical picture included a mild-moderate phenotype with onset around adolescence, but great variability. Consistently, ankle dorsiflexion and plantar flexion were impaired to a similar degree. Nerve conduction studies revealed an axonal neuropathy. Muscle magnetic resonance imaging studies demonstrated selective involvement of intrinsic foot muscles in all patients and a uniform pattern of fatty infiltration in the calf, with distal and superficial posterior predominance. Pathological abnormalities included depletion of myelinated fibers, regenerative clusters and features of axonal degeneration with mitochondrial aggregates. Our findings highlight the relevance of dominantly transmitted p.R120W GDAP1 gene mutations which can cause an axonal CMT with a wide clinical profile., We are grateful to the propositi and their relatives for their kind collaboration. We also want to thank I. Llopis and M. Escutia for their help with sample management. This work was supported by the Instituto de Salud Carlos III [PI08/90857, PI08/0889, CP08/00053 and PS09/00095], the Fundacion para la Investigacion del Hospital Universitari La Fe [CM06/00154], the Spanish Ministry Science and Innovation [grant number SAF2006-01047], and the Generalitat Valenciana [grant no. Prometeo/2009/05]. Dr. C. Espinos has a "Miguel Servet'' contract funded by the Fondo de Investigacion Sanitaria. Both Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) and Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) are initiatives from the Instituto de Salud Carlos III.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Sleep patterns, sleep disorders and mammographic density in spanish women: The DDM-Spain/Var-DDM study

  • Pedraza-Flechas, Ana María
  • Lope, Virginia
  • Moreo, Pilar
  • Ascunce, Nieves
  • Miranda-García, Josefa
  • Vidal, Carmen
  • Sánchez-Contador, Carmen
  • Santamariña, Carmen
  • Pedraz-Pingarrón, Carmen
  • Aragonés, Nuria
  • Salas -Trejo, Dolores
  • Pollán, Marina
  • Pérez-Gómez, Beatriz
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] We explored the relationship between sleep patterns and sleep disorders and mammographic density (MD), a marker of breast cancer risk. Participants in the DDM-Spain/var-DDM study, which included 2878 middle-aged Spanish women, were interviewed via telephone and asked questions on sleep characteristics. Two radiologists assessed MD in their left craneo-caudal mammogram, assisted by a validated semiautomatic-computer tool (DM-scan). We used log-transformed percentage MD as the dependent variable and fitted mixed linear regression models, including known confounding variables. Our results showed that neither sleeping patterns nor sleep disorders were associated with MD. However, women with frequent changes in their bedtime due to anxiety or depression had higher MD (e¿:1.53;95%CI:1.04¿2.26)., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness - Carlos III Institute of Health (ISCIII) (FI14CIII/00013, FIS PI060386 & PS09/0790), from the Spanish Federation of Breast Cancer Patients (FECMA 485 EPY 1170-10), Gent per Gent Fund (EDEMAC Project), the EPY1306/06 collaboration agreement between Astra-Zeneca and the ISCIII and partially funded by the European Regional Development Fund (FEDER)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer

  • Sanmartín, Elena
  • Usó, Marta
  • Blasco, Ana
  • Gallach, Sandra
  • Figueroa, Santiago
  • Martínez, Nieves
  • Hernando, Cristina
  • Honguero, Antonio
  • Martorell, Miguel
  • Guijarro, Ricardo
  • Rosell, Rafael
  • Jantus-Lewintre, Eloisa
  • Camps, Carlos
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background. Angiogenesis and lymphangiogenesis are key mechanisms for tumor growth and dissemination. They are mainly regulated by the vascular endothelial growth factor (VEGF) family of ligands and receptors. The aim of this study was to analyze relative expression levels of angiogenic markers in resectable non-small cell lung cancer patients in order to asses a prognostic signature that could improve characterization of patients with worse clinical outcomes. Methods. RNA was obtained from tumor and normal lung specimens from 175 patients. Quantitative polymerase chain reaction was performed to analyze the relative expression of HIF1A, PlGF, VEGFA, VEGFA(165b), VEGFB, VEGFC, VEGFD, VEGFR1, VEGFR2, VEGFR3, NRP1 and NRP2. Results. Univariate analysis showed that tumor size and ECOG-PS are prognostic factors for time to progression (TTP) and overall survival (OS). This analysis in the case of angiogenic factors also revealed that PlGF, VEGFA, VEGFB and VEGFD distinguish patients with different outcomes. Taking into account the complex interplay between the different ligands of the VEGF family and to more precisely predict the outcome of the patients, we considered a new analysis combining several VEGF ligands. In order to find independent prognostic variables, we performed a multivariate Cox analysis, which showed that the subgroup of patients with higher relative expression of VEGFA plus lower VEGFB and VEGFD presented the poorest outcome for both TTP and OS. Conclusions. The relative expression of these three genes can be considered as an angiogenic gene signature whose applicability for the selection of candidates for targeted therapies needs to be further validated., This study was partially supported by a grant from the Instituto de Salud Carlos III (FIS PI06/1041 and PS09/1149), Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/1024), and FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

  • Usó, Marta
  • Calabuig-Farinas, Silvia
  • Blasco, Ana
  • Garcia del Olmo, Eva
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Tumors develop mechanisms to recruit tolerogenic immune cells and to induce the expression of molecules that act as immune checkpoints. This regulation of the immune microenvironment favors immune tolerance to the neoplastic cells. In this study, we have investigated the prognostic role of immune-checkpoint expression markers in a cohort of resectable non-small cell lung cancer (NSCLC) patients. RNA was isolated from fresh-frozen lung specimens (tumor and normal lung) (n = 178). RTqPCR was performed to analyze the relative expression of 20 immune-related genes that were normalized by the use of endogenous genes selected by GeNorm algorithm. Patients with higher expression levels of IL23A and LGALS2 presented better outcomes. In the clustering expression patterns, we observed that patients with higher expression of immunoregulatory genes had better survival rates. Additionally, these data were used to develop a gene expression score. Since CTLA4 and PD1 were associated with prognosis based on Cox regression analysis (Z-score > 1.5), a multivariate model including these two genes was created. Absolute regression coefficients from this analysis were used in order to calculate the immunecheckpoint score: (PD1 x 0.116) + (CTLA4 x 0.059) for each case. Kaplan-Meier survival analysis showed that patients with high immune-checkpoint score have longer overall survival (OS) [NR vs. 40.4 mo, p = 0.008] and longer relapse-free survival (RFS) [82.6 vs. 23 mo, p = 0.009]. Multivariate analysis in the entire cohort indicated that the immune-checkpoint score was an independent biomarker of prognosis for OS [HR: 0.308; 95% CI, 0.156-0.609; p = 0.001] and RFS [HR: 0.527; 95% CI, 0.298-0.933; p = 0.028] in early-stage NSCLC patients. In conclusion, this score provides relevant prognostic information for a better characterization of early stage NSCLS patients with strikingly different outcomes and who may be candidates for immune-based therapies., This work was supported by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025) and the Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

High mammographic density in long-term night shift workers: DDM-Spain /Var-DDM

  • Pedraza-Flechas, Ana María
  • Lope, Virginia
  • Sanchez-Contador, Carmen
  • Santamarina, Carmen
  • Pedraz-Pingarron, Carmen
  • Moreo, Pilar
  • Ederra, María
  • Miranda-Garcia, Josefa
  • Vidal, Carmen
  • Aragonés, Nuria
  • Salas-Trejo, Dolores
  • Pollán, Marina
  • Pérez-Gómez, Beatriz
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Background: Night-shift work (NSW) has been suggested as a possible cause of breast cancer, and its association with mammographic density (MD), one of the strongest risk factors for breast cancer, has been scarcely addressed. This study examined NSW and MD in Spanish women. Methods: The study covered 2,752 women aged 45-68 years recruited in 2007-2008 in 7 population-based public breast cancer screening centers, which included 243 women who had performed NSW for at least one year. Occupational data and information on potential confounders were collected by personal interview. Two trained radiologist estimated the percentage of MD assisted by a validated semiautomatic computer tool (DM-scan). Multivariable mixed linear regression models with random screening center-specific intercepts were fitted using log-transformed percentage of MD as the dependent variable and adjusting by known confounding variables. Results: Having ever worked in NSW was not associated with MD [e(beta):0.96; 95% confidence interval (CI), 0.86-1.06]. However, the adjusted geometric mean of the percentage of MD in women with NSW for more than 15 years was 25% higher than that of those without NSW history (MD>15 (years):20.7% vs. MDnever:16.5%; e(beta):1.25; 95% CI, 1.01-1.54). This association was mainly observed in postmenopausal participants (e(beta):1.28; 95% CI, 1.00-1.64). Among NSW-exposed women, those with <= 2 night-shifts per week had higher MD than those with 5 to 7 nightshifts per week (e(beta):1.42; 95% CI, 1.10-1.84). Conclusions: Performing NSW was associated with higherMD only in women with more than 15 years of cumulated exposure. These findings warrant replication in futures studies. (C)2017 AACR., We would like to thank the participants in the DDM-Spain/Var-DDM-Spain study for their contribution to breast cancer research. Other members of DDM-Spain/Var-DDM: Gonzalo. López-Abente, Roberto Pastor-Barriuso, Pablo Fernández-Navarro, Anna Cabanes, Soledad Laso, Manuela Alcaraz, María Casals, Inmaculada Martínez, Juan Carlos Pérez Cortés, Joaquín Antón, Nieves Ascunce, Isabel González-Román, Ana Belén Fernández, Montserrat Corujo, Soledad Abad, and Jesús Vioque. A.M. Pedraza-Flechas FI14CIII/00013 PFIS; B. Perez-Gomez FIS PS09/0790; M. Pollán FIS PI060386, EPY1306/06 collaboration agreement between Astra-Zeneca and ISCIII, and FECMA 485 EPY 1170 10; R. LLobet Gent per Gent Fund (EDEMAC Project); All authors: European Regional Development Fund (FEDER). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones

  • Aranda, A.
  • Mayorga, C.
  • Ariza, A.
  • Doña, I.
  • Rosado, A.
  • Blanca-López, N.
  • Torres, M.J.
  • Andreu, Inmaculada|||0000-0003-3409-9443
Background: Hypersensitivity IgE-mediated reactions to quinolones are not easy to diagnose, with skin testing inducing false positive results. The aim of the study was to evaluate the in vitro-specific IgE response in patients with immediate allergic reactions to quinolones. Methods: We evaluated 38 patients with confirmed immediate allergic reactions to quinolones. Those with anaphylaxis were considered allergic by clinical history, once other possible causes were ruled out, and those with urticaria by drug provocation. Sepharose-radioimmunoassay (RIA) and basophil activation test (BAT) with ciprofloxacin, moxifloxacin and levofloxacin were performed. Results: The quinolones involved were moxifloxacin (N = 24), ciprofloxacin (N = 11) and levofloxacin (N = 3). Sepharose-RIA was positive in 12 cases (31.57%) and BAT in 27 (71.05%). With Sepharose-RIA, 8 (21%) were positive to ciprofloxacin, 7 (18.4%) to moxifloxacin and 7 (18.4%) to levofloxacin. With BAT, 23 (60.5%) were positive to ciprofloxacin, 12 (31.6%) to moxifloxacin and 8 (21%) to levofloxacin. The specificity of the Sepharose-RIA was demonstrated by inhibition tests. To confirm that the BAT results observed were IgE mediated, the PI3K inhibitor wortmannin was used, with this compound inhibiting the BAT when stimulated with anti-IgE and the different quinolones, but not when fMLP was used as the basophil stimulator. Sepharose-RIA and BAT were repeated in positive cases 1 year later, detecting a decrease in all cases, with four becoming negative. Conclusion: Immediate hypersensitivity reactions to quinolones do occur, with moxifloxacin being the drug most frequently involved. The BAT is a useful method for diagnosing patients. Specific IgE was demonstrated by Sepharose-RIA and inhibition assay. © 2010 John Wiley & Sons A/S., This work has been financed by Grants from Fondo de Investigacion Sanitaria (PS09/01768) and FIS-Thematic Networks and Co-operative Research Centers: RIRAAF (RD07/0064).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ventricular fibrillation conduction through an isthmus of preserved myocardium between radiofrequency lesions

  • CHORRO GASCO, FCO JAVIER
  • Ibañez Catala, Xavier
  • TRAPERO, ISABEL
  • SUCH-MIQUEL, LUIS M
  • PELECHANO, FRANCISCA
  • CÁNOVES, JOAQUÍN
  • MAINAR LATORRE, LUIS
  • CERDA, JOSE M.
  • ALBEROLA, ANTONIO
  • SUCH, L
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[EN] Background: Selective local acceleration of myocardial activation during ventricular fibrillation (VF) contributes information on the interactions between neighboring zones during the arrhythmia. This study analyzes these interactions, centering the observations on an isthmus of myocardium between two radiofrequency (RF) lesions. Methods: In nine isolated rabbit hearts, a gap of preserved myocardium was established between two RF lesions in the anterolateral left ventricle (LV) wall. Before, during, and after increasing the spatial heterogeneity of VF by local myocardial stretching, VF epicardial recordings were obtained. Results: Local stretch in the anterior LV wall decreased the excitable window (17 ±7ms vs 26 ±7ms; P < 0.05) and increased the dominant frequency (DFr; 18.9 ± 5.0 Hz vs 15.2 ± 3.6 Hz; P < 0.05) in this zone, without changes in the non-stretched posterolateral zone (25 ±4ms vs 27 ± 6 ms, ns and 14.1 ± 2.7 Hz vs 14.3 ± 3.0 Hz, ns). The DFr ratio at both sides of the gap was inversely correlated to the excitable window ratio (R = ¿0.57; P = 0.002). Before (31% vs 26%), during (29% vs 22%), and after stretch suppression (35% vs 25%), the wavefronts passing through the gap from the posterolateral to the anterior LV wall were seen to predominate. The number of wavefronts that passed from the anterior to the posterolateral LV wall was related to the excitable window in this zone (R = 0.41; P = 0.03). Conclusions: The VF acceleration induced in the stretched zone does not increase the flow of wavefronts toward the non-stretched zone in the adjacent gap of preserved myocardium. The absence of significant changes in the electrophysiological parameters of the non-stretched myocardium limits the arrival of wavefronts in this zone. (PACE 2013; 36:286¿298), Grants: This work was supported by Spanish Ministry of Science "Instituto de Salud Carlos III" Grants FIS PS09/02417 and RETIC REDINSCOR RD06/0003/0010, and by "Generalitat Valenciana" Grant PROMETEO 2010/093.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Occupation and mammographic density: A population-based study (DDM-Occup)

  • García-Pérez, Javier
  • Pollán, Marina
  • Pérez-Gómez, Beatriz
  • González-Sánchez, Mario
  • Cortés Barragán, Rosa Ana
  • Maqueda Blasco, Jerónimo
  • González-Galarzo, María Carmen
  • Alba, Miguel Ángel
  • van der Haar, Rudolf
  • Casas, Silvia
  • Vicente, Cándida
  • Medina, Pilar
  • Ederra, María
  • Santamariña, Carmen
  • Moreno, María Pilar
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Introduction: High mammographic density is one of the main risk factors for breast cancer. Although several occupations have been associated with breast cancer, there are no previous occupational studies exploring the association with mammographic density. Our objective was to identify occupations associated with high mammographic density in Spanish female workers. Methods: We conducted a population-based cross-sectional study of occupational determinants of high mammographic density in Spain, based on 1476 women, aged 45-68 years, recruited from seven screening centers within the Spanish Breast Cancer Screening Program network. Reproductive, family, personal, and occupational history data were collected. The latest occupation of each woman was collected and coded according to the 1994 National Classification of Occupations. Mammographic density was assessed from the cranio-caudal mammogram of the left breast using a semi-automated computer-assisted tool. Association between mammographic density and occupation was evaluated by using mixed linear regression models, using log-transformed percentage of mammographic density as dependent variable. Models were adjusted for age, body mass index,menopausal status, parity, smoking, alcohol intake, educational level, type of mammography, first-degree relative with breast cancer, and hormonal replacement therapy use. Screening center and professional reader were included as random effects terms. Results: Mammographic density was higher, although non-statistically significant, among secondary school teachers (e(beta) = 1.41; 95%CI = 0.98-2.03) and nurses (e(beta) = 1.23; 95%CI = 0.96-1.59), whereas workers engaged in the care of people (e(beta) = 0.81; 95%CI = 0.66-1.00) and housewives (e(beta) = 0.87; 95%CI = 0.79-0.95) showed an inverse association with mammographic density. A positive trend for every 5 years working as secondary school teachers was also detected (p-value = 0.035). Conclusions: Nurses and secondary school teachers were the occupations with the highest mammographic density in our study, showing the latter a positive trend with duration of employment. Future studies are necessary to confirm if these results are due to chance or are the result of a true association whose causal hypothesis is, for the moment, unknown., This study was funded by Strategic Action of Intramural Health (Accion Estrategica de Salud Intramural - AESI PI15CIII/00013); the Scientific Foundation of the Spanish Association Against Cancer (Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC) EVP-1178/14); the Research Grant FIS PI060386 & PS09/790 from Spain's Health Research Fund (Fondo de Invesdgacion Sanitaria); the EPY 1306/06 Collaboration Agreement between Astra-Zeneca and the Carlos III Institute of Health; and a grant from the Spanish Federation of Breast Cancer patients (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Semi-automated and fully automated mammographic density measurement and breast cancer risk prediction

  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
  • Pollán, Marina
  • Antón Guirao, Joaquín
  • Miranda-García, Josefa
  • Casals el Busto, María
  • Martinez Gomez, Inmaculada
  • Ruiz Perales, Francisco
  • Pérez Gómez, Beatriz
  • Salas-Trejo, Dolores
  • Perez-Cortes, Juan-Carlos
The task of breast density quantification is becoming increasingly relevant due to its association with breast cancer risk. In this work, a semi-automated and a fully automated tools to assess breast density from full-field digitized mammograms are presented. The first tool is based on a supervised interactive thresholding procedure for segmenting dense from fatty tissue and is used with a twofold goal: for assessing mammographic density(MD) in a more objective and accurate way than via visual-based methods and for labeling the mammograms that are later employed to train the fully automated tool. Although most automated methods rely on supervised approaches based on a global labeling of the mammogram, the proposed method relies on pixel-level labeling, allowing better tissue classification and density measurement on a continuous scale. The fully automated method presented combines a classification scheme based on local features and thresholding operations that improve the performance of the classifier. A dataset of 655 mammograms was used to test the concordance of both approaches in measuring MD. Three expert radiologists measured MD in each of the mammograms using the semi-automated tool (DM-Scan). It was then measured by the fully automated system and the correlation between both methods was computed. The relation between MD and breast cancer was then analyzed using a case-control dataset consisting of 230 mammograms. The Intraclass Correlation Coefficient (ICC) was used to compute reliability among raters and between techniques. The results obtained showed an average ICC = 0.922 among raters when using the semi-automated tool, whilst the average correlation between the semi-automated and automated measures was ICC = 0.838. In the case-control study, the results obtained showed Odds Ratios (OR) of 1.38 and 1.50 per 10% increase in MD when using the semi-automated and fully automated approaches respectively. It can therefore be concluded that the automated and semi-automated MD assessments present a good correlation. Both the methods also found an association between MD and breast cancer risk, which warrants the proposed tools for breast cancer risk prediction and clinical decision making. A full version of the DM-Scan is freely available. (C) 2014 Elsevier Ireland Ltd. All rights reserved., This work was supported by research grants from Gent per Gent Fund (EDEMAC Project); Spain's Health Research Fund (Fondo de Investigacion Santiaria) (PI060386 & FIS PS09/00790); Spanish MICINN grants TIN2009-14205-C04-02 and Consolider-Ingenio 2010: MIPRCV (CSD2007-00018); Spanish Federation of Breast Cancer Patients (Federacion Espanola de Cancer de Mama) (FECMA 485 EPY 1170-10). The English revision of this paper was funded by the Universitat Politecnica de Valencia, Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Modifications in Ventricular Fibrillation and Capture Capacity Induced by a Linear Radiofrequency Lesion, Modificaciones de la fibrilación ventricular y de la capacidad de captura inducidas por una lesión lineal con radiofrecuencia

  • Chorro, Francisco J.
  • Pelechano Ribes, Francisca
  • Trapero, Isabel
  • Ibañez Catala, Xavier
  • Such-Miquel, Luis
  • Guerrero, Juan
  • Canoves, Joaquin
  • Mainar, Luis
  • Alberola, Antonio
  • Such, Luis
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
  • Millet Roig, José|||0000-0002-8879-003X
[EN] Introduction and objectives: An analysis was made of the effects of a radiofrequency-induced linear lesion during ventricular fibrillation and the capacity to capture myocardium through high-frequency pacing. Methods: Using multiple epicardial electrodes, ventricular fibrillation was recorded in 22 isolated perfused rabbit hearts, analyzing the activation maps upon applying trains of stimuli at 3 different frequencies close to that of the arrhythmia: a) at baseline; b) after radio-frequency ablation to induce a lesion of the left ventricular free wall (length=10 [1] mm), and c) after lengthening the lesion (length=23 [2] mm). Results: Following lesion induction, the regularity of the recorded signals decreased and significant variations in the direction of the activation fronts were observed. On lengthening the lesion, there was a slight increase in the episodes with at least 3 consecutive captures when pacing at cycles 10% longer than the arrhythmia (baseline: 0.6 [0.7]; initial lesion: 1 [1] no significant differences; lengthened lesion: 3 [2.8]; P<.001), while a decrease was observed in those obtained upon pacing at cycles 10% shorter than the arrhythmia. Conclusions: The radio-frequency -induced lesion increases the heterogeneity of myocardial activation during ventricular fibrillation and modifies arrival of the activation fronts in the adjacent zones. High-frequency pacing during ventricular fibrillation produces occasional captures during at least 3 consecutive stimuli. The lengthened lesion in turn slightly increases capture capacity when using cycles slightly longer than the arrhythmia. (C) 2011 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L. All rights reserved., [ES] Introducción y objetivos Analizar los efectos, en la fibrilación ventricular y en la capacidad de capturar al miocardio mediante estimulación a frecuencias rápidas, de una lesión lineal producida con radiofrecuencia. Métodos En 22 corazones de conejo aislados y perfundidos, se utilizaron electrodos múltiples epicárdicos para registrar la fibrilación ventricular. Se analizaron los mapas de activación al aplicar trenes de estímulos a tres frecuencias distintas, cercanas a las de la arritmia, en tres situaciones: a) basalmente, b) tras producir con radiofrecuencia una lesión en la pared libre del ventrículo izquierdo (longitud, 10 ± 1 mm), y c) tras ampliar su extensión (longitud, 23 ± 2 mm). Resultados Tras la lesión, se observó una disminución de la regularidad de las señales registradas y variaciones significativas en la dirección de los frentes de activación. Con la lesión ampliada, se incrementaron ligeramente los episodios con al menos tres capturas consecutivas al estimular con ciclos un 10% más largos que los de la arritmia (basal, 0,6 ± 0,7; lesión inicial, 1 ± 1, diferencias no significativas; lesión ampliada, 3 ± 2,8; p < 0,001), mientras que se redujeron los obtenidos al estimular con ciclos un 10% más cortos que los de la arritmia. Conclusiones La lesión efectuada con radiofrecuencia aumenta la heterogeneidad de la activación miocárdica durante la fibrilación ventricular y modifica la llegada de los frentes de activación a las zonas adyacentes. La estimulación durante la fibrilación ventricular a frecuencias rápidas provoca capturas ocasionales durante al menos tres estímulos consecutivos. La lesión ampliada incrementa ligeramente la capacidad de captura al utilizar ciclos ligeramente más largos que los de la fibrilación ventricular., This study was funded by research grants from the Instituto de Salud Carlos III FIS PI06/0758-PS09/02417 and RETIC REDINSCOR RD06/0003/0010, from the Generalitat Valenciana PROMETEO 2010/093, and from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Genetic epidemiology of the Charcot-Marie-Tooth in the Spanish Gypsy population: the Hereditary Motor and Sensory Neuropathy type Russe in depth

  • Sevilla, T.
  • Martínez-Rubio, D.
  • Márquez, C.
  • Paradas, C.
  • Colomer, J.
  • Jaijo, T.
  • Millán, JM
  • Palau, F.
  • Espinós-Armero, Carmen Ángeles
[EN] Four private mutations responsible for three forms demyelinating of Charcot-Marie-Tooth (CMT) or hereditary motor and sensory neuropathy (HMSN) have been associated with the Gypsy population: the NDRG1 p.R148X in CMT type 4D (CMT4D/HMSN-Lom); p.C737_P738delinsX and p.R1109X mutations in the SH3TC2 gene (CMT4C); and a G>C change in a novel alternative untranslated exon in the HK1 gene causative of CMT4G (CMT4G/HMSN-Russe). Here we address the findings of a genetic study of 29 Gypsy Spanish families with autosomal recessive demyelinating CMT. The most frequent form is CMT4C (57.14%), followed by HMSN-Russe (25%) and HMSN-Lom (17.86%). The relevant frequency of HMSN-Russe has allowed us to investigate in depth the genetics and the associated clinical symptoms of this CMT form. HMSN-Russe probands share the same haplotype confirming that the HK1 g.9712G>C is a founder mutation, which arrived in Spain around the end of the 18th century. The clinical picture of HMSN-Russe is a progressive CMT disorder leading to severe weakness of the lower limbs and prominent distal sensory loss. Motor nerve conduction velocity was in the demyelinating or intermediate range., We thank all patients and their relatives for their kind collaboration. We also thank Drs G. Glover, R. Vilches, F. Galan, and C. Diaz for referring patients for genetic analysis. We also acknowledge F Barraclough for English corrections. This work was supported by the Instituto de Salud Carlos III (ISCIII) (grants number PI08/90857, PI08/0889, CP08/00053 and PS09/00095) co-funded with FEDER funds and by the ISCIII-IRDiRC Programme (TREAT-CMT grant). C. E. has a 'Miguel Servet' contract funded by the ISCIII. Both Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) and Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) are initiative from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Occupational exposures and mammographic density in Spanish women

  • Lope, Virginia
  • García-Pérez, Javier
  • Pérez-Gómez, Beatriz
  • Pedraza-Flechas, Ana María
  • Alguacil, Juan
  • González-Galarzo, María Carmen
  • Alba, Miguel Angel
  • van der Haar, Rudolf
  • Cortés Barragán, Rosa Ana
  • Pedraz-Pingarrón, Carmen
  • Moreo, María Pilar
  • Santamariña, Carmen
  • Ederra, María
  • Vidal, Carmen
  • Salas-Trejo, Dolores
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Objectives The association between occupational exposures and mammographic density (MD), a marker of breast cancer risk, has not been previously explored. Our objective was to investigate the influence of occupational exposure to chemical, physical and microbiological agents on MD in adult women. Methods This is a population-based cross-sectional study based on 1476 female workers aged 45-65 years from seven Spanish breast cancer screening programmes. Occupational history was surveyed by trained staff. Exposure to occupational agents was assessed using the Spanish job-exposure matrix MatEmESp. Percentage of MD was measured by two radiologists using a semiautomatic computer tool. The association was estimated using mixed log-linear regression models adjusting for age, education, body mass index, menopausal status, parity, smoking, alcohol intake, type of mammography, family history of breast cancer and hormonal therapy use, and including screening centre and professional reader as random effects terms. Results Although no association was found with most of the agents, women occupationally exposed to perchloroethylene (e(beta)=1.51; 95% CI 1.04 to 2.19), ionising radiation (e(beta)=1.23; 95% CI 0.99 to 1.52) and mould spores (e(beta)=1.44; 95% CI 1.01 to 2.04) tended to have higher MD. The percentage of density increased 12% for every 5 years exposure to perchloroethylene or mould spores, 11% for every 5 years exposure to aliphatic/alicyclic hydrocarbon solvents and 3% for each 5 years exposure to ionising radiation. Conclusions Exposure to perchloroethylene, ionising radiation, mould spores or aliphatic/alicyclic hydrocarbon solvents in occupational settings could be associated with higher MD. Further studies are needed to clarify the accuracy and the reasons for these findings., This study was funded by the Spanish Ministry of Economy and Competitiveness - Carlos II Institute of Health (ISCI) (AESI PI15CI/00013); the Scientific Foundation of the Spanish Association Against Cancer (Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AEC) - EVP-1178/14); the Spanish Public Health Research Fund (FIS PI060386 & PS09/0790); the collaboration agreement between Astra-Zeneca and the ISCI (EPY1306/06) and a grant from the Spanish Federation of Breast Cancer Patients (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Thyroid disorders and mammographic density in Spanish women: Var-DDM study

  • Pedraza-Flechas, Ana Maria
  • Lope, Virginia
  • Vidal, Carmen
  • Sanchez-Contador, Carmen
  • Santamariña, Carmen
  • Pedraz-Pingarrón, Carmen
  • Moreo, Pilar
  • Ascunce, Nieves
  • Miranda-Garcia, Josefa
  • Aragonés, Nuria
  • Salas-Trejo, Dolores
  • Pollán, Marina
  • Perez Gómez, Beatriz
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Objectives: The association between breast cancer (BC) and thyroid disorders has been widely explored with unclear results. Mammographic density (MD) is one of the strongest risk factor for BC. This study explores the relationship between thyroid diseases and MD in Spanish women. Materials & methods: This cross-sectional study covered 2883 women aged 47-71 years participating in 7 BC screening programs in 2010. They allowed access to their mammograms, had anthropometrical-measures taken, and answered a telephonic epidemiological interview which included specific questions on thyroid diseases. Percentage of MD was assessed with a semiautomatic-computer tool (DM-scan) by two trained radiologists. We calculated the geometric mean of MD percentages (mean MD). Multivariable mixed linear regression models with random screening-center-specific intercepts were fitted, using log-transformed percentage of MD as dependent variable and adjusting for age, body mass index, menopausal status and other confounders. e(beta) represents the relative increase of mean MD. Results: 13.9% of the participants reported personal history of thyroid disease. MD was not associated to hyperthyroidism (e(beta): 1.05, 95%CI: 0.82-1.36), hypothyroidism (e(beta):1.02, 95%CI: 0.75-1.38), thyroid nodules (e(beta):1.01, 95%CI: 0.85-1.19) or thyroid cancer (e(beta):1.03, 95%CI: 0.56-1.92). However, women with goiter had lower MD (mean MDno-goiter: 13.4% vs mean MDgoiter: 10.6%; e(beta):0.79, 95%CI: 0.64-0.98) and those with Hashimoto thyroiditis had higher MD (mean MDno-thyroiditis: 13.3% vs mean MDthyroidits: 25.8%; e(beta) 95%CI: 1.00-3.77). Conclusion: Functional thyroid disorders were not related to MD. However, MD was lower in women with goiter and higher in those reporting Hashimoto's thyroiditis. These relationships should be confirmed in future studies. (C) 2017 Elsevier Ltd. All rights reserved., This work was supported by the Spanish Ministry of Economy and Competitiveness - Carlos III Institute of Health (ISCIII) (FI14CIII/00013, FIS PI060386 & PS09/0790); the Spanish Federation of Breast Cancer Patients (FECMA 485 EPY 1170-10); the Gent per Gent Fund (EDEMAC Project); and the EPY1306/06 collaboration agreement between Astra-Zeneca and the ISCIII and partially funded by the European Regional Development Fund. None of these funding sources had any role in the study design, in the collection, analysis or interpretation of data. Other members of DDM-Spain/Var-DDM: María Casals, Inmaculada Martínez, María Ederra and Jesús Vioque.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Sh3tc2 deficiency affects neuregulin-1/ErbB signaling

  • Estelle Arnaud Gouttenoire
  • Lupo,V
  • Calpena-Corpas, Eduardo
  • Luca Bartesaghi
  • Fanny Schüpfer
  • Jean-Jacques Médard
  • Fabienne Maurer
  • Jacques S Beckmann
  • Jan Senderek
  • Palau, Francesc
  • Espinós-Armero, Carmen Ángeles
  • Roman Chrast
[EN] Mutations in SH3TC2 trigger autosomal recessive demyelinating Charcot-Marie-Tooth type 4C (CMT4C) neuropathy. Sh3tc2 is specifically expressed in Schwann cells and is necessary for proper myelination of peripheral axons. In line with the early onset of neuropathy observed in patients with CMT4C, our analyses of the murine model of CMT4C revealed that the myelinating properties of Sh3tc2-deficient Schwann cells are affected at an early stage. This early phenotype is associated with changes in the canonical Nrg1/ErbB pathway involved in control of myelination. We demonstrated that Sh3tc2 interacts with ErbB2 and plays a role in the regulation of ErbB2 intracellular trafficking from the plasma membrane upon Nrg1 activation. Interestingly, both the loss of Sh3tc2 function in mice and the pathological mutations present in CMT4C patients affect ErbB2 internalization, potentially altering its downstream intracellular signaling pathways. Altogether, our results indicate that the molecular mechanism for the axonal size sensing is disturbed in Sh3tc2-deficient myelinating Schwann cells, thus providing a novel insight into the pathophysiology of CMT4C neuropathy., Grant sponsor: Swiss National Science Foundation (SNSF); Grant number: 31003A_135735/1; Grant sponsor: Instituto de Salud Carlos III (ISCIII); Grant numbers: CP08/00053, PS09/00095; Grant sponsor: Association Francaise contre les Myopathies; Neuromuscular Research Association Basel; CSIC; ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Experimental Study of the Effects of EIPA, Losartan, and BQ-123 on Electrophysiological Changes Induced by Myocardial Stretch, Estudio experimental de los efectos de EIPA, losartán y BQ-123 sobre las modificaciones electrofisiológicas inducidas por el estiramiento miocárdico

  • Chorro, Francisco J.
  • Canto Serrano, Irene Del
  • Brines, Laia
  • Such-Miquel, Luis
  • Soler, Carlos
  • Zarzoso, Manuel
  • Trapero, Isabel
  • Such, Luis
  • Calvo Saiz, Conrado Javier
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[ES] Introducción y objetivos Se han implicado diversos mecanismos en la respuesta mecánica al estiramiento miocárdico, que incluyen la activación del intercambiador Na+/H+ por acciones autocrinas y paracrinas. Se estudia la participación de estos mecanismos en las respuestas electrofisiológicas al estiramiento agudo miocárdico mediante el análisis de los cambios inducidos con fármacos. Métodos Se analizan las modificaciones de la fibrilación ventricular inducidas por el estiramiento agudo miocárdico en corazones de conejo aislados y perfundidos utilizando electrodos múltiples epicárdicos y técnicas cartográficas. Se estudian 4 series: control (n = 9); durante la perfusión del antagonista de los receptores de la angiotensina II, losartán (1 ¿M, n = 8); durante la perfusión del bloqueador del receptor de la endotelina A, BQ-123 (0,1 ¿M, n = 9), y durante la perfusión del inhibidor del intercambiador Na+/H+, EIPA (5-[N-ethyl-N-isopropyl]-amiloride) (1 ¿M, n = 9). Resultados EIPA atenuó el aumento de la frecuencia dominante de la fibrilación producido por el estiramiento (control = 40,4%; losartán = 36% [no significativo]; BQ-123 = 46% [no significativo], y EIPA = 22% [p < 0,001]). Durante el estiramiento, la complejidad de los mapas de activación fue menor en la serie con EIPA (p < 0,0001) y también en esta serie fue mayor la concentración espectral de la arritmia (mayor regularidad): control = 18 ± 3%; EIPA = 26 ± 9% (p < 0,02); losartán = 18 ± 5% (no significativo), y BQ-123 = 18 ± 4% (no significativo). Conclusiones El inhibidor del intercambiador Na+/H+ EIPA atenúa los efectos electrofisiológicos responsables de la aceleración y del aumento de la complejidad de la fibrilación ventricular producidos por el estiramiento agudo miocárdico. Por el contrario, el antagonista de los receptores de la angiotensina II, losartán, y el del receptor A de la endotelina, BQ-123, no modifican estos efectos., [EN] Introduction and objectives Mechanical response to myocardial stretch has been explained by various mechanisms, which include Na+/H+ exchanger activation by autocrine-paracrine system activity. Drug-induced changes were analyzed to investigate the role of these mechanisms in the electrophysiological responses to acute myocardial stretch. Methods Multiple epicardial electrodes and mapping techniques were used to analyze changes in ventricular fibrillation induced by acute myocardial stretch in isolated perfused rabbit hearts. Four series were studied: control (n = 9); during perfusion with the angiotensin receptor blocker losartan (1 ¿M, n = 8); during perfusion with the endothelin A receptor blocker BQ-123 (0.1 ¿M, n = 9), and during perfusion with the Na+/H+ exchanger inhibitor EIPA (5-[N-ethyl-N-isopropyl]-amiloride) (1 ¿M, n = 9). Results EIPA attenuated the increase in the dominant frequency of stretch-induced fibrillation (control = 40.4%; losartan = 36% [not significant]; BQ-123 = 46% [not significant]; and EIPA = 22% [P < .001]). During stretch, the activation maps were less complex (P < .0001) and the spectral concentration of the arrhythmia was greater (greater regularity) in the EIPA series: control = 18 (3%); EIPA = 26 (9%) (P < .02); losartan = 18 (5%) (not significant); and BQ-123 = 18 (4%) (not significant). Conclusions The Na+/H+ exchanger inhibitor EIPA attenuated the electrophysiological effects responsible for the acceleration and increased complexity of ventricular fibrillation induced by acute myocardial stretch. The angiotensin II receptor antagonist losartan and the endothelin A receptor blocker BQ-123 did not modify these effects., This study was funded by the Spanish Department of Science (Instituto de Salud Carlos III): projects FIS PS09/02417, FIS PI12/00407, and RETIC "RIC" RD12/0042/0048, and Generalitat Valenciana: project PROMETEO 2010/093
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Biodistribution of Amino-Functionalized Diamond Nanoparticles. In Vivo Studies Based on (18)F Radionuclide Emission

  • Rojas, Santiago
  • Gispert, Juan D.
  • Martín González, Roberto
  • Abad, Sergio
  • Menchón, Cristina
  • Pareto, Deborah
  • Víctor, Víctor M.
  • Alvaro Rodríguez, Maria Mercedes|||0000-0001-5070-4207
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
  • Herance, J. Raúl
[EN] Nanoparticles have been proposed for several biomedical applications; however, in vivo biodistribution studies to con¿rm their potential are scarce. Nanodiamonds are carbon nanoparticles that have been recently proposed as a promising biomaterial. In this study, we labeled nanodiamonds with 18F to study their in vivo biodistribution by positron emission tomography. Moreover, the impact on the biodistribution of their kinetic particle size and of the surfactant agents has been evaluated. Radiolabeled diamond nanoparticles accumulated mainly in the lung, spleen, and liver and were excreted into the urinary tract. The addition of surfactant agents did not lead to signi¿cant changes in this pattern, with the exception of a slight reduction in the urinary excretion rate. On the other hand, after ¿ltration of the radiolabeled diamond nanoparticles to remove those with a larger kinetic size, the uptake in the lung and spleen was completely inhibited and signi¿cantly reduced in the liver, The present work was supported by Spanish MICINN (Grant CTQ-2009-11586); the Fondo de Investigacion Sanitaria (FIS) of the Instituto de Salud Carlos III (Grants PS09/02620, PI10/1195, and PS09/02217), La Marato TV3 Foundation (Grant 090530), and CDTI under the CENIT Programme (AMIT Project) and supported by the Spanish Ministry of Science and Innovation. R.M. thanks the Spanish Ministry for a postgraduate scholarship. V.M.V. is a recipient of Fond de Investigacion Sanitaria (FIS) and Generalitat Valenciana contract (CES10/030)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography

  • Rojas, Santiago
  • Domingo Gispert, Juan
  • Abad Fuentes, Sergio
  • Buaki-Sogo, Mireia
  • Victor, Victor M.
  • Herance Camacho, Jose Raul
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
A variety of nanoparticles have been proposed for several biomedical applications. To gauge the therapeutic potential of these nanoparticles, in vivo biodistribution is essential and mandatory. In the present study, ceria nanoparticles (5 nm average particle size) were labeled with F-18 to study their in vivo biodistribution in rats by positron emission tomography (PET). The F-18 isotope was anchored by reaction of N-succinimidyl 4-[F-18]fluorobenzoate (F-18-SFB) with a modified nanoparticle surface obtained by silylation with 3-aminopropylsilyl. Radiolabeled ceria nanoparticles accumulated mainly in lungs, spleen, and liver. Metabolic products of the radiolabeled nanoparticulate material were excreted into the urinary tract., The present work was supported by the Spanish MICINN (Grants CTQ-2009-11586, CTQ2006-06785, and CTQ2007-67805-AR07, PI10/1195, AP192/11); the Fondo de Investigacion Sanitaria (FIS) of the Instituto de Salud Carlos III (Grants PS09/02620, PI10/1195, and PS09/02217), the Generalitat Valenciana (Grant ACOMP/2012/045), La Marato Fundation (Grant 090530), and by CDTI under the CENIT Programme (AMIT Project) and the Spanish Ministry of Science and Innovation. V.M.V. is a recipient of a contract from the Regional Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030).
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Topical axitinib is a potent inhibitor of corneal neovascularization

  • Lledó Riquelme, Mariola
  • Campos Mollo, Ezequiel
  • Fernández-Sánchez, Laura
  • Fernández-Sánchez, Laura|||/items/1676ebd7-acc8-4ea8-bff6-d2b805dae60b
Background: This study evaluated the effects of topically applied axitinib, a tyrosine kinase inhibitor, in an experimental model of corneal neovascularization (CNV). Methods: A total of 48 New Zealand rabbits were used. CNV was induced by placing five silk sutures in the upper cornea of one eye per rabbit. Rabbits were randomized into four groups (12 rabbits each): 0.9% saline (control group), 0.02 mg/mL axitinib, 0.35 mg/mL axitinib and 0.5 mg/mL axitinib groups. All treatments were administered three times daily for 14 days. Photographs were taken using a slit lamp on days 7 and 14. The area of neovascularization was measured in mm2, as the percentage of total corneal area and as the percentage of corneal surface covered by sutures (SCS). Results: On day 14, the CNV area in the control group (31.50 ± 7.47 mm2; 115.00 ± 22.55% of the corneal SCS) was larger than that in the 0.02 mg/mL axitinib group (19.20 ± 8.92 mm2; 73.89 ± 34.98%), the 0.35 mg/mL axitinib group (8.83 ± 3.92 mm2; 31.90 ± 13.59%) and the 0.5 mg/mL axitinib group (5.12 ± 3.97 mm2; 18.38 ± 13.65%). Compared with saline, CNV was inhibited 39.04% by 0.02 mg/mL axitinib, 71.96% by 0.35 mg/mL axitinib and 84.73% by 0.5 mg/mL axitinib. Conclusion: Topical administration of the three axitinib concentrations inhibited CNV in rabbits, blocking both vascular endothelial growth factor and platelet‐derived growth factor pathways. Axitinib at 0.5 mg/mL induced profound inhibition of corneal angiogenesis.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A Rapid in Situ Procedure for Determination of Bacterial Susceptibility or Resistance to Antibiotics That Inhibit Peptidoglycan Biosynthesis

  • Santiso, Rebeca
  • Tamayo, María
  • Gosálvez, Jaime
  • Bou, Germán
  • Fernández-López, María del Carmen
  • Fernández, José Luis
[Abstract] Background: Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. Critical clinical situations should benefit from a rapid procedure to evaluate the sensitivity or resistance to antibiotics that act at the cell wall. We have adapted a kit for rapid determination of bacterial DNA fragmentation, to assess cell wall integrity. Results: Cells incubated with the antibiotic were embedded in an agarose microgel on a slide, incubated in an adapted lysis buffer, stained with a DNA fluorochrome, SYBR Gold and observed under fluorescence microscopy. The lysis affects the cells differentially, depending on the integrity of the wall. If the bacterium is susceptible to the antibiotic, the weakened cell wall is affected by the lysing solution so the nucleoid of DNA contained inside the bacterium is released and spread. Alternatively, if the bacterium is resistant to the antibiotic, it is practically unaffected by the lysis solution and does not liberate the nucleoid, retaining its normal morphological appearance. In an initial approach, the procedure accurately discriminates susceptible, intermediate and resistant strains of Escherichia coli to amoxicillin/clavulanic acid. When the bacteria came from an exponentially growing liquid culture, the effect on the cell wall of the β-lactam was evident much earlier that when they came from an agar plate. A dose-response experiment with an E. coli strain susceptible to ampicillin demonstrated a weak effect before the MIC dose. The cell wall damage was not homogenous among the different cells, but the level of damage increased as dose increased with a predominant degree of effect for each dose. A microgranular-fibrilar extracellular background was evident in gram-negative susceptible strains after β-lactam treatment. This material was digested by DNase I, hybridised with a specific whole genome probe, and so recognized as DNA fragments released by the bacteria. Finally, 46 clinical strains from eight gram-negative and four gram-positive species were evaluated blind for susceptibility or resistance to one of four different β-lactams and vancomycin, confirming the applicability of the methodology. Conclusion: The technique to assess cell wall integrity appears to be a rapid and simple procedure to identify resistant and susceptible strains to antibiotics that interfere with peptidoglycan biosynthesis., This work has been supported by a grant from the Xunta de Galicia 10CSA916020P. GB was funded by FIS PI081613 and PS09/00687.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems

  • Papp-Wallace, Krisztina M.
  • Mallo Cancela, Susana
  • Bethel, Christopher R.
  • Taracila, Magdalena A.
  • Hujer, Andrea M.
  • Viña Fernández, Anabel María
  • Gatta, Julian A.
  • Smith, Kerri M.
  • Xu, Yan
  • Page, Malcolm G.P.
  • Desarbre, Eric
  • Bou, Germán
  • Bonomo, Robert
[Abstract] Objectives: Class C β-lactamases are prevalent among Enterobacteriaceae; however, these enzymes are resistant to inactivation by commercially available β-lactamase inhibitors. In order to find novel scaffolds to inhibit class C β-lactamases, the comparative efficacy of monocyclic β-lactam antibiotics (aztreonam and the siderophore monosulfactam BAL30072), the bridged monobactam β-lactamase inhibitor BAL29880, and carbapenems (imipenem, meropenem, doripenem and ertapenem) were tested in kinetic assays against FOX-4, a plasmid-mediated class C β-lactamase (pmAmpC). Methods: The FOX-4 β-lactamase was purified. Steady-state kinetics, electrospray ionization mass spectrometry (ESI-MS) and ultraviolet difference (UVD) spectroscopy were conducted using the β-lactam scaffolds described. Results: The K(i) values for the monocyclic β-lactams against FOX-4 β-lactamase were 0.04 ± 0.01 μM (aztreonam) and 0.66 ± 0.03 μM (BAL30072), and the Ki value for the bridged monobactam BAL29880 was 8.9 ± 0.5 μM. For carbapenems, the Ki values ranged from 0.27 ± 0.05 μM (ertapenem) to 2.3 ± 0.3 μM (imipenem). ESI-MS demonstrated the formation of stable covalent adducts when the monocyclic β-lactams and carbapenems were reacted with FOX-4 β-lactamase. UVD spectroscopy suggested the appearance of different chromophoric intermediates. Conclusions: Monocyclic β-lactam and carbapenem antibiotics are effective mechanism-based inhibitors of FOX-4 β-lactamase, a clinically important pmAmpC, and provide stimulus for the development of new inhibitors to inactivate plasmidic and chromosomal class C β-lactamases., G. B. was funded by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-FEDER, Spanish Network for Research in Infectious Diseases (REIPI RD06/0008). This work was also funded by FIS PI12/00552, PS09/00687 and PS07/90 from Xunta de Galicia. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01 AI100560 and R01 AI063517 to R. A. B.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism

  • Cabral, M. P.
  • Soares, Nelson C.
  • Aranda Rodríguez, Jesús
  • Parreira, José Ricardo
  • Rumbo, Carlos
  • Poza, Margarita
  • Valle, Jaione
  • Calamia, Valentina
  • Lasa, Íñigo
  • Bou, Germán
[Abstract] Biofilm formation is one of the main causes for the persistence of Acinetobacter baumannii, a pathogen associated with severe infections and outbreaks in hospitals. Here, we performed comparative proteomic analyses (2D-DIGE and MALDI-TOF/TOF and iTRAQ/SCX-LC-MS/MS) of cells at three different conditions: exponential, late stationary phase, and biofilms. These results were compared with alterations in the proteome resulting from exposure to a biofilm inhibitory compound (salicylate). Using this multiple-approach strategy, proteomic patterns showed a unique lifestyle for A. baumannii biofilms and novel associated proteins. Several cell surface proteins (such as CarO, OmpA, OprD-like, DcaP-like, PstS, LysM, and Omp33), as well as those involved in histidine metabolism (like Urocanase), were found to be implicated in biofilm formation, this being confirmed by gene disruption. Although l-His uptake triggered biofilms efficiently in wild-type A. baumannii, no effect was observed in Urocanase and OmpA mutants, while a slight increase was observed in a CarO deficient strain. We conclude that Urocanase plays a crucial role in histidine metabolism leading to biofilm formation and that OmpA and CarO can act as channels for L-His uptake. Finally, we propose a model in which novel proteins are suggested for the first time as targets for preventing the formation of A. baumannii biofilms., This work was funded by the Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008), FIS PI081613, PS09/00687, PS07/90, PS07/51, and 08CSA064916PR from Xunta de Galicia., Xunta de Galicia; 08CSA064916PR, SERGAS; PS07/90, SERGAS; PS07/51
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Involvement of the AcrAB-TolC Efflux Pump in the Resistance, Fitness, and Virulence of Enterobacter cloacae

  • Pérez Gómez, Astrid
  • Poza, Margarita
  • Fernández González, Ana
  • Fernández-López, María del Carmen
  • Mallo Cancela, Susana
  • Merino Carballeira, María
  • Rumbo-Feal, Soraya
  • Cabral, M. P.
  • Bou, Germán
[Abstract] Multidrug efflux pumps have emerged as important mechanisms of antimicrobial resistance in bacterial pathogens. In order to cause infection, pathogenic bacteria require mechanisms to avoid the effects of host-produced compounds, and express efflux pumps may accomplish this task. In this study, we evaluated the effect of the inactivation of AcrAB-TolC on antimicrobial resistance, fitness, and virulence in Enterobacter cloacae, an opportunistic pathogen usually involved in nosocomial infections. Two different clinical isolates of E. cloacae were used, EcDC64 (multidrug resistance overexpressing the AcrAB-TolC efflux pump) and Jc194 (basal AcrAB-TolC expression). The acrA and tolC genes were deleted in strains EcDC64 and Jc194 to produce, respectively, EcΔacrA and EcΔtolC and JcΔacrA and JcΔtolC knockout (KO) derivatives. Antibiotic susceptibility testing was performed with all isolates, and we discovered that these mechanisms are involved in the resistance of E. cloacae to several antibiotics. Competition experiments were also performed with wild-type and isogenic KO strains. The competition index (CI), defined as the mutant/wild-type ratio, revealed that the acrA and tolC genes both affect the fitness of E. cloacae, as fitness was clearly reduced in the acrA and tolC KO strains. The median CI values obtained in vitro and in vivo were, respectively, 0.42 and 0.3 for EcDC64/EcΔacrA, 0.24 and 0.38 for EcDC64/EcΔtolC, 0.15 and 0.11 for Jc194/JcΔacrA, and 0.38 and 0.39 for Jc194/JcΔtolC. Use of an intraperitoneal mouse model of systemic infection revealed reduced virulence in both E. cloacae clinical strains when either the acrA or tolC gene was inactivated. In conclusion, the structural components of the AcrAB-TolC efflux pump appear to play a role in antibiotic resistance as well as environmental adaptation and host virulence in clinical isolates of E. cloacae., This work was supported by an Agustí Pumarola grant (SCMIMC and SEIMC), by the Fondo de Investigaciones Sanitarias (PI081368, PS09/00687) and SERGAS (PS07/90), and by grants from the Xunta de Galicia (07CSA050916PR) to G.B. A.P. and M.M. are in receipt of scholarships from REIPI (Spanish Network for Research in Infectious Diseases). A.F. is in receipt of a Rio Hortega research support contract from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. M.P.C. was supported by a doctoral grant (SFRH/BD/6474/2009). M.P. and S.R.-F. are in receipt of research contracts from the Xunta de Galicia (Programa Isidro Parga Pondal and Instituto de Salud Carlos III, respectively). We thank COST Action BM0701 members for their helpful collaboration and advice., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR, Portugal. Fundação para a Ciência e a Tecnologia; SFRH/BD/6474/2009
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Expression of OXA-Type and SFO-1 β-Lactamases Induces Changes in Peptidoglycan Composition and Affects Bacterial Fitness

  • Fernández González, Ana
  • Pérez Gómez, Astrid
  • Ayala, Juan A.
  • Mallo Cancela, Susana
  • Rumbo-Feal, Soraya
  • Tomás, María
  • Poza, Margarita
  • Bou, Germán
[Abstract] β-Lactamases and penicillin-binding proteins (PBPs) have evolved from a common ancestor. β-Lactamases are enzymes that degrade β-lactam antibiotics, whereas PBPs are involved in the synthesis and processing of peptidoglycan, which forms an elastic network in the bacterial cell wall. This study analyzed the interaction between β-lactamases and peptidoglycan and the impact on fitness and biofilm production. A representative set of all classes of β-lactamases was cloned in the expression vector pBGS18 under the control of the CTX-M promoter and expressed in Escherichia coli MG1655. The peptidoglycan composition of all clones was evaluated, and quantitative changes were found in E. coli strains expressing OXA-24, OXA-10-like, and SFO-1 (with its upstream regulator AmpR) β-lactamases; the level of cross-linked muropeptides decreased, and their average length increased. These changes were associated with a statistically significant fitness cost, which was demonstrated in both in vitro and in vivo experiments. The observed changes in peptidoglycan may be explained by the presence of residual dd-endopeptidase activity in these β-lactamases, which may result in hydrolysis of the peptide cross bridge. The biological cost associated with these changes provides important data regarding the interaction between β-lactamases and the metabolism of peptidoglycan and may provide an explanation for the epidemiology of these β-lactamases in Enterobacteriaceae., This work was supported by REIPI, Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III, RD06/0008/0025), Fondo de Investigaciones Sanitarias (PI061368, PI081368, and PS09/00687), and SERGAS (PS07/90) and grants from Xunta de Galicia (07CSA050916PR) to G.B. A.F. is in receipt of a Rio Hortega research support contract from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This work was partly supported by a grant from the Spanish Society for Microbiology and Infectious Disease (SEIMC) and by grant BFU2009-09200 awarded by the Ministry of Science and Innovation (MICINN) to J.A.A., Xunta de Galicia; PS07/90, Xunta de Galicia (07CSA050916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Effect of Transcriptional Activators SoxS, RobA, and RamA on Expression of Multidrug Efflux Pump AcrAB-TolC in Enterobacter cloacae

  • Pérez Gómez, Astrid
  • Poza, Margarita
  • Aranda Rodríguez, Jesús
  • Latasa, Cristina
  • Medrano, Francisco Javier
  • Tomás, María
  • Romero, A.
  • Lasa, Íñigo
  • Bou, Germán
[Abstract] Control of membrane permeability is a key step in regulating the intracellular concentration of antibiotics. Efflux pumps confer innate resistance to a wide range of toxic compounds such as antibiotics, dyes, detergents, and disinfectants in members of the Enterobacteriaceae. The AcrAB-TolC efflux pump is involved in multidrug resistance in Enterobacter cloacae. However, the underlying mechanism that regulates the system in this microorganism remains unknown. In Escherichia coli, the transcription of acrAB is upregulated under global stress conditions by proteins such as MarA, SoxS, and Rob. In the present study, two clinical isolates of E. cloacae, EcDC64 (a multidrug-resistant strain overexpressing the AcrAB-TolC efflux pump) and Jc194 (a strain with a basal AcrAB-TolC expression level), were used to determine whether similar global stress responses operate in E. cloacae and also to establish the molecular mechanisms underlying this response. A decrease in susceptibility to erythromycin, tetracycline, telithromycin, ciprofloxacin, and chloramphenicol was observed in clinical isolate Jc194 and, to a lesser extent in EcDC64, in the presence of salicylate, decanoate, tetracycline, and paraquat. Increased expression of the acrAB promoter in the presence of the above-described conditions was observed by flow cytometry and reverse transcription-PCR, by using a reporter fusion protein (green fluorescent protein). The expression level of the AcrAB promoter decreased in E. cloacae EcDC64 derivates deficient in SoxS, RobA, and RamA. Accordingly, the expression level of the AcrAB promoter was higher in E. cloacae Jc194 strains overproducing SoxS, RobA, and RamA. Overall, the data showed that SoxS, RobA, and RamA regulators were associated with the upregulation of acrAB, thus conferring antimicrobial resistance as well as a stress response in E. cloacae. In summary, the regulatory proteins SoxS, RobA, and RamA were cloned and sequenced for the first time in this species. The involvement of these proteins in conferring antimicrobial resistance through upregulation of acrAB was demonstrated in E. cloacae., This study was supported by Ayudas a la Movilidad (SEIMC), the Fondo de Investigaciones Sanitarias (PI081368, PS09/00687), and SERGAS (PS07/90) and a grant from the Xunta de Galicia (07CSA050916PR) to G.B. A.P. received scholarships from REIPI (Spanish Network for Research in Infectious Diseases). M.P. was supported by a research contract from the Xunta de Galicia, Spain (Programa Isidro Parga Pondal). J.A. received a Sara Borrell research support contract from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. M.T. was financially supported by the Miguel Servet Programme (CHU A Coruña and ISCIIII). G.B. is a member of the Cost Action BM0701 (ATENS) of the European Commission/European Science Foundation. We thank COST Action BM0701 members for their helpful collaboration and advice., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

  • Miró, Elisenda
  • Agüero-Balbín, Jesús
  • Larrosa, Nieves
  • Viña Fernández, Anabel María
  • Conejo, María del Carmen
  • Bou, Germán
  • González-López, Juan José
  • Lara, Noelia
  • Martínez-Martínez, Luis
  • Oliver, Antonio
Multicenter study, [Abstract] The purpose of this investigation was to determine the prevalence of plasmid-mediated AmpC (pAmpC) and carbapenemases in Enterobacteriaceae collected from 35 hospitals in Spain and to establish their epidemiological relationships. We conducted a prospective multi-centre study on pAmpC- or carbapenemase-producing Enterobacteriaceae isolates from clinical samples collected from February to July 2009. The strains suspected to carry pAmpC were resistant or showed intermediate susceptibility to co-amoxiclav and second- or third-generation cephalosporins. Strains suspected to carry a carbapenemase were selected because they showed a minimum inhibitory concentration (MIC) to imipenem >1 mg/L. Polymerase chain reaction (PCR) and a sequencing strategy were used to characterise the enzymes. The clonal relationships between isolates was analysed by pulsed field gel electrophoresis (PFGE). Among 100,132 Enterobacteriaceae isolates collected, 1,654 were compatible with the production of pAmpC or carbapenemases. We found a prevalence of 0.64 % of pAmpC (n = 635) and 0.04 % of carbapenemases (n = 43). The most prevalent pAmpC enzymes were CMY-type (78.3 %), DHA-type (19.5 %), ACC-type (1.6 %) and FOX-type (0.6 %). The CMY-type was the most frequent in Escherichia coli and Proteus mirabilis species, whereas the DHA-type was mainly found in Klebsiella spp. The enzymes involved in carbapenem resistance were VIM-1, IMP-22 and the new IMP-28. Nine new bla genes were described: bla (CMY-54), bla (CMY-55), bla (CMY-56), bla (CMY-57), bla (CMY-96), bla (DHA-6), bla (DHA-7), bla (FOX-8) and bla (IMP-28). The prevalence of pAmpC or carbapenemases found is not negligible. The CMY-types were the predominant pAmpC, whereas the VIM or IMP enzymes were the predominant carbapenemases. Furthermore, we observed a great genetic diversity among pAmpC-producing strains and a close clonal relationship between carbapenemase-producing strains., This study was partially supported by the Ministry of Health and Consumer Affairs, Instituto de Salud Carlos III—FEDER, the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), by a grant from the Fondo de Investigación Sanitaria (PS09/00125) and by AstraZeneca Farmacéutica Spain and Wyeth (now Pfizer) pharmaceutical industries.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A Rapid and Simple Method for Constructing Stable Mutants of Acinetobacter baumannii

  • Aranda Rodríguez, Jesús
  • Poza, Margarita
  • Gómez Pardo, M. Belén
  • Rumbo-Feal, Soraya
  • Rumbo, Carlos
  • Parreira, José Ricardo
  • Rodríguez-Velo, Patricia
  • Bou, Germán
[Abstract] Background: Acinetobacter baumannii is a multidrug-resistant bacterium responsible for nosocomial infections in hospitals worldwide. Study of mutant phenotypes is fundamental for understanding gene function. The methodologies developed to inactivate A. baumannii genes are complicated and time-consuming; sometimes result in unstable mutants, and do not enable construction of double (or more) gene knockout mutant strains of A. baumannii. Results: We describe here a rapid and simple method of obtaining A. baumannii mutants by gene replacement via double crossover recombination, by use of a PCR product that carries an antibiotic resistance cassette flanked by regions homologous to the target locus. To demonstrate the reproducibility of the approach, we produced mutants of three different chromosomal genes (omp33, oxyR, and soxR) by this method. In addition, we disrupted one of these genes (omp33) by integration of a plasmid into the chromosome by single crossover recombination, the most widely used method of obtaining A. baumannii mutants. Comparison of the different techniques revealed absolute stability when the gene was replaced by a double recombination event, whereas up to 40% of the population reverted to wild-type when the plasmid was disrupting the target gene after 10 passages in broth without selective pressure. Moreover, we demonstrate that the combination of both gene disruption and gene replacement techniques is an easy and useful procedure for obtaining double gene knockout mutants in A. baumannii. Conclusions: This study provides a rapid and simple method of obtaining stable mutants of A. baumannii free of foreign plasmidic DNA, which does not require cloning steps, and enables construction of multiple gene knockout mutants., The present study was supported by grants from SERGAS (PS08/24 and PS07/90) and INCITE 08CSA064916PR from the Xunta de Galicia, by the Spanish Network for Research in Infectious Diseases RD06/0008/0025, and by grants PI081613 and PS09/00687 from the Instituto de Salud Carlos III (Madrid). J. Aranda is in receipt of a Sara Borrell post-doctoral grant from the Instituto de Salud Carlos III (Madrid). M. Poza and B. Gómez are in receipt of Isidro Parga Pondal postdoctoral grants from the Xunta de Galicia. S. Rumbo and C. Rumbo are in receipt of pre-doctoral grants from the Instituto de Salud Carlos III (Madrid)., Xunta de Galicia; PS08/24, Xunta de Galicia; PS07/90, Xunta de Galicia; 08CSA064916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Emergence in Spain of a Multidrug-Resistant Enterobacter cloacae Clinical Isolate Producing SFO-1 Extended-Spectrum β-Lactamase

  • Fernández González, Ana
  • Pereira Rodríguez, María José
  • Suárez-Lorenzo, J. M.
  • Poza, Margarita
  • Treviño, Mercedes
  • Villalón, Pilar
  • Saéz-Nieto, Juan Antonio
  • Regueiro, Benito
  • Villanueva, Rosa
  • Bou, Germán
[Abstract] Between February 2006 and October 2009, 38 patients in different wards at the A Coruña University Hospital (northwest Spain) were either infected with or colonized by an epidemic, multidrug-resistant (MDR), and extended-spectrum-β-lactamase (ESBL)-producing strain of Enterobacter cloacae (EbSF), which was susceptible only to carbapenems. Semiautomated repetitive extragenic palindromic sequence-based PCR (rep-PCR) and pulsed-field gel electrophoresis (PFGE) analysis revealed that all of the E. cloacae isolates belonged to the same clone. Cloning and sequencing enabled the detection of the SFO-1 ESBL in the epidemic strain and the description of its genetic environment. The presence of the ampR gene was detected upstream of bla SFO-1, and two complete sequences of IS26 surrounding ampR and ampA were detected. These IS26 sequences are bordered by complete left and right inverted repeats (IRL and IRR, respectively), which suggested that they were functional. The whole segment flanked by two IS26 copies may be considered a putative large composite transposon. A gene coding for aminoglycoside acetyltransferase (gentamicin resistance gene [aac3]) was found downstream of the 3′ IS26. Despite the implementation of strict infection control measures, strain EbSF spread through different areas of the hospital. A case-control study was performed to assess risk factors for EbSF acquisition. A multivariate analysis revealed that the prior administration of β-lactam antibiotics, chronic renal failure, tracheostomy, and prior hospitalization were statistically associated with SFO-1-producing E. cloacae acquisition. This study describes for the first time an outbreak in which an SFO-1-producing E. cloacae strain was involved. Note that so far, this β-lactamase has previously been isolated in only a single case of E. cloacae infection in Japan., This work was supported by REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and A.F. is the receipt of a research support contract (Rio Hortega) from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This work was also funded by FIS grants PI081613, PS09/00687, and PS07/90 and grant 08CSA064916PR from Xunta de Galicia., Xunta de Galicia; PS07/90, Xunta de Galicia; 08CSA064916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii

  • Méndez, José Antonio
  • Soares, Nelson C.
  • Mateos, Jesús
  • Gayoso Babío, Carmen María
  • Rumbo, Carlos
  • Aranda Rodríguez, Jesús
  • Tomás, María
  • Bou, Germán
[Abstract] The study of the extracellular proteomes of pathogenic bacteria is essential for gaining insights into the mechanisms of pathogenesis and for the identification of virulence factors. Through the use of different proteomic approaches, namely Nano-LC and 2DE combined with MALDI-TOF/TOF, we have characterized the extracellular proteome of a highly invasive, multidrug-resistant strain of A. baumannii (clone AbH12O-A2). This study focused on two main protein fractions of the extracellular proteome: proteins that are exported by outer membrane vesicles (OMVs) and freely soluble extracellular proteins (FSEPs) present in the culture medium of A. baumannii. Herein, a total of 179 nonredundant proteins were identified in the OMV protein fraction and a total of 148 nonredundant proteins were identified in FSEP fraction. Of the OMV proteins, 39 were associated with pathogenesis and virulence, including proteins associated with attachment to host cells (e.g., CsuE, CsuB, CsuA/B) and specialized secretion systems for delivery of virulence factors (e.g., P. pilus assembly and FilF), whereas the FSEP fraction possesses extracellular enzymes with degradative activity, such as alkaline metalloprotease. Furthermore, among the FSEP we have detected at least 18 proteins with a known role in oxidative stress response (e.g., catalase, thioredoxin, oxidoreductase, superoxide dismutase). Further assays demonstrated that in the presence of FSEPs, bacterial cells withstand much higher concentrations of H2O2 showing higher survival rate (approximately 2.5 fold) against macrophages. In this study we have identified an unprecedented number of novel extracellular proteins of A. baumannii and we provide insight into their potential role in relevant processes such as oxidative stress response and defense against macrophage attack., This work was funded by the Spanish Network for the Research in Infectious Diseases-REIPI-(Instituto de Salud Carlos III, RD06/0008/0025), FIS PI081613, PI10/00056, PS09/00687, PS07/90, PS07/51, and 08CSA064916PR from Xunta de Galicia. We thank Dr. Phil Jackson from ITQB/UNL for the useful comments on the manuscript. We acknowledge helpful advice from Dr. Cristina Ruiz-Romero and Dr. Patricia Fuentes (ProteoRed) and Ireneu Soares Costa for helping us with the table of contents graphic.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain, Prevalencia en España de mecanismos de resistencia a quinolonas en enterobacterias productoras de betalactamasas de clase C adquiridas y/o carbapenemasas

  • Machuca, Jesús
  • Agüero-Balbín, Jesús
  • Miró, Elisenda
  • Conejo, María del Carmen
  • Oteo, Jesús
  • Bou, Germán
  • González-López, Juan José
  • Oliver, Antonio
  • Navarro, Ferrán
  • Pascual, Álvaro
  • Martínez-Martínez, Luis
[Abstract] Background: Quinolone resistance in Enterobacteriaceae species has increased over the past few years, and is significantly associated to beta-lactam resistance. The aim of this study was to evaluate the prevalence of chromosomal- and plasmid-mediated quinolone resistance in acquired AmpC β-lactamase and/or carbapenemase-producing Enterobacteriaceae isolates. Methods: The presence of chromosomal- and plasmid-mediated quinolone resistance mechanisms [mutations in the quinolone resistance determining region (QRDR) of gyrA and parC and qnr, aac(6')-Ib-cr and qepA genes] was evaluated in 289 isolates of acquired AmpC β-lactamase- and/or carbapenemase-producing Enterobacteriaceae collected between February and July 2009 in 35 Spanish hospitals. Results: Plasmid mediated quinolone resistance (PMQR) genes were detected in 92 isolates (31.8%), qnr genes were detected in 83 isolates (28.7%), and the aac(6')-Ib-cr gene was detected in 20 isolates (7%). qnrB4 gene was the most prevalent qnr gene detected (20%), associated, in most cases, with DHA-1. Only 14.6% of isolates showed no mutations in gyrA or parC with a ciprofloxacin MIC of 0.5mg/L or higher, whereas PMQR genes were detected in 90% of such isolates. Conclusion: qnrB4 gene was the most prevalent PMQR gene detected, and was significantly associated with acquired AmpC β-lactamase DHA-1. PMQR determinants in association with other chromosomal-mediated quinolone resistance mechanisms, different to mutations in gyrA and parC (increased energy-dependent efflux, altered lipopolysaccharide or porin loss), could lead to ciprofloxacin MIC values that exceed breakpoints established by the main international committees to define clinical antimicrobial susceptibility breakpoints., [Resumen] Introducción. En los últimos años se ha observado un incremento de la resistencia a fluoroquinolonas en enterobacterias, estando asociado significativamente a la resistencia a betalactámicos. Nuestro objetivo fue conocer la prevalencia de mecanismos cromosómicos y plasmídicos de resistencia a quinolonas en aislados productores de betalactamasas de clase C adquiridas y/o carbapenemasas. Métodos. Se evaluó la presencia de mecanismos cromosómicos y plasmídicos de resistencia a quinolonas [mutaciones en la región determinante de resistencia a quinolonas de gyrA y parC y genes qnr, aac(6′)-Ib-cr y qepA] en 289 aislados de enterobacterias productoras de betalactamasas de clase C adquiridas y/o carbapenemasas recogidos entre febrero y julio de 2009 en 35 hospitales españoles. Resultados. Se detectaron determinantes plasmídicos en 92 aislados (31,8%); en 83 aislados (28,7%) se detectó algún gen qnr, y en 20 (7%), la variante aac(6′)-Ib-cr. El gen qnr más prevalente fue qnrB4 (20%), asociado en la mayoría de los casos a DHA-1. El 14,6% de los aislados con una CMI de ciprofloxacino superior a 0,25 mg/l no presentaban mutaciones en gyrA ni parC, detectándose en el 90% de los mismos algún determinante plasmídico de resistencia a quinolonas. Conclusión. qnrB4 fue el determinante plasmídico más prevalente, claramente asociado a DHA-1. Los mecanismos plasmídicos en asociación con mecanismos cromosómicos diferentes a las mutaciones en los genes de las topoisomerasas (sobreexpresión de bombas de expulsión, alteración del lipopolisacárido o disminución de porinas) pueden dar lugar a valores de CMI de ciprofloxacino que superan los puntos de corte establecidos por los principales comités internacionales de definición de puntos de corte para interpretación de datos de sensibilidad., This study was partially funded by the Ministerio de Sanidad, Servicios Sociales e Igualdad [Ministry of Health, Social Services and Equality], Instituto de Salud Carlos III-FEDER [Carlos III-FEDER Health Institute], Red Española de Investigación en Patología Infecciosa [Spanish Network of Infectious Disease Research] (REIPI RD06/0008), via subsidies from the Fondo de Investigación Sanitaria [Health Research Fund] (PS09/00125 and PI11/01117) and assistance from AstraZeneca Farmacéutica España and Wyeth (now Pfizer).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

OXA-207, a Novel OXA-24 Variant With Reduced Catalytic Efficiency Against Carbapenems in Acinetobacter Pittii From Spain

  • Cayo, Rodrigo
  • Merino Carballeira, María
  • Ruiz del Castillo, Belén
  • Cano, María E.
  • García Calvo-Montes, Jorge
  • Bou, Germán
  • Martínez-Martínez, Luis
Brief report, [Abstract] A carbapenem-resistant Acinetobacter pittii strain carrying an OXA-24-like enzyme was isolated in northern Spain in 2008. Sequence analysis confirmed the presence of the novel bla(OXA-207) gene flanked by the site-specific XerC/XerD-like recombination binding sites and showing a unique Gly222Val substitution compared to OXA-24. Cloning and kinetic analysis showed that OXA-207 presents a reduction in the catalytic efficiency against carbapenems and a noticeable increase for oxacillin., This work was partially supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III - cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and by the Fondo de Investigación Sanitaria (PI080209, PS09/00687, and PI12/00552). We are grateful to the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), which gave a PDEE grant to R.C. (protocol 4149/08-4).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii

  • Gayoso Babío, Carmen María
  • Mateos, Jesús
  • Méndez, José Antonio
  • Fernández-Puente, Patricia
  • Rumbo, Carlos
  • Tomás, María
  • Martínez de Ilarduya, Óskar
  • Bou, Germán
[Abstract] Desiccation tolerance contributes to the maintenance of bacterial populations in hospital settings and may partly explain its propensity to cause outbreaks. Identification and relative quantitation of proteins involved in bacterial desiccation tolerance was made using label-free quantitation and iTRAQ labeling. Under desiccating conditions, the population of the Acinetobacter baumannii clinical strain AbH12O-A2 decreased in the first week, and thereafter, a stable population of 0.5% of the original population was maintained. Using label-free quantitation and iTRAQ labeling, 727 and 765 proteins, respectively, were detected; 584 of them by both methods. Proteins overexpressed under desiccation included membrane and periplasmic proteins. Proteins associated with antimicrobial resistance, efflux pumps, and quorum quenching were overexpressed in the samples subjected to desiccation stress. Electron microscopy revealed clear morphological differences between desiccated and control bacteria. We conclude that A. baumannii is able to survive long periods of desiccation through the presence of cells in a dormant state, via mechanisms affecting control of cell cycling, DNA coiling, transcriptional and translational regulation, protein stabilization, antimicrobial resistance, and toxin synthesis, and that a few surviving cells embedded in a biofilm matrix are able to resume growth and restore the original population in appropriate environmental conditions following a "bust-and-boom" strategy., This work was funded by the Spanish Network for the Research in Infectious Diseases-REIPI-(Instituto de Salud Carlos III, RD12/00552), FIS PI081613, PI10/00056, PS09/00687, PS07/90, PS07/51, PI12/00552, and 08CSA064916PR from Xunta de Galicia. This study was also funded by grants from the European Community, FP7, ID: 278232 (MagicBullet).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain

  • Acosta Barriga, Joshi
  • Merino Carballeira, María
  • Viedma Moreno, Esther
  • Poza, Margarita
  • Sanz, Francisca
  • Otero, Joaquín R.
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] In February 2006, a patient colonized with a multidrug-resistant sequence type 56 Acinetobacter baumannii strain was admitted to a hospital in Madrid, Spain. This strain spread rapidly and caused a large outbreak in the hospital. Clinicians should be alert for this strain because its spread would have serious health consequences., This study was supported by the Spanish Network for Research in Infectious Diseases (grants RD06/0008/0011, RD06/0008/0025, PI081613, and PS09/00687) for the Instituto de Salud Carlos III.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Exploring Bacterial Diversity in Hospital Environments by GS-FLX Titanium Pyrosequencing

  • Poza, Margarita
  • Gayoso Babío, Carmen María
  • Gómez, Manuel J.
  • Rumbo-Feal, Soraya
  • Tomás, María
  • Aranda Rodríguez, Jesús
  • Fernández González, Ana
  • Bou, Germán
[Abstract] Understanding microbial populations in hospital environments is crucial for improving human health. Hospital-acquired infections are an increasing problem in intensive care units (ICU). In this work we present an exploration of bacterial diversity at inanimate surfaces of the ICU wards of the University Hospital A Coruña (Spain), as an example of confined hospital environment subjected to selective pressure, taking the entrance hall of the hospital, an open and crowded environment, as reference. Surface swab samples were collected from both locations and recovered DNA used as template to amplify a hypervariable region of the bacterial 16S rRNA gene. Sequencing of the amplicons was performed at the Roche 454 Sequencing Center using GS-FLX Titanium procedures. Reads were pre-processed and clustered into OTUs (operational taxonomic units), which were further classified. A total of 16 canonical bacterial phyla were detected in both locations. Members of the phyla Firmicutes (mainly Staphylococcus and Streptococcus) and Actinobacteria (mainly Micrococcaceae, Corynebacteriaceae and Brevibacteriaceae) were over-represented in the ICU with respect to the Hall. The phyllum Proteobacteria was also well represented in the ICU, mainly by members of the families Enterobacteriaceae, Methylobacteriaceae and Sphingomonadaceae. In the Hall sample, the phyla Proteobacteria, Bacteroidetes, Deinococcus-Thermus and Cyanobacteria were over-represented with respect to the ICU. Over-representation of Proteobacteria was mainly due to the high abundance of Enterobacteriaceae members. The presented results demonstrate that bacterial diversity differs at the ICU and entrance hall locations. Reduced diversity detected at ICU, relative to the entrance hall, can be explained by its confined character and by the existence of antimicrobial selective pressure. This is the first study using deep sequencing techniques made in hospital wards showing substantial hospital microbial diversity., This work was supported by the Spanish Network for Research in Infectious Diseases (REIPI, RD06/0008/0025), grants from Fondo de Investigaciones Sanitarias (PI081368 and PS09/00687), SERGAS (PS07/90) and Xunta de Galicia (07CSA050916PR) to GB and a grant from SERGAS (PS08/24, Galicia, Spain) to MP. MP was supported by the Isidro Parga Pondal Program (Xunta de Galicia, Spain), CG by the Spanish Network for Research in Infectious Diseases (REIPI, RD025/0008), MJG by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) and SRF, MT, JA and AF by Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR, Xunta de Galicia; PS08/24
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate

  • Soares, Nelson C.
  • Spät, Philipp
  • Méndez Arredondo, José Antonio
  • Nakedi, Kehilwe
  • Aranda Rodríguez, Jesús
  • Bou, Germán
[Abstract] In the current study, the Ser/Thr/Tyr phosphoproteomes of two Acinetobacter baumannii strains, reference (ATCC17978) and highly invasive multidrug-resistant clinical isolate (Abh12O-A2) were analyzed using SCX and TiO2 chromatography followed by high resolution mass spectrometry. We detected a total of 201 unique phosphorylation sites (p-sites), and, after manual validation of peptide spectra, 91 high-confidence phosphorylation events (p-events) could be localized to a specific amino acid residue. The percentage distribution of Ser/Thr/Tyr phosphorylation was 68.9% on serine, 24.1% on threonine and 5.2% on tyrosine in ATCC17978, and 70.8% on serine, 25.2% on threonine and 3.8% on tyrosine in AbH12O-A2. Across all identified p-sites, 11 were identified in ATCC17978 only, while 43 were identified in Abh12O-A2 only, and 37 overlapped between the two strains. Here for the first time we describe the phosphoproteome of A. baumanii, and significance of selected phosphorylation sites is discussed in the context of stress/starvation, pathogenicity and drug resistance. Biological significance: It is now well established that protein phosphorylation on Ser/Thr/Tyr residues is an important post-translational modification in bacteria. Herein we employed SCX and TiO2 chromatographic phosphopeptide enrichment combined with LTQ-Orbitrap mass spectrometric analyses to characterize and establish a qualitative comparison between the Ser/Thr/Tyr phosphoproteomes of two Acinetobacter baumannii strains: a reference strain and a highly invasive multidrug-resistant clinical isolate. We highlight the identification of phosphoproteins with a role in pathogenicity and those involved in drug resistance., Xunta de Galicia; 08CSA06491PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial Outbreak

  • Merino Carballeira, María
  • Acosta Barriga, Joshi
  • Poza, Margarita
  • Sanz, Francisca
  • Beceiro Casas, Alejandro
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] A clinical strain of Acinetobacter calcoaceticus resistant to carbapenems was isolated from a blood culture sample from an inpatient in a hospital in Madrid (Spain) during a large outbreak of infection (affecting more than 300 inpatients), caused by a multidrug-resistant Acinetobacter baumannii clone. The carbapenem resistance in both the A. calcoaceticus and A. baumannii clones was due to a blaOXA-24 gene harbored in different plasmids. The plasmids were fully sequenced, revealing the presence of site-specific recombination binding sites putatively involved in mobilization of the blaOXA-24 gene. Comparison of plasmids contained in the two strains revealed possible horizontal transmission of resistance genes between the Acinetobacter species., This study was supported by the Spanish Network for Research on Infectious Diseases—REIPI (Instituto de Salud Carlos III, RD06/0008/0025 and RD006/0008/0011), Fondo de Investigaciones Sanitarias (PI061368, PI081368, and PS09/00687), and SERGAS (PS07/90) and by grants from Xunta de Galicia (07CSA050916PR). Margarita Poza and Alejandro Beceiro are in receipt of Isidro Parga Pondal and Angeles Alvariño grants, respectively (research contracts from Xunta de Galicia)., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Horizontal Transfer of the OXA-24 Carbapenemase Gene via Outer Membrane Vesicles: a New Mechanism of Dissemination of Carbapenem Resistance Genes in Acinetobacter baumannii

  • Rumbo, Carlos
  • Fernández-Moreira, Esteban
  • Merino Carballeira, María
  • Poza, Margarita
  • Méndez Arredondo, José Antonio
  • Soares, Nelson C.
  • Mosquera Rey, Alejandro
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] The resistance of Acinetobacter baumannii strains to carbapenems is a worrying problem in hospital settings. The main mechanism of carbapenem resistance is the expression of β-lactamases (metalloenzymes or class D enzymes). The mechanisms of the dissemination of these genes among A. baumannii strains are not fully understood. In this study we used two carbapenem-resistant clinical strains of A. baumannii (AbH12O-A2 and AbH12O-CU3) expressing the plasmid-borne blaOXA-24 gene (plasmids pMMA2 and pMMCU3, respectively) to demonstrate that A. baumannii releases outer membrane vesicles (OMVs) during in vitro growth. The use of hybridization studies enabled us to show that these OMVs harbored the blaOXA-24 gene. The incubation of these OMVs with the carbapenem-susceptible A. baumannii ATCC 17978 host strain yielded full resistance to carbapenems. The presence of the original plasmids harboring the blaOXA-24 gene was detected in strain ATCC 17978 after the transformation of OMVs. New OMVs harboring blaOXA-24 were released by A. baumannii ATCC 17978 after it was transformed with the original OMV-mediated plasmids, indicating the universality of the process. We present the first experimental evidence that clinical isolates of A. baumannii may release OMVs as a mechanism of horizontal gene transfer whereby carbapenem resistance genes are delivered to surrounding A. baumannii bacterial isolates., This work was supported by SERGAS grants (PS07/51 and PS07/90) and INCITE grant 08CSA064916PR from Xunta de Galicia, by Spanish Network for Research in Infectious Diseases grants RD06/0008/0011 and RD06/0008/0025, and by grants PI081613 and PS09/00687 from the Instituto de Salud Carlos III. Margarita Poza and Carlos Rumbo are recipients of an Isidro Parga Pondal research contract (Xunta de Galicia) and a scholarship from the Instituto de Salud Carlos III, respectively. Nelson C. Soares is a recipient of an Angeles Alvariño research contract (Xunta de Galicia). Jose A. Mendez is supported by a Río Hortega research contract from the Instituto de Salud Carlos III., Xunta de Galicia; PS07/51, Xunta de Galicia; PS07/90, Xunta de Galicia; 08CSA064916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii

  • McConnell. MIchael J.
  • Rumbo, Carlos
  • Bou, Germán
  • Pachón, Jerónimo
[Abstract] Acinetobacter baumannii produces different types of infections including pneumonia, meningitis, and bloodstream infections. The optimal treatment of these infections has been complicated by the global emergence of multidrug resistant strains, requiring the development of novel approaches for treatment and prevention. Outer membrane vesicles are outpouchings of the bacterial outer membrane that are secreted from numerous pathogenic Gram-negative bacteria. In the present study, we describe the isolation of outer membrane vesicles from A. baumannii and their use as a vaccine in a mouse model of disseminated sepsis. Immunization produced a robust antibody response against multiple bacterial antigens which consisted of antigen-specific IgG and IgM. In addition, both IgG1 and IgG2c subtypes were produced by immunization. Immunized mice had lower tissue bacterial loads and lower serum levels of the pro-inflammatory cytokines IL-6 and IL-1β post-infection compared to control mice. Importantly, vaccination protected mice from challenge with the ATCC 19606 strain and provided protection against two clinical isolates, including a pan-resistant strain. These results indicate that vaccination with outer membrane vesicles may be a viable strategy for preventing A. baumannii infection., This work was funded by the Consejería de Innovación, Ciencia y Empresa de la Junta de Andalucía P08-CTS-03842 awarded to JP and by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III – co-financed by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008/0000). MJM is supported by the Subprograma Juan de la Cierva from the Ministerio de Ciencia y Innovación of Spain. GB was funded by FIS grants PI081613, PS09/00687, and PS07/90 and grant 08CSA064916PR from Xunta de Galicia. Carlos Rumbo is a recipient of a scholarship from Instituto de Salud Carlos III.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Cohort profile: The Girona heart registry

  • Degano, Irene R.
  • Herrera-Marín, Nuria
  • Subirana, Isaac
  • Camps-Vilaró, Anna
  • Hernáez, Álvaro
  • Sala, Joan
  • Masià, Rafael
  • Ramos, Rafel
  • Elosua, Roberto
  • Marrugat, Jaume
The Girona Heart Registry (REGICOR) is a population-based study designed to analyse the magnitude of and factors related to cardiovascular (CV) diseases in Southern Europe. The REGICOR cohort integrates the participants of four population-based surveys conducted in 1995, 2000, 2005, and 2018 in the Girona province (North-Eastern Spain), with a current reference population of approximately 790 000 inhabitants. The REGICOR cohort includes 11 631 individuals (1748 in 1995, 3030 in 2000, 6308 in 2005, and 545 in 2018). At inclusion, 52% of the study population were females; their mean ages were 51, 50, 57, and 45, respectively. Two re-examinations were conducted for the participants recruited in 1995, 2000, and 2005. Follow-up data on CV events and cause-specific mortality are available for 11 518 participants since baseline, with a median follow-up time of 18.6 years. Follow-up data on non-CV events have been available since 2008. During inclusion and re-examinations, we obtained blood samples and information on CV and other risk factors using validated questionnaires, standardized tests, and imaging assessments. Genotyping was performed on the whole cohort. Circulating biomarkers, DNA methylation, microRNAs, and proteomics have been measured in a cohort subset., info:eu-repo/semantics/publishedVersion
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications

  • Luque, Raúl M.
  • Ibáñez-Costa, Alejandro
  • López-Sánchez, Laura María
  • Jiménez Reina, L.
  • Venegas-Moreno, Eva
  • Gálvez-Moreno, M. Ángeles
  • Villa-Osaba, Alicia
  • Madrazo Atutxa, Ainara M.
  • Japón, Miguel Ángel
  • de la Riva, Andrés
  • Cano, David A.
  • Benito-López, Pedro
  • Soto-Moreno, Alfonso
  • Gahete Ortiz, Manuel D.
  • Leal-Cerro, Alfonso
  • Castaño, Justo P.
Context: Desmopressin is a synthetic agonist of vasopressin receptors (AVPRs). The desmopressin stimulation test is used in the diagnosis and postsurgery prognosis of Cushing disease (CD). However, the cellular and molecular mechanisms underlying the desmopressin-induced ACTH increase in patients with CD are poorly understood. Objective: The objectives of this study were to determine, for the first time, whether desmopressin acts directly and exclusively on pituitary corticotropinoma cells to stimulate ACTH expression/release and to elucidate the cellular and molecular mechanisms involved in desmopressin-induced ACTH increase in CD. Design: A total of 8 normal pituitaries (NPs), 23 corticotropinomas, 14 nonfunctioning pituitary adenomas, 17 somatotropinomas, and 3 prolactinomas were analyzed for AVPR expression by quantitative real-time RT-PCR. Primary cultures derived from corticotropinomas, nonfunctioning pituitary adenomas, somatotropinomas, prolactinomas, and NPs were treated with desmopressin, and ACTH secretion/expression, [Ca2+]i kinetics, and AVPR expression and/or proliferative response were evaluated. The relationship between AVPR expression and plasma adrenocorticotropin/cor-tisol levels obtained from desmopressin tests was assessed. Results: Desmopressin affects all functional parameters evaluated in corticotropinoma cells but not in NPs or other pituitary adenomas cells. These effects might be due to the dramatic elevation of AVPR1b expression levels found in corticotropinomas. In line with this notion, the use of an AVPR1b antagonist completely blocked desmopressin stimulatory effects. Remarkably, only AVPR1b expression was positively correlated with elevated plasma adrenocorticotropin levels in corticotropinomas. Conclusions: The present results provide a cellular and molecular basis to support the desmopressin stimulation test as a reliable, specific test for the diagnosis and postsurgery prognosis of CD. Furthermore, our data indicate that AVPR1b is responsible for the direct/exclusive desmopressin stimulatory pituitary effects observed in CD, thus opening the possibility of exploring AVPR1b antagonists as potential therapeutic tools for CD treatment.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in type 2 Diabetes Mellitus

  • Alcubierre Calvo, Núria
  • Valls Marsal, Joan
  • Rubinat, Esther
  • Cao, Gonzalo
  • Esquerda, Aureli
  • Traveset Maeso, Alicia
  • Granado Casas, Minerva
  • Jurjo Campo, Carmen
  • Mauricio Puente, Dídac
There is very few evidences on the role of vitamin D in the development of diabetic retinopathy. The aim of the current study was to explore whether there is an association of vitamin D status and diabetic retinopathy in type 2 diabetes. Two groups of patients were selected: 139 and 144 patients with and without retinopathy, respectively, as assessed by an experienced ophthalmologist. Subjects with advanced late diabetic complications were excluded to avoid confounding biases. 25-Hydroxy-vitamin D3 (25(OH)D) concentrations and vitamin D deficiency were associated with the presence of diabetic retinopathy. Additionally, patients with more advanced stages of retinopathy (grades 2<br>4) had lower concentrations of 25(OH)D and were more frequently vitamin D deficient as compared with patients not carrying this eye complication. In conclusion, our study confirms the association of vitamin D deficiency with the presence and severity of diabetic retinopathy in type 2 diabetes. Further experimental and prospective studies on this issue are clearly warranted., The authors are grateful to all staff members of the institutions involved in the study that contributed to the recruitment of participants and supported our activities. This study was supported by Grant PS09/01035 from Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spain. Nuria Alcubierre holds a predoctoral fellowship also from Instituto de Salud Carlos III FI11/0008.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

  • Arrospide, Arantzazu
  • Forné Izquierdo, Carles
  • Rué i Monné, Montserrat
  • Torà, Núria
  • Mar, Javier
  • Baré, Marisa
Background: The aim of this study was to evaluate the calibration and discriminatory power of three predictive models of breast cancer risk. Methods: We included 13,760 women who were first-time participants in the Sabadell-Cerdanyola Breast Cancer Screening Program, in Catalonia, Spain. Projections of risk were obtained at three and five years for invasive cancer using the Gail, Chen and Barlow models. Incidence and mortality data were obtained from the Catalan registries. The calibration and discrimination of the models were assessed using the Hosmer-Lemeshow C statistic, the area under the receiver operating characteristic curve (AUC) and the Harrell’s C statistic. Results: The Gail and Chen models showed good calibration while the Barlow model overestimated the number of cases: the ratio between estimated and observed values at 5 years ranged from 0.86 to 1.55 for the first two models and from 1.82 to 3.44 for the Barlow model. The 5-year projection for the Chen and Barlow models had the highest discrimination, with an AUC around 0.58. The Harrell’s C statistic showed very similar values in the 5-year projection for each of the models. Although they passed the calibration test, the Gail and Chen models overestimated the number of cases in some breast density categories. Conclusions: These models cannot be used as a measure of individual risk in early detection programs to customize screening strategies. The inclusion of longitudinal measures of breast density or other risk factors in joint models of survival and longitudinal data may be a step towards personalized early detection of BC., This study was funded by grant PS09/01340 and The Spanish Network on Chronic Diseases REDISSEC (RD12/0001/0007) from the Health Research Fund (Fondo de Investigación Sanitaria) of the Spanish Ministry of Health.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Left carotid adventitial vasa vasorum signal correlates directly with age and with left carotid intima-media thickness in individuals without atheromatous risk factors

  • Arcidiacono, Maria V.
  • Rubinat, Esther
  • Borràs, Mercè
  • Betriu i Bars, M. Àngels
  • Trujillano Cabello, Javier
  • Vidal, Teresa
  • Mauricio Puente, Dídac
  • Fernández i Giráldez, Elvira
Objective: The early identification of the onset of subclinical atheromatosis is essential in reducing the high mortality risk from cardiovascular disease (CVD) worldwide. Although carotid intima-media thickness (cIMT) is the most commonly used early predictor of ongoing atherosclerosis, an experimental model of atherosclerosis, demonstrated that increases in adventitial microvessels (vasa vasorum (VV)) precede endothelial dysfunction. Using the reported accuracy of contrast-enhanced ultrasound (CEU) to measure carotid adventitial VV, this study assessed whether measurements of carotid adventitial VV serve as a marker of subclinical atherosclerotic lesions in a control population with none of the classical risk factors for CVD. Methods and results: Measurements of cIMT (B-mode ultrasound) and adventitial VV (CEU) were conducted in 65 subjects, 30–70 years old, 48% men, with none of the classical risk factors for CVD. Adventitial VV strongly correlated with its own cIMT only in the left carotid artery. Importantly, the left carotid adventitial VV directly correlated with age. Conclusions: The increases with age in left carotid adventitial VV in individuals with zero risk for atheromatosis suggest that the measurement of carotid adventitial VV could be an accurate and sensitive marker for the diagnosis of subclinical atheromatosis and therefore a prominent tool for monitoring the efficacy of anti-atheromatous therapies. Keywords: Atheromatosis, Vasa vasorum, Contrast-enhanced ultrasound, Carotid arteries, Adventitial layer, This study was funded by grants No. PI09/1999; No. PS09/01035 and PI12/00183, from the Health Institute Carlos III, Ministry of Economy and Competitiveness, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer

  • Vilaprinyo Terré, Ester
  • Forné Izquierdo, Carles
  • Carles Lavila, Misericordia
  • Sala i Serra, Maria
  • Pla Farnós, Roger
  • Castells, Xavier
  • Domingo, Laia
  • Rué i Monné, Montserrat
  • Interval Cancer Study Group
The one-size-fits-all paradigm in organized screening of breast cancer is shifting towards a personalized approach. The present study has two objectives: 1) To perform an economic evaluation and to assess the harm-benefit ratios of screening strategies that vary in their intensity and interval ages based on breast cancer risk; and 2) To estimate the gain in terms of cost and harm reductions using risk-based screening with respect to the usual practice. We used a probabilistic model and input data from Spanish population registries and screening programs, as well as from clinical studies, to estimate the benefit, harm, and costs over time of 2,624 screening strategies, uniform or risk-based. We defined four risk groups, low, moderate-low, moderate-high and high, based on breast density, family history of breast cancer and personal history of breast biopsy. The risk-based strategies were obtained combining the exam periodicity (annual, biennial, triennial and quinquennial), the starting ages (40, 45 and 50 years) and the ending ages (69 and 74 years) in the four risk groups. Incremental cost-effectiveness and harm-benefit ratios were used to select the optimal strategies. Compared to risk-based strategies, the uniform ones result in a much lower benefit for a specific cost. Reductions close to 10% in costs and higher than 20% in false-positive results and overdiagnosed cases were obtained for risk-based strategies. Optimal screening is characterized by quinquennial or triennial periodicities for the low or moderate risk-groups and annual periodicity for the high-risk group. Risk-based strategies can reduce harm and costs. It is necessary to develop accurate measures of individual risk and to work on how to implement risk-based screening strategies., This study was funded by grants PS09/01340 and PS09/01153 from the Health Research Fund (Fondo de Investigación Sanitaria) of the Spanish Ministry of Health. The authors thank the Breast Cancer Surveillance Consortium and the funding that the BCSC received from the National Cancer Institute (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy

  • Sanahuja Montesinos, Jordi
  • Alonso, Núria
  • Diez, Javier
  • Ortega, Emilio
  • Rubinat, Esther
  • Traveset Maeso, Alicia
  • Alcubierre Calvo, Núria
  • Betriu i Bars, M. Àngels
  • Castelblanco Echavarría, Esmeralda
  • Hernández García, Marta
  • Purroy Garcia, Francisco
  • Arcidiacono, Maria V.
  • Jurjo Campo, Carmen
  • Fernández i Giráldez, Elvira
  • Puig-Domingo, Manuel
  • Groop, Per-Henrik
  • Mauricio Puente, Dídac
OBJECTIVE We sought to examine the presence and severity of brain small vessel disease (SVD) in patients with type 2 diabetes and diabetic retinopathy (DR) compared with those without DR. RESEARCH DESIGN AND METHODS We evaluated 312 patients with type 2 diabetes without previous cardiovascular disease (men 51%; mean age 57 years; age range 40–75 years); 153 patients (49%) had DR. MRI was performed to evaluate the presence and severity (age-related white matter changes scale) of white matter lesions (WMLs) and lacunes, and transcranial Doppler ultrasound was used to measure the Gosling pulsatility index (PI) of the middle cerebral artery (MCA). RESULTS The prevalence of lesions of cerebral SVD (WML and/or lacunes) was higher in patients with DR (40.2% vs. 30.1% without DR, P = 0.04). Age (P < 0.01) and systolic blood pressure (P = 0.02) were associated with the presence of SVD. The severity of SVD was associated with age and the presence of DR (P < 0.01 and P = 0.01, respectively). Patients with DR showed a higher MCA PI compared with those without DR (P < 0.01). Age, systolic and diastolic blood pressure, and retinopathy and its severity were associated with an increased MCA PI (P < 0.01 for all variables). A positive correlation was found between MCA PI values and the presence and severity of SVD (P < 0.01 for both variables). CONCLUSIONS Patients with type 2 diabetes who have DR have an increased burden of cerebral SVD compared with those without DR. Our findings suggest that the brain is a target organ for microangiopathy, similar to other classic target organs, like the retina., This study was supported by grant PS09/01035 from Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spain, and CIBERDEM is an initiative from Instituto de Salud Carlos III (Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)

  • Carles Lavila, Misericordia
  • Vilaprinyo Terré, Ester
  • Cots, Francesc
  • Gregori Gomis, Aleix
  • Pla Farnós, Roger
  • Román, Rubén
  • Sala i Serra, Maria
  • Macià, Francesc
  • Castells, Xavier
  • Rué i Monné, Montserrat
Background: Breast cancer (BC) causes more deaths than any other cancer among women in Catalonia. Early detection has contributed to the observed decline in BC mortality. However, there is debate on the optimal screening strategy. We performed an economic evaluation of 20 screening strategies taking into account the cost over time of screening and subsequent medical costs, including diagnostic confirmation, initial treatment, follow-up and advanced care. Methods: We used a probabilistic model to estimate the effect and costs over time of each scenario. The effect was measured as years of life (YL), quality-adjusted life years (QALY), and lives extended (LE). Costs of screening and treatment were obtained from the Early Detection Program and hospital databases of the IMAS-Hospital del Mar in Barcelona. The incremental cost-effectiveness ratio (ICER) was used to compare the relative costs and outcomes of different scenarios. Results: Strategies that start at ages 40 or 45 and end at 69 predominate when the effect is measured as YL or QALYs. Biennial strategies 50-69, 45-69 or annual 45-69, 40-69 and 40-74 were selected as cost-effective for both effect measures (YL or QALYs). The ICER increases considerably when moving from biennial to annual scenarios. Moving from no screening to biennial 50-69 years represented an ICER of 4,469€ per QALY. Conclusions: A reduced number of screening strategies have been selected for consideration by researchers, decision makers and policy planners. Mathematical models are useful to assess the impact and costs of BC screening in a specific geographical area., This study was funded by grants PI06/1649, PI06/90355 and PS09/01340 from the Health Research Fund (Fondo de Investigación Sanitaria) of the Spanish Ministry of Health and by grant 068/27/06 from the Catalan Agency for Health Technology Assessment (Agència d'Avaluació de Tecnologia i Recerca Mèdiques).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe

  • Cornago Protomártir, Marta
  • Garcia-Alberich, C.
  • Blasco Angulo, Natividad
  • Vall-llaura Espinosa, Núria
  • Nàger Grifo, Mireia
  • Herreros Danés, Judit
  • Comella i Carnicé, Joan Xavier
  • Sanchis, Daniel
  • Llovera i Tomàs, Marta
Glioblastoma multiforme is resistant to conventional anti-tumoral treatments due to its infiltrative nature and capability of relapse; therefore, research efforts focus on characterizing gliomagenesis and identifying molecular targets useful on therapy. New therapeutic strategies are being tested in patients, such as Histone deacetylase inhibitors (HDACi) either alone or in combination with other therapies. Here two HDACi included in clinical trials have been tested, suberanilohydroxamic acid (SAHA) and valproic acid (VPA), to characterize their effects on glioma cell growth in vitro and to determine the molecular changes that promote cancer cell death. We found that both HDACi reduce glioma cell viability, proliferation and clonogenicity. They have multiple effects, such as inducing the production of reactive oxygen species (ROS) and activating the mitochondrial apoptotic pathway, nevertheless cell death is not prevented by the pan-caspase inhibitor Q-VD-OPh. Importantly, we found that HDACi alter cell cycle progression by decreasing the expression of G2 checkpoint kinases Wee1 and checkpoint kinase 1 (Chk1). In addition, HDACi reduce the expression of proteins involved in DNA repair (Rad51), mitotic spindle formation (TPX2) and chromosome segregation (Survivin) in glioma cells and in human glioblastoma multiforme primary cultures. Therefore, HDACi treatment causes glioma cell entry into mitosis before DNA damage could be repaired and to the formation of an aberrant mitotic spindle that results in glioma cell death through mitotic catastrophe-induced apoptosis., This work was supported by the Spanish Ministry of Health grant ISCIII and the European Fund for Regional Development (FEDER) PS09/00140 to ML, ISCIII-PI080790 to JH and Programa de Suport a Grups de Recerca from the Government of Catalonia (AGAUR) (2009-SGR-346) to ML, DS and JXC.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers

  • López-Mejías, Raquel
  • Castañeda, Santos
  • González-Juanatey, Carlos
  • Corrales, Alfonso
  • Ferraz-Amaro, Iván
  • Genre, Fernanda
  • Rodríguez-Rodríguez, Luis
  • Blanco, Ricardo
  • Llorca, Javier
  • Martín, J.
  • González-Gay, Miguel A.
Cardiovascular disease (CV) is the most common cause of premature mortality in patients with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process. Adequate CV risk stratification has special relevance in RA to identify patients at risk of CV disease. However, current CV risk screening and management strategies underestimate the actual CV risk in RA. Consequently, the search for additional tools that may help to identify those patients at high CV risk has become a key objective in the last years. In this regard, non-invasive surrogates, such as carotid ultrasonography, have been found to be excellent predictors of future CV events. In addition, several studies have revealed the relevance of a genetic component in the development of CV disease in RA patients. Besides an association with HLA-DRB1* shared epitope alleles other gene polymor-phisms located inside and outside the HLA seem to influence the risk of cardiovascular disease in RA. Moreover, serum levels of some metabolic syndrome-related biomarkers, adipokines such as adiponectin and biomarkers of endothelial cell activation and inflammation such as Osteoprotegerin and Asymmetric dimethylarginine have recently been found useful for the prediction of CV disease in these patients. An update of the current knowledge on these potential markers, especially focused on new genetic and serological biomarkers is shown in this review. (C) 2016 The Authors. Published by Elsevier B.V., This work was supported by European Union FEDER funds and "Fondo de Investigation Sanitaria" (grants PI06/0024, PS09/00748, PI12/00060 and PI15/00525) from 'Institut de Salud Carlos III' (ISCIII, Health Ministry, Spain). It was also partially supported by RETICS Programs RD12/0009 (RIER) from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain), and in part by grants from the European IMI BTCure Program. We wish to specially thank Mercedes Garcia-Bermudez, Begona Ubilla, Veronica Mijares, Patricia Fuentevilla Rodriguez, Virginia Portilla Gonzalez and all the clinicians from Spanish National Health Care system that have been involved in our studies., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients., Deletion at 6q24.2–26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

  • Kamieniak, Marta M.
  • Rico, Daniel
  • Milne, Roger L.
  • Muñoz-Repeto, Ivan
  • Ibáñez, Kristina
  • Grillo, Miguel A.
  • Domingo, Samuel
  • Borrego, Salud
  • Cazorla, Alicia
  • García-Bueno, José M.
  • Hernando, Susana
  • García-Donas, Jesús
  • Hernández-Agudo, Elena
  • Y Cajal, Teresa Ramón
  • Robles-Díaz, Luis
  • Márquez-Rodas, Ivan
  • Cusidó, Maite
  • Sáez, Raquel
  • Lacambra-Calvet, Carmen
  • Osorio, Ana
  • Urioste, Miguel
  • Cigudosa, Juan C.
  • Paz-Ares, Luis
  • Palacios Calvo, José
  • Benítez, Javier
  • García, María J.
Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome. Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR = 0.15, 95%CI = 0.03–0.81; Padj = 0.03). We found that loss at 6q24.2–26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01–0.43, Padj = 0.005). The prognostic value of this deletion was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P = 0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR = 0.67, 95%CI = 0.48–0.93, Padj = 0.019). In addition, we confirmed the association of low expression of the genes from the region with longer survival in 799 HGSOCs (HR = 0.74, 95%CI = 0.61–0.90, log-rank P = 0.002) and 675 high-FIGO stage HGSOCs (HR = 0.76, 95%CI = 0.61–0.96, log-rank P = 0.02) available from the online tool KM-plotter. Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate genes that can potentially explain the association. Altogether our findings indicate that the 6q24.2–26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life., This study was financially supported by the Fondo de Investigación Sanitaria (FIS), Instituto de Salud Carlos III (grants PS09/01094 and PI12/01319). MJG is recipient of a research contract from the Instituto de Salud Carlos III of the Ministerio Español de Sanidad y Consumo (Miguel Servet tipo II Program, CPII 13/00047). MMK and KI have financial support from the Fundación La Caixa. DR and KI are supported by grant BIO2012-40205. LP-A, JCC and JP are recipients of financial support from Red Temática de Investigación Cooperativa en Cáncer (RTICC) (grants RD12/0036/0028, RD12/0036/0037 and RD12/0036/0064)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Image analysis for the quantitative comparison of stress fibers and focal adhesions

  • Elosegui-Artola, A.
  • Jorge-Peñas, A.
  • Moreno-Arotzena, O.
  • Oregi, A.
  • Lasa, M.
  • García-Aznar, J.M.
  • De Juan-Pardo, E.M.
  • Aldabe, R.
Actin stress fibers (SFs) detect and transmit forces to the extracellular matrix through focal adhesions (FAs), and molecules in this pathway determine cellular behavior. Here, we designed two different computational tools to quantify actin SFs and the distribution of actin cytoskeletal proteins within a normalized cellular morphology. Moreover, a systematic cell response comparison between the control cells and those with impaired actin cytoskeleton polymerization was performed to demonstrate the reliability of the tools. Indeed, a variety of proteins that were present within the string beginning at the focal adhesions (vinculin) up to the actin SFs contraction (non-muscle myosin II (NMMII)) were analyzed. Finally, the software used allows for the quantification of the SFs based on the relative positions of FAs. Therefore, it provides a better insight into the cell mechanics and broadens the knowledge of the nature of SFs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: Results of the randomized AZABACHE Spanish trial

  • García-Sanz, R.
  • Oriol, A.
  • Moreno, M.J.
  • Rubia, De La
  • Payer, A.R.
  • Hernández, M.T.
  • Palomera, L.
  • Teruel, A.I.
  • Blanchard, M.J.
  • Gironella, M.
  • Ribas, P.
  • Bargay, J.
  • Abellá, E.
  • Granell, M.
  • Ocio, E.M.
  • Ribera, J.M.
  • San Miguel, J.F.
  • Mateos, M.V.
This study analyzed the anti-myeloma effect of zoledronic acid monotherapy by investigating patients at the time of asymptomatic biochemical relapse. One hundred patients were randomized to receive either zoledronic acid (4 mg iv/4 weeks, 12 doses) (n=51) or not (n=49). Experimental and control groups were well balanced for disease and prognostic features. Zoledronic acid did not show an antitumor effect according to changes in M-component. However, there were fewer symptomatic progressions in the experimental group than in the control group (34 ver- sus 41, respectively; P=0.05) resulting in a median time to symptoms of 16 versus 10 months (P=0.161). The median time to next therapy was also slightly longer for the treated group than the untreated, control group (13.4 versus 10.1 months), although the difference was not statistically significant (P=0.360). The pattern of relapses was dif- ferent for treated versus control patients: progressive bone disease (8 versus 20), anemia (24 versus 18), renal dysfunc- tion (1 versus 2), and plasmacytomas (1 versus 1, respectively). This concurred with fewer skeletal-related events in the treated group than in the control group (2 versus 14), with a projected 4-year event proportion of 6% versus 40% (P<0.001). In summary, zoledronic acid monotherapy does not show an antitumor effect on biochemical relapses in multiple myeloma, but does reduce the risk of progression with symptomatic bone disease and skeletal compli- cations. This trial was registered in the ClinicalTrials.gov database with code NCT01087008
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes

  • Cano, V.
  • March, C.
  • Insua, J.L.
  • Aguiló, N.
  • Llobet, E.
  • Moranta, D.
  • Regueiro, V.
  • Brennan, G.P.
  • Millán-Lou, M.I.
  • Martín, C.
  • Garmendia, J.
  • Bengoechea, J.A.
Klebsiella pneumoniae is an important cause of community-acquired and nosocomial pneumonia. Evidence indicates that Klebsiella might be able to persist intracellularly within a vacuolar compartment. This study was designed to investigate the interaction between Klebsiella and macrophages. Engulfment of K.pneumoniae was dependent on host cytoskeleton, cell plasma membrane lipid rafts and the activation of phosphoinositide 3-kinase (PI3K). Microscopy studies revealed that K.pneumoniae resides within a vacuolar compartment, the Klebsiella-containing vacuole (KCV), which traffics within vacuoles associated with the endocytic pathway. In contrast to UV-killed bacteria, the majority of live bacteria did not co-localize with markers of the lysosomal compartment. Our data suggest that K.pneumoniae triggers a programmed cell death in macrophages displaying features of apoptosis. Our efforts to identify the mechanism(s) whereby K.pneumoniae prevents the fusion of the lysosomes to the KCV uncovered the central role of the PI3K-Akt-Rab14 axis to control the phagosome maturation. Our data revealed that the capsule is dispensable for Klebsiella intracellular survival if bacteria were not opsonized. Furthermore, the environment found by Klebsiella within the KCV triggered the down-regulation of the expression of cps. Altogether, this study proves evidence that K.pneumoniae survives killing by macrophages by manipulating phagosome maturation that may contribute to Klebsiella pathogenesis. Prevailing belief states that the human pathogens Klebsiella pneumoniae is an extracellular pathogen. However, in this work, we demonstrate that K. pneumoniae co-opts the maturation of the phagosome manipulating a PI3K-AKT-RAB14 signalling cascade. Here, we also demonstrate that by preventing the activation of this cascade, the macrophages eliminate intracellular Klebsiella.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: Results of a prospective phase 2 Spanish/PETHEMA trial

  • Mateos, M.V
  • Orio, A.
  • Rosiño, L.
  • Arriba, F.D.
  • Puig, N.
  • Martín, J.
  • Martínez-López, J.
  • Echeveste, M.A.
  • Sarrá, J.
  • Ocio, E.
  • Ramírez, G.
  • Martínez, R.
  • Palomera, L.
  • Payer, A.
  • Iglesias, R.
  • De Rubia, J.L.
  • Alegre, A.
  • Chinea, A.I.
  • Bladé, J.
  • Lahuerta, J.J.
  • Miguel, J.F S.
Bendamustine is a bifunctional alkylating agent with proven activity in myeloma. In this study 60 newly diag- nosed myeloma patients were given bendamustine plus bortezomib and prednisone in a regimen consisting of one cycle of bortezomib twice weekly for 6 weeks (1.3 mg/m2 on days 1, 4, 8, 11, 22, 25, 29, and 32), plus bendamus- tine (90 mg/m2 on days 1 and 4) and prednisone. The following cycles included bortezomib once weekly. Patients who were transplant candidates proceeded to stem cell collection after four cycles and the transplant was per- formed after six cycles. Patients who were not candidates for transplantation received up to nine cycles. Forty-two patients were transplant candidates and after six cycles, 50% achieved at least a very good partial response, with 24% having complete responses; 35 proceeded to a transplant, and the complete response rate was 54%. Seventeen patients continued up to nine cycles, and 57% achieved at least a very good partial response, including 26% with complete responses. The 2-year progression-free survival and overall survival rates were 62% and 86%, respectively. The safety profile was manageable, but stem cell mobilization was compromised in 35% of patients. In summary, this combination is effective in untreated patients, with an acceptable toxicity profile, but given the introduction of second-generation novel agents and monoclonal antibodies, the combination will probably be bet- ter reserved for relapsing patients, in whom stem cell collection is not needed, while cost-effective combinations with non-cross-resistant drugs continue to represent a medical need. This trial was registered with ClinicalTrials.gov, number NCT01376401.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Fernblock (Polypodium leucotomos extract): Molecular mechanisms and pleiotropic effects in light-related skin conditions, photoaging and skin cancers, a review

  • Parrado, C.
  • Mascaraque, M.
  • Gilaberte, Y.
  • Juarranz, A.
  • Gonzalez, S.
Healthier life styles include increased outdoors time practicing sports and walking. This means increased exposure to the sun, leading to higher risk of sunburn, photoaging and skin cancer. In addition to topical barrier products, oral supplementations of various botanicals endowed with antioxidant activity are emerging as novel method of photoprotection. Polypodium leucotomos extract (PL, commercial name Fernblock®, IFC Group, Spain) is a powerful antioxidant due to its high content of phenolic compounds. PL is administered orally, with proven safety, and it can also be used topically. Its mechanisms include inhibition of the generation and release of reactive oxygen species (ROS) by ultraviolet (UV) light. It also prevents UV- and ROS-induced DNA damage with inhibition of AP1 and NF-¿B and protection of natural antioxidant enzyme systems. At the cellular level, PL decreases cellular apoptosis and necrosis mediated UV and inhibits abnormal extracellular matrix remodeling. PL reduces inflammation, prevents immunosuppression, activates tumor suppressor p53 and inhibits UV-induced cyclooxygenase-2 (COX-2) enzyme expression. In agreement with increased p53 activity, PL decreased UV radiation-induced cell proliferation. PL also prevents common deletions mitochondrial DNA damage induced by UVA, and MMP-1 expression induced Visible Light and Infrared Radiation. These cellular and molecular effects are reflected in inhibitions of carcinogenesis and photoaging.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation

  • Srivastava, Girish Kumar
  • Rodríguez-Crespo, David
  • Singh, Amar Kumar
  • Casado-Coterillo, Clara
  • Fernandez-Bueno, Ivan
  • Garcia-Gutierrez, Maria T.
  • Coronas, Joaquin
  • Pastor, J. Carlos
Retinal stem cells (RSCs) are promising in cell replacement strategies for retinal diseases. RSCs can migrate, differentiate, and integrate into retina. However, RSCs transplantation needs an adequate support; chitosan membrane (ChM) could be one, which can carry RSCs with high feasibility to support their integration into retina. RSCs were isolated, evaluated for phenotype, and subsequently grown on sterilized ChM and polystyrene surface for 8 hours, 1, 4, and 11 days for analysing cell adhesion, proliferation, viability, and phenotype. Isolated RSCs expressed GFAP, PKC, isolectin, recoverin, RPE65, PAX-6, cytokeratin 8/18, and nestin proteins. They adhered (28 ± 16%, 8 hours) and proliferated (40 ± 20 cells/field, day 1 and 244 ± 100 cells/field, day 4) significantly low on ChM. However, they maintained similar viability (>95%) and phenotype (cytokeratin 8/18, PAX6, and nestin proteins expression, day 11) on both surfaces (ChM and polystyrene). RSCs did not express alpha-SMA protein on both surfaces. RSCs express proteins belonging to epithelial, glial, and neural cells, confirming that they need further stimulus to reach a final destination of differentiation that could be provided in in vivo condition. ChM does not alternate RSCs behaviour and therefore can be used as a cell carrier so that slow proliferating RSCs can migrate and integrate into retina.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Preventing the onset of major depression based on the level and profile of risk of primary care attendees: Protocol of a cluster randomised trial (the predictD-CCRT study)

  • Bellón, J.A.
  • Conejo-Cerón, S.
  • Moreno-Peral, P.
  • King, M.
  • Nazareth, I.
  • Martín-Pérez, C.
  • Fernández-Alonso, C.
  • Ballesta-Rodríguez, M.I.
  • Fernández, A.
  • Aiarzaguena, J.M.
  • Montón-Franco, C.
  • Ibanez-Casas, I.
  • Rodríguez-Sánchez, E.
  • Rodríguez-Bayón, A.
  • Serrano-Blanco, A.
  • Gómez, M. C.
  • LaFuente, P.
  • Muñoz García, M.M.
  • Mínguez-Gonzalo, P.
  • Araujo, L.
  • Palao, D.
  • Espinosa-Cifuentes, M.
  • Zubiaga, F.
  • Navas-Campaña, D.
  • Mendive, J.
  • Aranda-Regules, J.
  • Rodriguez-Morejón, A.
  • Salvador-Carulla, L.
  • de Dios Luna, J.
Background: The ''predictD algorithm'' provides an estimate of the level and profile of risk of the onset of major depression in primary care attendees. This gives us the opportunity to develop interventions to prevent depression in a personalized way. We aim to evaluate the effectiveness, cost-effectiveness and cost-utility of a new intervention, personalized and implemented by family physicians (FPs), to prevent the onset of episodes of major depression.Methods/Design: This is a multicenter randomized controlled trial (RCT), with cluster assignment by health center and two parallel arms. Two interventions will be applied by FPs, usual care versus the new intervention predictD-CCRT. The latter has four components: a training workshop for FPs; communicating the level and profile of risk of depression; building up a tailored bio-psycho-family-social intervention by FPs to prevent depression; offering a booklet to prevent depression; and activating and empowering patients. We will recruit a systematic random sample of 3286 non-depressed adult patients (1643 in each trial arm), nested in 140 FPs and 70 health centers from 7 Spanish cities. All patients will be evaluated at baseline, 6, 12 and 18 months. The level and profile of risk of depression will be communicated to patients by the FPs in the intervention practices at baseline, 6 and 12 months. Our primary outcome will be the cumulative incidence of major depression (measured by CIDI each 6 months) over 18 months of follow-up. Secondary outcomes will be health-related quality of life (SF-12 and EuroQol), and measurements of cost-effectiveness and cost-utility. The inferences will be made at patient level. We shall undertake an intention-to-treat effectiveness analysis and will handle missing data using multiple imputations. We will perform multi-level logistic regressions and will adjust for the probability of the onset of major depression at 12 months measured at baseline as well as for unbalanced variables if appropriate. The economic evaluation will be approached from two perspectives, societal and health system.Discussion: To our knowledge, this will be the first RCT of universal primary prevention for depression in adults and the first to test a personalized intervention implemented by FPs. We discuss possible biases as well as other limitations.Trial registration: ClinicalTrials.gov identifier: NCT01151982.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A tool to assess sex-gender when selecting health research projects

  • Tomás, C.
  • Yago, T.
  • Eguiluz, M.
  • Samitier, M. L.
  • Oliveros, T.
  • Palacios, G.
Objective To validate the questionnaire “Gender Perspective in Health Research” (GPIHR) to assess the inclusion of gender perspective in research projects. Design Validation study in two stages. Feasibility was analysed in the first, and reliability, internal consistence and validity in the second. Where Aragón Institute of Health Science, Aragón, Spain. Participants GPIHR was applied to 118 research projects funded in national and international competitive tenders from 2003 to 2012. Main measurements Analysis of inter- and intra-observer reliability with Kappa index and internal consistency with Cronbach's alpha. Content validity analysed through literature review and construct validity with an exploratory factor analysis. Results Validated GPIHR has 10 questions: 3 in the introduction, 1 for objectives, 3 for methodology and 3 for research purpose. Average time of application was 13 min Inter-observer reliability (Kappa) varied between 0.35 and 0.94 and intra-observer between 0.40 and 0.94. Theoretical construct is supported in the literature. Factor analysis identifies three levels of GP inclusion: “difference by sex”, “gender sensitive” and “feminist research” with an internal consistency of 0.64, 0.87 and 0.81, respectively, which explain 74.78% of variance. Conclusions GPIHR questionnaire is a valid tool to assess GP and useful for those researchers who would like to include GP in their projects.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, S.
  • Lorenzo Bermejo, J.
  • Chang Claude, J.
  • Hoffmeister, M.
  • Fernández Rozadilla, C.
  • Carracedo, A.
  • Castells, A.
  • Castellví Bel, S.
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Antoni, C.
  • Virgínia, P.
  • Sergi, C.B.
  • Balaguer, F.
  • Victoria, G.
  • Teresa, O.
  • María Dolores, G.
  • Maria, P.
  • Anna, S.
  • Leticia, M.
  • Miriam, C.
  • Josep, M.P.
  • Lanas, A.
  • Alcedo, J.
  • Ortego, F.J.
  • Joaquin, C.
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Montserrat, A.
  • Anna, A.
  • Xavier, B.
  • Mar, I.
  • Agustín, S.
  • Felipe, B.
  • Gemma, N.
  • Beatriz, B.
  • De Josep, M.
  • Cristina, Á.
  • Marc, P.
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, d.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Cristina, A.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Jaime, C.
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Jaime, S.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Antoni, T.
  • Juan, C.
  • Vicent, H.
  • Xavier, L.
  • Rosa, M.X.
  • Marta, P.
  • Mercè, R.
  • Anna, R.
  • Elisenda, P.
  • José, M.H.
  • Miquel, A.G.
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, E.
  • Montserrat, F.
  • Maria, E.
  • Josep, M.R.
  • Carmen, P.
  • Juan, B.
  • Joan, V.
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • Dolors, G.
  • Eva, R.
  • Teresa, R.
  • Maria, P.
  • Ma, M.C.
  • Marta, M.
  • Lourdes, P.
  • Daniel, M.
  • Ángel, C.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno, V.
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, H.
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Impact of multimorbidity on disability and quality of life in the Spanish older population

  • Garin, N.
  • Olaya, B.
  • Moneta, M. V.
  • Miret, M.
  • Lobo, A.
  • Ayuso-Mateos, J.
  • Haro, J. M.
Background Population aging is closely related to high prevalence of chronic conditions in developed countries. In this context, health care policies aim to increase life span cost-effectively while maintaining quality of life and functional ability. There is still, however, a need for further understanding of how chronic conditions affect these health aspects. The aim of this paper is to assess the individual and combined impact of chronic physical and mental conditions on quality of life and disability in Spain, and secondly to show gender trends. Methods Cross-sectional data were collected from the COURAGE study. A total of 3,625 participants over 50 years old from Spain were included. Crude and adjusted multiple linear regressions were conducted to detect associations between individual chronic conditions and disability, and between chronic conditions and quality of life. Separate models were used to assess the influence of the number of diseases on the same variables. Additional analogous regressions were performed for males and females. Results All chronic conditions except hypertension were statistically associated with poor results in quality of life and disability. Depression, anxiety and stroke were found to have the greatest impact on outcomes. The number of chronic conditions was associated with substantially lower quality of life [ß for 4+ diseases: -18.10 (-20.95,-15.25)] and greater disability [ß for 4+ diseases: 27.64 (24.99,30.29]. In general, women suffered from higher rates of multimorbidity and poorer results in quality of life and disability. Conclusions Chronic conditions impact greatly on quality of life and disability in the older Spanish population, especially when co-occurring diseases are added. Multimorbidity considerations should be a priority in the development of future health policies focused on quality of life and disability. Further studies would benefit from an expanded selection of diseases. Policies should also deal with gender idiosyncrasy in certain cases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial

  • Fernandez, A.
  • Mendive, J.M.
  • Conejo-Ceron, S.
  • Moreno-Peral, P.
  • King, M.
  • Nazareth, I.
  • Martin-Perez, C.
  • Fernandez-Alonso, C.
  • Rodriguez-Bayon, A.
  • Aiarzaguena, J.M.
  • Monton-Franco, C.
  • Serrano-Blanco, A.
  • Ibanez-Casas, I.
  • Rodriguez-Sanchez, E.
  • Salvador-Carulla, L.
  • Garay, P.B.
  • Ballesta-Rodriguez, M.I.
  • LaFuente, P.
  • Munoz-Garcia, M.D.
  • Minguez-Gonzalo, P.
  • Araujo, L.
  • Palao, D.
  • Gomez, M.C.
  • Zubiaga, F.
  • Navas-Campana, D.
  • Aranda-Regules, J.M.
  • Rodriguez-Morejon, A.
  • Luna, J.D.
  • Bellon, J.A.
Background: Depression is viewed as a major and increasing public health issue, as it causes high distress in the people experiencing it and considerable financial costs to society. Efforts are being made to reduce this burden by preventing depression. A critical component of this strategy is the ability to assess the individual level and profile of risk for the development of major depression. This paper presents the cost-effectiveness of a personalized intervention based on the risk of developing depression carried out in primary care, compared with usual care. Methods: Cost-effectiveness analyses are nested within a multicentre, clustered, randomized controlled trial of a personalized intervention to prevent depression. The study was carried out in 70 primary care centres from seven cities in Spain. Two general practitioners (GPs) were randomly sampled from those prepared to participate in each centre (i.e. 140 GPs), and 3326 participants consented and were eligible to participate. The intervention included the GP communicating to the patient his/her individual risk for depression and personal risk factors and the construction by both GPs and patients of a psychosocial programme tailored to prevent depression. In addition, GPs carried out measures to activate and empower the patients, who also received a leaflet about preventing depression. GPs were trained in a 10- to 15-h workshop. Costs were measured from a societal and National Health care perspective. Qualityadjustedlife years were assessed using the EuroQOL five dimensions questionnaire. The time horizon was 18 months. Results: With a willingness-to-pay threshold of (sic)10, 000 ((sic)8568) the probability of cost-effectiveness oscillated from 83% (societal perspective) to 89% (health perspective). If the threshold was increased to (sic)30, 000 ((sic)25, 704), the probability of being considered cost-effective was 94% (societal perspective) and 96%, respectively (health perspective). The sensitivity analysis confirmed these results. Conclusions: Compared with usual care, an intervention based on personal predictors of risk of depression implemented by GPs is a cost-effective strategy to prevent depression. This type of personalized intervention in primary care should be further developed and evaluated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

  • Lopez-Anglada, L.
  • Cueto-Felgueroso, C.
  • Rosiñol, L.
  • Oriol, A.
  • Teruel, A.I.
  • Lopez de la Guia, A.
  • Bengoechea, E.
  • Palomera, L.
  • de Arriba, F.
  • Hernandez, J.M.
  • Granell, M.
  • Peñalver, F.J.
  • Garcia-Sanz, R.
  • Besalduch, J.
  • Gonzalez, Y.
  • Martinez, R.B.
  • Hernandez, M.T.
  • Gutierrez, N.C.
  • Puerta, P.
  • Valeri, A.
  • Paiva, B.
  • Blade, J.
  • Mateos, M.V.
  • Miguel, J.S.
  • Lahuerta, J.J.
  • Martinez-Lopez, J.
We investigated the prognostic impact and clinical utility of serum free light chains (sFLC) and serum heavy-light chains (sHLC) in patients with multiple myeloma treated according to the GEM2005MENOS65, GEM2005MAS65, and GEM2010MAS65 PETHEMA/GEM phase III clinical trials. Serum samples collected at diagnosis were retrospectively analyzed for sFLC (n = 623) and sHLC (n = 183). After induction or autologous transplantation, 309 and 89 samples respectively were available for sFLC and sHLC assays. At diagnosis, a highly abnormal (HA) sFLC ratio (sFLCr) (<0.03 or >32) was not associated with higher risk of progression. After therapy, persistence of involved-sFLC levels >100 mg/L implied worse survival (overall survival [OS], P = 0.03; progression-free survival [PFS], P = 0.007). Among patients that achieved a complete response, sFLCr normalization did not necessarily indicate a higher quality response. We conducted sHLC investigations for IgG and IgA MM. Absolute sHLC values were correlated with monoclonal protein levels measured with serum protein electrophoresis. At diagnosis, HA-sHLCrs (<0.29 or >73) showed a higher risk of progression (P = 0.006). Additionally, involved-sHLC levels >5 g/L after treatment were associated with shorter survival (OS, P = 0.001; PFS, P = 0.018). The HA-sHLCr could have prognostic value at diagnosis; absolute values of involved-sFLC >100 mg/L and involved-sHLC >5 g/L could have prognostic value after treatment.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Variability of the prevalence of depression in function of sociodemographic and environmental factors: ecological model

  • Llorente, J.M.
  • Oliván-Blázquez, B.
  • Zuñiga-Antón, M.
  • Masluk, B.
  • Andres, E.
  • Garcia-Campayo, J.
  • Magallon-Botaya, R.
Major depression etiopathogenesis is related to a wide variety of genetics, demographic and psychosocial factors, as well as to environmental factors. The objective of this study is to analyze sociodemographic and environmental variables that are related to the prevalence of depression through correlation analysis and to develop a regression model that explains the behavior of this disease from an ecological perspective. This is an ecological, retrospective, cross-sectional study. The target population was 1,148,430 individuals over the age of 16 who were registered in Aragon (Spain) during 2010, with electronic medical records in the community’s primary health care centers. The spatial unit was the Basic Health Area (BHA). The dependent variable was the diagnosis of Depression and the ecological independent variables were: Demographic variables (gender and age), population distribution, typology of the entity, population structure by sex and age, by nationality, by education, by work, by salary, by marital status, structure of the household by number of members, and state of the buildings. The results show moderate and positive correlations with higher rates of depression in areas having a higher femininity index, higher population density, areas with a higher unemployment rate and higher average salary. The results of the linear regression show that aging +75 and rural entities act as protective factors for depression, while urban areas and deficient buildings act as risk factors. In conclusion, the ecological methodology may be a useful tool which, together with the statistical epidemiological analysis, can help in the political decision making process.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project

  • Giraldo, P.
  • Andrade-Campos, M.
  • Alfonso, P.
  • Irun, P.
  • Atutxa, K.
  • Acedo, A.
  • Barez, A.
  • Blanes, M.
  • Diaz-Morant, V.
  • Fernández-Galán, M.A.
  • Franco, R.
  • Gil-Cortes, C.
  • Giner, V.
  • Ibañez, A.
  • Latre, P.
  • Loyola, I.
  • Luño, E.
  • Hernández-Martin, R.
  • Medrano-Engay, B.
  • Puerta, J.
  • Roig, I.
  • de la Serna, J.
  • Salamero, O.
  • Villalón, L.
  • Pocovi, M.
We report data from a prospective, observational study (ZAGAL) evaluating miglustat 100 mg three times daily orally. in treatment-naïve patients and patients with type 1 Gaucher Disease (GD1) switched from previous enzyme replacement therapy (ERT). Clinical evolution, changes in organ size, blood counts, disease biomarkers, bone marrow infiltration (S-MRI), bone mineral density by broadband ultrasound densitometry (BMD), safety and tolerability annual reports were analysed. Between May 2004 and April 2016, 63 patients received miglustat therapy; 20 (32%) untreated and 43 (68%) switched. At the time of this report 39 patients (14 [36%] treatment-naïve; 25 [64%] switch) remain on miglustat. With over 12-year follow-up, hematologic counts, liver and spleen volumes remained stable. In total, 80% of patients achieved current GD1 therapeutic goals. Plasma chitotriosidase activity and CCL-18/PARC concentration showed a trend towards a slight increase. Reductions on S-MRI (p = 0.042) with an increase in BMD (p < 0.01) were registered. Gastrointestinal disturbances were reported in 25/63 (40%), causing miglustat suspension in 11/63 (17.5%) cases. Thirty-eight patients (60%) experienced a fine hand tremor and two a reversible peripheral neuropathy. Overall, miglustat was effective as a long-term therapy in mild to moderate naïve and ERT stabilized patients. No unexpected safety signals were identified during 12-years follow-up.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

  • Anguita-Ruiz, Augusto
  • Zarza-Rebollo, Juan Antonio
  • Pérez-Gutiérrez, Ana M.
  • Molina, Esther
  • Gutiérrez, Blanca
  • Bellón, Juan Ángel
  • Moreno-Peral, Patricia
  • Conejo-Cerón, Sonia
  • Aiarzagüena, Jose María
  • Ballesta-Rodríguez, M. Isabel
  • Fernández, Anna
  • Fernández-Alonso, Carmen
  • Martín-Pérez, Carlos
  • Montón-Franco, Carmen
  • Rodríguez-Bayón, Antonina
  • Torres-Martos, Álvaro
  • López-Isac, Elena
  • Cervilla, Jorge
  • Rivera, Margarita
Depression is strongly associated with obesity among other chronic physical diseases. The latest mega- and meta-analysis of genome-wide association studies have identified multiple risk loci robustly associated with depression. In this study, we aimed to investigate whether a genetic-risk score (GRS) combining multiple depression risk single nucleotide polymorphisms (SNPs) might have utility in the prediction of this disorder in individuals with obesity. A total of 30 depression-associated SNPs were included in a GRS to predict the risk of depression in a large case-control sample from the Spanish PredictD-CCRT study, a national multicentre, randomized controlled trial, which included 104 cases of depression and 1546 controls. An unweighted GRS was calculated as a summation of the number of risk alleles for depression and incorporated into several logistic regression models with depression status as the main outcome. Constructed models were trained and evaluated in the whole recruited sample. Non-genetic-risk factors were combined with the GRS in several ways across the five predictive models in order to improve predictive ability. An enrichment functional analysis was finally conducted with the aim of providing a general understanding of the biological pathways mapped by analyzed SNPs. We found that an unweighted GRS based on 30 risk loci was significantly associated with a higher risk of depression. Although the GRS itself explained a small amount of variance of depression, we found a significant improvement in the prediction of depression after including some non-genetic-risk factors into the models. The highest predictive ability for depression was achieved when the model included an interaction term between the GRS and the body mass index (BMI), apart from the inclusion of classical demographic information as marginal terms (AUC = 0.71, 95% CI = [0.65, 0.76]). Functional analyses on the 30 SNPs composing the GRS revealed an over-representation of the mapped genes in signaling pathways involved in processes such as extracellular remodeling, proinflammatory regulatory mechanisms, and circadian rhythm alterations. Although the GRS on its own explained a small amount of variance of depression, a significant novel feature of this study is that including non-genetic-risk factors such as BMI together with a GRS came close to the conventional threshold for clinical utility used in ROC analysis and improves the prediction of depression. In this study, the highest predictive ability was achieved by the model combining the GRS and the BMI under an interaction term. Particularly, BMI was identified as a trigger-like risk factor for depression acting in a concerted way with the GRS component. This is an interesting finding since it suggests the existence of a risk overlap between both diseases, and the need for individual depression genetics-risk evaluation in subjects with obesity. This research has therefore potential clinical implications and set the basis for future research directions in exploring the link between depression and obesity-associated disorders. While it is likely that future genome-wide studies with large samples will detect novel genetic variants associated with depression, it seems clear that a combination of genetics and non-genetic information (such is the case of obesity status and other depression comorbidities) will still be needed for the optimization prediction of depression in high-susceptibility individuals.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

3D collagen migration patterns reveal a SMAD3-dependent and TGF-ß1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma

  • Juste-Lanas, Y.
  • Díaz-Valdivia, N.
  • Llorente, A.
  • Ikemori, R.
  • Bernardo, A.
  • Arshakyan, M.
  • Borau, C.
  • Ramírez, J.
  • Ruffinelli, J. C.
  • Nadal, E.
  • Reguart, N.
  • García-Aznar, J. M.
  • Alcaraz, J.
Background: The TGF-β1 transcription factor SMAD3 is epigenetically repressed in tumour-associated fibroblasts (TAFs) from lung squamous cell carcinoma (SCC) but not adenocarcinoma (ADC) patients, which elicits a compensatory increase in SMAD2 that renders SCC-TAFs less fibrotic. Here we examined the effects of altered SMAD2/3 in fibroblast migration and its impact on the desmoplastic stroma formation in lung cancer. Methods: We used a microfluidic device to examine descriptors of early protrusions and subsequent migration in 3D collagen gels upon knocking down SMAD2 or SMAD3 by shRNA in control fibroblasts and TAFs. Results: High SMAD3 conditions as in shSMAD2 fibroblasts and ADC-TAFs exhibited a migratory advantage in terms of protrusions (fewer and longer) and migration (faster and more directional) selectively without TGF-β1 along with Erk1/2 hyperactivation. This enhanced migration was abrogated by TGF-β1 as well as low glucose medium and the MEK inhibitor Trametinib. In contrast, high SMAD2 fibroblasts were poorly responsive to TGF-β1, high glucose and Trametinib, exhibiting impaired migration in all conditions. Conclusions: The basal migration advantage of high SMAD3 fibroblasts provides a straightforward mechanism underlying the larger accumulation of TAFs previously reported in ADC compared to SCC. Moreover, our results encourage using MEK inhibitors in ADC-TAFs but not SCC-TAFs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain

  • Agúndez, J. A. G.
  • Abad-Santos, F.
  • Aldea, A.
  • Alonso-Navarro, H.
  • Bernal, M. L.
  • Borobia, A. M.
  • Borrás, E.
  • Carballo, M.
  • Carvajal, A.
  • García-Muñiz, J. D.
  • Gervasini,G.
  • Jiménez-Jiménez,F. J.
  • Lucena,M. I.
  • Martínez,C.
  • Sacristán,J. A.
  • Salado,I.
  • Sinués,B.
  • Vicente,J.
  • García-Martín,E.
The development of clinical practice recommendation sor guide lines forthe clinical use of biomarkersis an issue of great importance with regard to averse drug reactions. Thepoten-tial of pharmacogenomic biomarkers has been extensively investigate dinrecent years. However, several barriers to implementing the use of pharmacogenomics testing exist. We conducted asurvey among members of the Spanish Societies of Pharmacology and Clinical Pharmacology to obtain in format in about the perception of uch barrier sand to compare the perceptions of participants about the relative importance of ma jorgene/drug pairs. Of 11 potential barriers, the highest importance was attributed to lack of institutional support for pharmacogenomics testing, and to the issues related to the lackof guidelines. Of the proposed gene/drug pairs the highest importance was as signed to HLA-B/abacavir, UGT1A1/irinotecan, andCYP2D6/tamoxifen. In this perspective article, we compare there lative importanceof 29 gene /drug pairs in the Spanish study witht hat of the same pair sinthe American Society for Clinical Pharmacology and Therapeutics study, and we provide suggestions and area soffocus to developaguide for clinical practice in pharmacogenomics testing.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Length variation in the mouse mitochondrial tRNAArg DHU loop size promotes oxidative phosphorylation functional differences

  • Moreno-Loshuertos, Raquel
  • Pérez-Martos, Acisclo
  • Fernández-Silva, Patricio
  • Enríquez, José Antonio
The efficiency of the cellular oxidative phosphorylation system was recently shown to be modulated by common mitochondrial tRNA(A) (rg) haplotypes. The molecular mechanism by which some mt-Tr haplotypes induce these functional differences remains undetermined. Common polymorphisms in mouse mt-Tr genes affect the size of the dihydrouridine loop in the mature tRNA, producing loops of between five and seven nucleotides, the largest being a rare variant among mammals. Here, we analyzed a new mt-Tr variant identified in C3H mice, and found that it is mitochondrial tRNA loop size, but not the specific sequence, that is responsible for the observed differences in cellular respiration. We further found that the sensitivity of mitochondrial protein synthesis to specific inhibitors is dependent on the mt-Tr gene haplotype, and confirmed that the differences in oxidative phosphorylation performance are masked by a reactive oxygen species-induced compensatory increase in mitochondrial biogenesis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Use of a personalised depression intervention in primary care to prevent anxiety: a secondary study of a cluster randomised trial

  • Moreno-Peral, P
  • Conejo-Ceron, S
  • Luna, JD
  • King, M
  • Nazareth, I
  • Martin-Perez, C
  • Fernandez-Alonso, C
  • Ballesta-Rodriguez, MI
  • Fernandez, A
  • Aiarzaguena, JM
  • Monton-Franco, C
  • Bellon, JA
Background In the predictD-intervention. GPs used a personalised biopsychosocial programme to prevent depression. This reduced the incidence of major depression by 21.0%. although the results were not statistically significant. Aim To determine whether the predictD-intervention is effective at preventing anxiety in primary cam patients without depression or anxiety. Design and setting Secondary study of a cluster randomised trial with practices randomly assigned to either the predictD-intervention or usual care. This study was conducted in seven Spanish cities from October 2010 to July 2012. Method In each city, 10 practices and two GPs per practice, as well as four to six patients every recruiting day, were randomly selected until there were 26-27 eligible patients for each GP The endpoint was cumulative incidence of anxiety as measured by the PRIME-MD screening tool over 18 months. Results A total of 3326 patients without depression and 140 GPs from 70 practices consented and were eligible to participate; 328 of these patients were removed because they had an anxiety syndrome at baseline. Of the 2998 valid patients. 2597 (86.6%) were evaluated at the end of the study. At 18 months. lac.% (95% CI = 8.7% to 12.1%) of the patients in the predictD-intervention group developed anxiety compared with 13.1% (95% CI =11.4% to 14.8%) in the usual-care group (absolute difference = -2.7%195% CI = -5.1% to -0.3%1; P=0.029). Conclusion A personalised intervention delivered by the prevention of depression prrmded a ; but statistically significant reduction in the incidence of anxiety
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice

  • Mòdol-Caballero, G.
  • Herrando-Grabulosa, M.
  • García-Lareu, B.
  • Solanes, N.
  • Verdés, S.
  • Osta, R.
  • Francos-Quijorna, I.
  • López-Vales, R.
  • Calvo, A. C.
  • Bosch, A.
  • Navarro, X.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting motoneurons (MNs), with no effective treatment currently available. The molecular mechanisms that are involved in MN death are complex and not fully understood, with partial contributions of surrounding glial cells and skeletal muscle to the disease. Neuregulin 1 (NRG1) is a trophic factor highly expressed in MNs and neuromuscular junctions. Recent studies have suggested a crucial role of the isoform I (NRG1-I) in the collateral reinnervation process in skeletal muscle, and NRG1-III in the preservation of MNs in the spinal cord, opening a window for developing novel therapies for neuromuscular diseases like ALS. In this study, we overexpressed NRG1-I widely in the skeletal muscles of the SOD1G93A transgenic mouse. The results show that NRG1 gene therapy activated the survival pathways in muscle and spinal cord, increasing the number of surviving MNs and neuromuscular junctions and reducing the astroglial reactivity in the spinal cord of the treated SOD1G93A mice. Furthermore, NRG1-I overexpression preserved motor function and delayed the onset of clinical disease. In summary, our data indicates that NRG1 plays an important role on MN survival and muscle innervation in ALS, and that viral-mediated overexpression of NRG1 isoforms may be considered as a promising approach for ALS treatment.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

  • Arrospide, Arantzazu
  • Forné Izquierdo, Carles
  • Rué i Monné, Montserrat
  • Torà, Núria
  • Mar, Javier
  • Baré, Marisa
Background: The aim of this study was to evaluate the calibration and discriminatory power of three predictive models of breast cancer risk. Methods: We included 13,760 women who were first-time participants in the Sabadell-Cerdanyola Breast Cancer Screening Program, in Catalonia, Spain. Projections of risk were obtained at three and five years for invasive cancer using the Gail, Chen and Barlow models. Incidence and mortality data were obtained from the Catalan registries. The calibration and discrimination of the models were assessed using the Hosmer-Lemeshow C statistic, the area under the receiver operating characteristic curve (AUC) and the Harrell’s C statistic. Results: The Gail and Chen models showed good calibration while the Barlow model overestimated the number of cases: the ratio between estimated and observed values at 5 years ranged from 0.86 to 1.55 for the first two models and from 1.82 to 3.44 for the Barlow model. The 5-year projection for the Chen and Barlow models had the highest discrimination, with an AUC around 0.58. The Harrell’s C statistic showed very similar values in the 5-year projection for each of the models. Although they passed the calibration test, the Gail and Chen models overestimated the number of cases in some breast density categories. Conclusions: These models cannot be used as a measure of individual risk in early detection programs to customize screening strategies. The inclusion of longitudinal measures of breast density or other risk factors in joint models of survival and longitudinal data may be a step towards personalized early detection of BC., This study was funded by grant PS09/01340 and The Spanish Network on Chronic Diseases REDISSEC (RD12/0001/0007) from the Health Research Fund (Fondo de Investigación Sanitaria) of the Spanish Ministry of Health.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe

  • Cornago Protomártir, Marta
  • Garcia-Alberich, C.
  • Blasco Angulo, Natividad
  • Vall-llaura Espinosa, Núria
  • Nàger Grifo, Mireia
  • Herreros Danés, Judit
  • Comella i Carnicé, Joan Xavier
  • Sanchis, Daniel
  • Llovera i Tomàs, Marta
Glioblastoma multiforme is resistant to conventional anti-tumoral treatments due to its infiltrative nature and capability of relapse; therefore, research efforts focus on characterizing gliomagenesis and identifying molecular targets useful on therapy. New therapeutic strategies are being tested in patients, such as Histone deacetylase inhibitors (HDACi) either alone or in combination with other therapies. Here two HDACi included in clinical trials have been tested, suberanilohydroxamic acid (SAHA) and valproic acid (VPA), to characterize their effects on glioma cell growth in vitro and to determine the molecular changes that promote cancer cell death. We found that both HDACi reduce glioma cell viability, proliferation and clonogenicity. They have multiple effects, such as inducing the production of reactive oxygen species (ROS) and activating the mitochondrial apoptotic pathway, nevertheless cell death is not prevented by the pan-caspase inhibitor Q-VD-OPh. Importantly, we found that HDACi alter cell cycle progression by decreasing the expression of G2 checkpoint kinases Wee1 and checkpoint kinase 1 (Chk1). In addition, HDACi reduce the expression of proteins involved in DNA repair (Rad51), mitotic spindle formation (TPX2) and chromosome segregation (Survivin) in glioma cells and in human glioblastoma multiforme primary cultures. Therefore, HDACi treatment causes glioma cell entry into mitosis before DNA damage could be repaired and to the formation of an aberrant mitotic spindle that results in glioma cell death through mitotic catastrophe-induced apoptosis., This work was supported by the Spanish Ministry of Health grant ISCIII and the European Fund for Regional Development (FEDER) PS09/00140 to ML, ISCIII-PI080790 to JH and Programa de Suport a Grups de Recerca from the Government of Catalonia (AGAUR) (2009-SGR-346) to ML, DS and JXC.